,title,year,doi,pmid,is_trial
0,Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies,2020,https://doi.org/10.3389/fimmu.2020.01708,32754163,False
1,Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis,2022,https://doi.org/10.1056/nejmoa2109927,35081280,True
2,"COVID-19 infection and rheumatoid arthritis: Faraway, so close!",2020,https://doi.org/10.1016/j.autrev.2020.102523,32205186,False
3,Translating IL-6 biology into effective treatments,2020,https://doi.org/10.1038/s41584-020-0419-z,32327746,False
4,SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity,2021,https://doi.org/10.1136/annrheumdis-2021-220781,34285048,False
5,EULAR definition of difficult-to-treat rheumatoid arthritis,2020,https://doi.org/10.1136/annrheumdis-2020-217344,33004335,False
6,Management of Rheumatoid Arthritis: An Overview,2021,https://doi.org/10.3390/cells10112857,34831081,False
7,"Macrophages: The Good, the Bad, and the Gluttony",2021,https://doi.org/10.3389/fimmu.2021.708186,34456917,False
8,Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement,2020,https://doi.org/10.1136/annrheumdis-2020-218398,33158881,False
9,The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19,2020,https://doi.org/10.1016/j.jaut.2020.102468,32317220,False
10,Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach,2022,https://doi.org/10.1038/s41584-021-00726-8,34987201,False
11,&lt;p&gt;JAK Inhibitors in Rheumatoid Arthritis: An Evidence-Based Review on the Emerging Clinical Data&lt;/p&gt;,2020,https://doi.org/10.2147/jir.s219586,32982367,False
12,Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial,2021,https://doi.org/10.1136/annrheumdis-2020-219214,33504485,True
13,COVID‐19 pneumonia treated with Sarilumab: A clinical series of eight patients,2020,https://doi.org/10.1002/jmv.26062,32472703,False
14,JAK-Inhibitors for the Treatment of Rheumatoid Arthritis: A Focus on the Present and an Outlook on the Future,2020,https://doi.org/10.3390/biom10071002,32635659,False
15,Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: A population-based study in the first two months of COVID-19 outbreak in Italy,2020,https://doi.org/10.1016/j.jbspin.2020.05.003,32445935,False
16,<scp>SARS</scp>–<scp>CoV</scp>‐2 Infection and<scp>COVID</scp>‐19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta‐Analysis,2022,https://doi.org/10.1002/art.42030,34807517,False
17,EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update,2022,https://doi.org/10.1136/ard-2022-223356,36357155,False
18,Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?,2020,https://doi.org/10.3390/ijms21145171,32708322,False
19,The Pretreatment Gut Microbiome Is Associated With Lack of Response to Methotrexate in New‐Onset Rheumatoid Arthritis,2021,https://doi.org/10.1002/art.41622,33314800,False
20,Pharmacomicrobiomics in inflammatory arthritis: gut microbiome as modulator of therapeutic response,2020,https://doi.org/10.1038/s41584-020-0395-3,32157196,False
21,"EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome",2022,https://doi.org/10.1136/annrheumdis-2021-221733,35110331,False
22,"Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial",2021,https://doi.org/10.1136/annrheumdis-2020-219213,33452004,True
23,Osteoporosis in Rheumatoid Arthritis: Dangerous Liaisons,2020,https://doi.org/10.3389/fmed.2020.601618,33330566,False
24,EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis,2021,https://doi.org/10.1136/annrheumdis-2021-220973,34407926,False
25,"Only Hyperuricemia with Crystalluria, but not Asymptomatic Hyperuricemia, Drives Progression of Chronic Kidney Disease",2020,https://doi.org/10.1681/asn.2020040523,32938648,False
26,Novel insights into macrophage diversity in rheumatoid arthritis synovium,2021,https://doi.org/10.1016/j.autrev.2021.102758,33476818,False
27,Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries,2020,https://doi.org/10.1136/annrheumdis-2020-218697,33158877,False
28,Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases,2021,https://doi.org/10.1001/jama.2021.21316,34932077,True
29,Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease,2020,https://doi.org/10.1093/rheumatology/keaa860,33331946,False
30,"Recent trends, challenges and future outlook of transdermal drug delivery systems for rheumatoid arthritis therapy",2020,https://doi.org/10.1016/j.jconrel.2020.09.016,32920080,False
31,Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial,2022,https://doi.org/10.1038/s41591-022-01789-0,35589854,True
32,The Impact of Cigarette Smoking on Risk of Rheumatoid Arthritis: A Narrative Review,2020,https://doi.org/10.3390/cells9020475,32092988,False
33,The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions,2021,https://doi.org/10.3389/fphar.2021.680043,34122106,False
34,Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis,2021,https://doi.org/10.3389/fimmu.2021.686155,34305919,False
35,Transforming clinical trials in rheumatology: towards patient-centric precision medicine,2020,https://doi.org/10.1038/s41584-020-0491-4,32887976,False
36,"Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial",2020,https://doi.org/10.1136/bmj.m4328,33268527,True
37,Cardiovascular effects of approved drugs for rheumatoid arthritis,2021,https://doi.org/10.1038/s41584-021-00593-3,33833437,False
38,Rheumatoid arthritis,2020,https://doi.org/10.1186/s41232-020-00133-8,32944095,False
39,Cellular Signaling Pathways in Medium and Large Vessel Vasculitis,2020,https://doi.org/10.3389/fimmu.2020.587089,33072134,False
40,"Osteoporosis in patients with rheumatoid arthritis: an update in epidemiology, pathogenesis, and fracture prevention",2020,https://doi.org/10.1080/14656566.2020.1787381,32605401,False
41,Managing rheumatoid arthritis during COVID-19,2020,https://doi.org/10.1007/s10067-020-05358-z,32892311,False
42,"Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases",2021,https://doi.org/10.1016/s2665-9913(21)00175-2,34316727,False
43,The JAK–STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms,2021,https://doi.org/10.1093/eurheartj/ehab447,34343257,False
44,Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies,2021,https://doi.org/10.3390/cells10113017,34831240,False
45,The pre-clinical phase of rheumatoid arthritis: From risk factors to prevention of arthritis,2021,https://doi.org/10.1016/j.autrev.2021.102797,33746022,False
46,Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study,2022,https://doi.org/10.1136/rmdopen-2021-002012,35121639,True
47,Anti-Citrullinated Protein Antibodies in Patients with Rheumatoid Arthritis: Biological Effects and Mechanisms of Immunopathogenesis,2020,https://doi.org/10.3390/ijms21114015,32512739,False
48,From Rheumatoid Factor to Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies for Diagnosis and Prognosis Prediction in Patients with Rheumatoid Arthritis,2021,https://doi.org/10.3390/ijms22020686,33445768,False
49,The role of IL-6 and IL-6 blockade in COVID-19,2021,https://doi.org/10.1080/1744666x.2021.1919086,33874829,False
50,"Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland",2020,https://doi.org/10.1136/rmdopen-2020-001174,32385143,False
51,Comparative effectiveness of biological medicines in rheumatoid arthritis: systematic review and network meta-analysis including aggregate results from reanalysed individual patient data,2020,https://doi.org/10.1136/bmj.m2288,32636183,False
52,Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart?,2021,https://doi.org/10.1016/j.autrev.2021.102750,33482338,False
53,"Prevalence of patients with rheumatoid arthritis and age‐stratified trends in clinical characteristics and treatment, based on the National Database of Health Insurance Claims and Specific Health Checkups of Japan",2020,https://doi.org/10.1111/1756-185x.13974,33016574,False
54,Frailty in Rheumatic Diseases,2020,https://doi.org/10.3389/fimmu.2020.576134,33193369,False
55,Pharmacological and non-pharmacological therapeutic strategies in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis,2021,https://doi.org/10.1136/rmdopen-2020-001512,33419871,False
56,Systemic diseases and the cornea,2021,https://doi.org/10.1016/j.exer.2021.108455,33485845,False
57,EULAR recommendations for intra-articular therapies,2021,https://doi.org/10.1136/annrheumdis-2021-220266,34035002,False
58,Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients,2020,https://doi.org/10.3389/fimmu.2020.01439,32655577,False
59,Autoantibodies in Rheumatoid Arthritis – Laboratory and Clinical Perspectives,2021,https://doi.org/10.3389/fimmu.2021.685312,34054878,False
60,Topical nanocarriers for management of Rheumatoid Arthritis: A review,2021,https://doi.org/10.1016/j.biopha.2021.111880,34328101,False
61,DMARD-free remission as novel treatment target in rheumatoid arthritis: A systematic literature review of achievability and sustainability,2020,https://doi.org/10.1136/rmdopen-2020-001220,32393523,False
62,Genetic Polymorphisms Associated with Rheumatoid Arthritis Development and Antirheumatic Therapy Response,2020,https://doi.org/10.3390/ijms21144911,32664585,False
63,Selectivity of Janus Kinase Inhibitors in Rheumatoid Arthritis and Other Immune-Mediated Inflammatory Diseases: Is Expectation the Root of All Headache?,2020,https://doi.org/10.1007/s40265-020-01349-1,32681420,False
64,Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission,2021,https://doi.org/10.1002/art.41589,33205906,True
65,Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic,2020,https://doi.org/10.3389/fphar.2020.598308,33442386,False
66,A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic review,2021,https://doi.org/10.1007/s10067-021-05700-z,33751280,False
67,Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series,2021,https://doi.org/10.1016/j.ejim.2021.07.016,34391591,False
68,Baricitinib for relapsing giant cell arteritis: a prospective open-label 52-week pilot study,2022,https://doi.org/10.1136/annrheumdis-2021-221961,35190385,False
69,JAK Inhibitors and Modulation of B Cell Immune Responses in Rheumatoid Arthritis,2021,https://doi.org/10.3389/fmed.2020.607725,33614673,False
70,"Olokizumab, a monoclonal antibody against interleukin 6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by methotrexate: efficacy and safety results of a randomised controlled phase III study",2021,https://doi.org/10.1136/annrheumdis-2021-219876,34344706,True
71,Critical Role of Synovial Tissue–Resident Macrophage and Fibroblast Subsets in the Persistence of Joint Inflammation,2021,https://doi.org/10.3389/fimmu.2021.715894,34539648,False
72,A review of upadacitinib in rheumatoid arthritis,2020,https://doi.org/10.1080/14397595.2020.1782049,32530345,False
73,Clinical characteristics of 17 patients with COVID-19 and systemic autoimmune diseases: a retrospective study,2020,https://doi.org/10.1136/annrheumdis-2020-217425,32546598,False
74,"Synovial tissue macrophages in joint homeostasis, rheumatoid arthritis and disease remission",2022,https://doi.org/10.1038/s41584-022-00790-8,35672464,False
75,In-depth bibliometric analysis and current scientific mapping research in the context of rheumatoid arthritis pharmacotherapy,2022,https://doi.org/10.1016/j.biopha.2022.113614,36058148,False
76,Revisiting the use of remission criteria for rheumatoid arthritis by excluding patient global assessment: an individual meta-analysis of 5792 patients,2020,https://doi.org/10.1136/annrheumdis-2020-217171,33023964,False
77,Upadacitinib in Rheumatoid Arthritis: A Benefit–Risk Assessment Across a Phase III Program,2021,https://doi.org/10.1007/s40264-020-01036-w,33527177,False
78,Characteristics of patients with difficult-to-treat rheumatoid arthritis in clinical practice,2021,https://doi.org/10.1093/rheumatology/keab209,33682890,False
79,Thromboembolic Adverse Drug Reactions in Janus Kinase (JAK) Inhibitors: Does the Inhibitor Specificity Play a Role?,2021,https://doi.org/10.3390/ijms22052449,33671049,False
80,Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations,2021,https://doi.org/10.1038/s41409-021-01326-6,34031556,False
81,The effect of exercise on cytokines: implications for musculoskeletal health: a narrative review,2022,https://doi.org/10.1186/s13102-022-00397-2,34991697,False
82,Response to: ‘Comment on: ‘EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update’ by Gossec<i>et al</i>’ by Wei<i>et al</i>,2020,https://doi.org/10.1136/annrheumdis-2020-218456,32873555,False
83,Efficacy of Oral Vitamin Supplementation in Inflammatory Rheumatic Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials,2020,https://doi.org/10.3390/nu13010107,33396851,False
84,Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs,2021,https://doi.org/10.3899/jrheum.201183,33526618,True
85,Use of telemedicine during the COVID-19 pandemic in patients with inflammatory arthritis: a retrospective study on feasibility and impact on patient-reported outcomes in a real-life setting,2021,https://doi.org/10.1007/s00296-021-04863-x,33944986,False
86,Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis,2021,https://doi.org/10.1136/annrheumdis-2021-220577,34215644,False
87,Greetings from the editor,2020,https://doi.org/10.1136/annrheumdis-2020-217811,,False
88,Methotrexate-related toxicity in patients with rheumatoid arthritis and renal dysfunction,2020,https://doi.org/10.1007/s00296-020-04547-y,32170389,False
89,Biotherapies in Uveitis,2020,https://doi.org/10.3390/jcm9113599,33171664,False
90,Clinical predictors of multiple failure to biological therapy in patients with rheumatoid arthritis,2020,https://doi.org/10.1186/s13075-020-02354-1,33298140,False
91,Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge,2022,https://doi.org/10.1177/1759720x211073001,35186126,False
92,"Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial",2022,https://doi.org/10.1136/annrheumdis-2021-221957,35641125,True
93,Insights into the treatment of rheumatoid arthritis: A paradigm in medicine,2020,https://doi.org/10.1016/j.jaut.2020.102425,32143989,False
94,Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal Trial,2020,https://doi.org/10.1007/s40744-020-00199-3,32185745,False
95,Tapering towards DMARD-free remission in established rheumatoid arthritis: 2-year results of the TARA trial,2020,https://doi.org/10.1136/annrheumdis-2020-217485,32482645,True
96,Modern treatment approach results in low disease activity in 90% of pregnant rheumatoid arthritis patients: the PreCARA study,2021,https://doi.org/10.1136/annrheumdis-2020-219547,33568387,False
97,"Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial",2022,https://doi.org/10.1016/s0140-6736(22)01193-x,35871815,True
98,Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis,2021,https://doi.org/10.1007/s00198-021-05871-0,33559714,False
99,Modeling Rheumatoid Arthritis In Vitro: From Experimental Feasibility to Physiological Proximity,2020,https://doi.org/10.3390/ijms21217916,33113770,False
100,The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative Review,2021,https://doi.org/10.3390/jcm10030509,33535498,False
101,"Biomedical applications of polysaccharide nanoparticles for chronic inflammatory disorders: Focus on rheumatoid arthritis, diabetes and organ fibrosis",2022,https://doi.org/10.1016/j.carbpol.2021.118923,35074100,False
102,Inflammation and Bone Metabolism in Rheumatoid Arthritis: Molecular Mechanisms of Joint Destruction and Pharmacological Treatments,2022,https://doi.org/10.3390/ijms23052871,35270012,False
103,"Drug-resistance in rheumatoid arthritis: the role of p53 gene mutations, ABC family transporters and personal factors",2020,https://doi.org/10.1016/j.coph.2020.08.002,32942096,False
104,Changing Patterns of Medical Visits and Factors Associated with No-show in Patients with Rheumatoid Arthritis during COVID-19 Pandemic,2020,https://doi.org/10.3346/jkms.2020.35.e423,33316859,False
105,Effect of hydroxychloroquine pre-exposure on infection with SARS-CoV-2 in rheumatic disease patients: a population-based cohort study,2021,https://doi.org/10.1016/j.cmi.2020.12.003,33316402,False
106,"Treatment Satisfaction, Patient Preferences, and the Impact of Suboptimal Disease Control in a Large International Rheumatoid Arthritis Cohort: SENSE Study",2021,https://doi.org/10.2147/ppa.s289692,33633444,False
107,Therapeutic potential of the FPR2/ALX agonist AT-01-KG in the resolution of articular inflammation,2021,https://doi.org/10.1016/j.phrs.2021.105445,33493655,False
108,Managing Osteoporosis and Joint Damage in Patients with Rheumatoid Arthritis: An Overview,2021,https://doi.org/10.3390/jcm10061241,33802804,False
109,The Risk of Infections Associated With JAK Inhibitors in Rheumatoid Arthritis,2021,https://doi.org/10.1097/rhu.0000000000001749,33902098,False
110,Mesenchymal stem/stromal cell-based therapy for the treatment of rheumatoid arthritis: An update on preclinical studies,2021,https://doi.org/10.1016/j.ebiom.2021.103427,34161884,False
111,"TREAT Early Arthralgia to Reverse or Limit Impending Exacerbation to Rheumatoid arthritis (TREAT EARLIER): a randomized, double-blind, placebo-controlled clinical trial protocol",2020,https://doi.org/10.1186/s13063-020-04731-2,33076964,False
112,The switch from etanercept originator to SB4: data from a real-life experience on tolerability and persistence on treatment in joint inflammatory diseases,2020,https://doi.org/10.1177/1759720x20964031,33133246,False
113,Dose Tapering of Biologics in Patients with Psoriasis: A Scoping Review,2021,https://doi.org/10.1007/s40265-020-01448-z,33453052,False
114,"Phytochemical add-on therapy to DMARDs therapy in rheumatoid arthritis: In vitro and in vivo bases, clinical evidence and future trends",2021,https://doi.org/10.1016/j.phrs.2021.105618,33878447,False
115,The PICASO cloud platform for improved holistic care in rheumatoid arthritis treatment—experiences of patients and clinicians,2021,https://doi.org/10.1186/s13075-021-02526-7,34044850,False
116,Drug treatment algorithm and recommendations from the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis—secondary publication,2022,https://doi.org/10.1093/mr/roac017,35297492,False
117,Effectiveness and safety of treat-to-target strategy in elderly-onset rheumatoid arthritis: a 3-year prospective observational study,2021,https://doi.org/10.1093/rheumatology/keaa922,33410490,False
118,Influence of Age and Sex on Disease Course and Treatment in Rheumatoid Arthritis,2021,https://doi.org/10.2147/oarrr.s306378,34079395,False
119,Body composition in patients with rheumatoid arthritis: a narrative literature review,2021,https://doi.org/10.1177/1759720x211015006,34221129,False
120,Telemedicine in rheumatology: high specificity and sensitivity of follow-up virtual video consultations during COVID-19 pandemic,2021,https://doi.org/10.1093/rheumatology/keab632,34352098,False
121,Mesenchymal Stem Cell-Based Therapy for Rheumatoid Arthritis,2021,https://doi.org/10.3390/ijms222111592,34769021,False
122,"Efficacy and safety of subcutaneous infliximab versus adalimumab, etanercept and intravenous infliximab in patients with rheumatoid arthritis: a systematic literature review and meta-analysis",2020,https://doi.org/10.1080/1744666x.2020.1858803,33305638,False
123,Prevalence of Sarcopenia and its Association with Antirheumatic Drugs in Middle-Aged and Older Adults with Rheumatoid Arthritis: A Systematic Review and Meta-analysis,2021,https://doi.org/10.1007/s00223-021-00873-w,34132852,False
124,Treatment of rheumatoid arthritis by phototherapy: advances and perspectives,2021,https://doi.org/10.1039/d1nr03623h,34473167,False
125,Reactivation of hepatitis B virus infection in patients with rheumatoid arthritis receiving tofacitinib,2021,https://doi.org/10.1111/1756-185x.14217,34506078,False
126,Treating Autoimmune Inflammatory Diseases with an siERN1-Nanoprodrug That Mediates Macrophage Polarization and Blocks Toll-like Receptor Signaling,2021,https://doi.org/10.1021/acsnano.1c03726,34586802,False
127,Pharmacomicrobiology of Methotrexate in Rheumatoid Arthritis: Gut Microbiome as Predictor of Therapeutic Response,2021,https://doi.org/10.3389/fimmu.2021.789334,34975886,False
128,"Current Status, Issues and Future Prospects of Personalized Medicine for Each Disease",2022,https://doi.org/10.3390/jpm12030444,35330444,False
129,Systemic inflammation response index (SIRI) as a novel biomarker in patients with rheumatoid arthritis: a multi-center retrospective study,2022,https://doi.org/10.1007/s10067-022-06122-1,35266094,False
130,Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis,2022,https://doi.org/10.1136/ard-2022-223357,36376026,False
131,Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study,2020,https://doi.org/10.3390/jcm9041227,32344563,False
132,Rheumatoid arthritis Primer — behind the scenes,2020,https://doi.org/10.1038/s41572-020-0168-y,32327647,False
133,"Long-term safety, immunogenicity and efficacy comparing FKB327 with the adalimumab reference product in patients with active rheumatoid arthritis: data from randomised double-blind and open-label extension studies",2020,https://doi.org/10.1136/rmdopen-2019-000987,32371430,True
134,Selection and perception of methotrexate treatment information in people with rheumatoid arthritis,2020,https://doi.org/10.1111/1756-185x.13833,32537893,False
135,Effect of methotrexate use on the development of type 2 diabetes in rheumatoid arthritis patients: A systematic review and meta-analysis,2020,https://doi.org/10.1371/journal.pone.0235637,33296441,False
136,Wearable Activity Trackers in the Management of Rheumatic Diseases: Where Are We in 2020?,2020,https://doi.org/10.3390/s20174797,32854412,False
137,Factors associated with treatment satisfaction in patients with rheumatoid arthritis: data from the biological register RABBIT,2020,https://doi.org/10.1136/rmdopen-2020-001290,33051270,False
138,Current treatment options and safety considerations when treating adult-onset Still’s disease,2020,https://doi.org/10.1080/14740338.2020.1839411,33078630,False
139,Healthcare utilization and economic burden of difficult-to-treat rheumatoid arthritis: a cost-of-illness study,2021,https://doi.org/10.1093/rheumatology/keab078,33502493,False
140,Cognitive Decline in Rheumatoid Arthritis: Insight into the Molecular Pathogenetic Mechanisms,2021,https://doi.org/10.3390/ijms22031185,33530359,False
141,Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial,2021,https://doi.org/10.1136/annrheumdis-2020-219825,33811036,False
142,Liposomal Nanosystems in Rheumatoid Arthritis,2021,https://doi.org/10.3390/pharmaceutics13040454,33801603,False
143,A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational Study,2021,https://doi.org/10.1007/s40744-021-00330-y,34148193,False
144,Biomimetic and Bioinspired Intervention Strategies for the Treatment of Rheumatoid Arthritis,2021,https://doi.org/10.1002/adfm.202104640,,False
145,The ideal mHealth-application for rheumatoid arthritis: qualitative findings from stakeholder focus groups,2021,https://doi.org/10.1186/s12891-021-04624-8,34461875,False
146,Efficacy and Safety of Metformin Use in Rheumatoid Arthritis: A Randomized Controlled Study,2021,https://doi.org/10.3389/fphar.2021.726490,34630103,False
147,DMARDs–Gut Microbiota Feedback: Implications in the Response to Therapy,2020,https://doi.org/10.3390/biom10111479,33114390,False
148,Identification of Metabolic Biomarkers in Relation to Methotrexate Response in Early Rheumatoid Arthritis,2020,https://doi.org/10.3390/jpm10040271,33321888,False
149,Efficacy of Spice Supplementation in Rheumatoid Arthritis: A Systematic Literature Review,2020,https://doi.org/10.3390/nu12123800,33322318,False
150,Complex Machine-Learning Algorithms and Multivariable Logistic Regression on Par in the Prediction of Insufficient Clinical Response to Methotrexate in Rheumatoid Arthritis,2021,https://doi.org/10.3390/jpm11010044,33466633,False
151,Current insights and future prospects for the pathogenesis and treatment for rheumatoid arthritis,2021,https://doi.org/10.1016/j.clim.2021.108680,33493672,False
152,Value of MRI and ultrasound for prediction of therapeutic response and erosive progression in patients with early rheumatoid arthritis managed by an aggressive treat-to-target strategy,2021,https://doi.org/10.1136/rmdopen-2020-001525,33547228,False
153,Upadacitinib improves patient-reported outcomes <i>vs</i> placebo or adalimumab in patients with rheumatoid arthritis: results from SELECT-COMPARE,2021,https://doi.org/10.1093/rheumatology/keab158,33590829,True
154,Real-world comparative effectiveness and safety of tofacitinib and baricitinib in patients with rheumatoid arthritis,2021,https://doi.org/10.1186/s13075-021-02582-z,34301311,False
155,Inclusion of Synovial Tissue–Derived Characteristics in a Nomogram for the Prediction of Treatment Response in Treatment‐Naive Rheumatoid Arthritis Patients,2021,https://doi.org/10.1002/art.41726,33750008,False
156,Comparative efficacy and safety of Janus kinase inhibitors and biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and network meta-analysis,2021,https://doi.org/10.1177/1759720x21999564,33815570,False
157,Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis,2021,https://doi.org/10.1155/2021/6652845,33976699,False
158,Machine learning model for identifying important clinical features for predicting remission in patients with rheumatoid arthritis treated with biologics,2021,https://doi.org/10.1186/s13075-021-02567-y,34229736,False
159,Disease-modifying anti-asthmatic drugs,2022,https://doi.org/10.1016/s0140-6736(22)00331-2,35461560,False
160,Anti-rheumatoid drugs advancements: New insights into the molecular treatment of rheumatoid arthritis,2022,https://doi.org/10.1016/j.biopha.2022.113126,35643074,False
161,Olokizumab versus Placebo or Adalimumab in Rheumatoid Arthritis,2022,https://doi.org/10.1056/nejmoa2201302,36001712,True
162,"Incidence, predictive factors and severity of methotrexate-related liver injury in rheumatoid arthritis: a longitudinal cohort study",2020,https://doi.org/10.1093/rap/rkaa020,33134809,False
163,The advances of methotrexate resistance in rheumatoid arthritis,2020,https://doi.org/10.1007/s10787-020-00741-3,32757110,False
164,Insights on the Evidence of Cardiotoxicity of Hydroxychloroquine Prior and During COVID‐19 Epidemic,2020,https://doi.org/10.1111/cts.12883,32964653,False
165,State of the art: approved and emerging JAK inhibitors for rheumatoid arthritis,2020,https://doi.org/10.1080/14656566.2020.1822325,32967471,False
166,Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics,2020,https://doi.org/10.3390/biom10121672,33327600,False
167,Patients and clinicians define symptom levels and meaningful change for PROMIS pain interference and fatigue in RA using bookmarking,2021,https://doi.org/10.1093/rheumatology/keab014,33471127,False
168,Hydroxychloroquine in systemic and autoimmune diseases: Where are we now?,2021,https://doi.org/10.1016/j.jbspin.2021.105143,33515791,False
169,A Machine Learning Approach for Predicting Sustained Remission in Rheumatoid Arthritis Patients on Biologic Agents,2021,https://doi.org/10.1097/rhu.0000000000001720,34542990,False
170,"Filgotinib, a novel JAK1-preferential inhibitor for the treatment of rheumatoid arthritis: An overview from clinical trials",2021,https://doi.org/10.1080/14397595.2021.1902617,33740386,False
171,Prevalence and predictive factors of difficult-to-treat rheumatoid arthritis: the KURAMA cohort,2021,https://doi.org/10.1080/25785826.2021.1928383,34033729,False
172,"Cascade of Inflammatory, Fibrotic Processes, and Stress-Induced Senescence in Chronic GVHD-Related Dry Eye Disease",2021,https://doi.org/10.3390/ijms22116114,34204098,False
173,High patient global assessment scores in patients with rheumatoid arthritis otherwise in remission do not reflect subclinical inflammation,2021,https://doi.org/10.1016/j.jbspin.2021.105242,34166795,False
174,Rheumatoid arthritis treatment using hydroxychloroquine and methotrexate co-loaded nanomicelles: In vivo results,2021,https://doi.org/10.1016/j.colsurfb.2021.111952,34273810,False
175,Blocking endogenous IL-6 impairs mobilization of free fatty acids during rest and exercise in lean and obese men,2021,https://doi.org/10.1016/j.xcrm.2021.100396,34622233,True
176,Positioning Filgotinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis,2021,https://doi.org/10.1093/ecco-jcc/jjab206,34791103,False
177,CTLA4-Ig treatment induces M1–M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patients,2021,https://doi.org/10.1186/s13075-021-02691-9,34952630,False
178,CaP-based anti-inflammatory HIF-1α siRNA-encapsulating nanoparticle for rheumatoid arthritis therapy,2022,https://doi.org/10.1016/j.jconrel.2022.01.029,35085700,False
179,A broad look into the future of rheumatoid arthritis,2022,https://doi.org/10.1177/1759720x221076211,35154419,False
180,Cellular deconstruction of inflamed synovium defines diverse inflammatory phenotypes in rheumatoid arthritis,2022,https://doi.org/10.1101/2022.02.25.481990,,False
181,Treatment of early rheumatoid arthritis: Methotrexate and beyond,2022,https://doi.org/10.1016/j.coph.2022.102227,35453032,False
182,"Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis",2022,https://doi.org/10.1136/ard-2022-223358,36410794,False
183,Cost-effectiveness analysis of treatment sequences containing tofacitinib for the treatment of rheumatoid arthritis in Spain,2020,https://doi.org/10.1007/s10067-020-05087-3,32303858,False
184,Tofacitinib and Baricitinib Are Taken up by Different Uptake Mechanisms Determining the Efficacy of Both Drugs in RA,2020,https://doi.org/10.3390/ijms21186632,32927842,False
185,Recommendations for the management of patients with systemic rheumatic diseases during the coronavirus disease pandemic,2020,https://doi.org/10.3904/kjim.2020.417,32972125,False
186,Validation of galectin-1 as potential diagnostic biomarker of early rheumatoid arthritis,2020,https://doi.org/10.1038/s41598-020-74185-8,33082382,False
187,Activity Prediction of Small Molecule Inhibitors for Antirheumatoid Arthritis Targets Based on Artificial Intelligence,2020,https://doi.org/10.1021/acscombsci.0c00169,33146518,False
188,Identifying Compound Effect of Drugs on Rheumatoid Arthritis Treatment Based on the Association Rule and a Random Walking-Based Model,2020,https://doi.org/10.1155/2020/4031015,33204694,False
189,Switching between Janus kinase inhibitor upadacitinib and adalimumab following insufficient response: efficacy and safety in patients with rheumatoid arthritis,2020,https://doi.org/10.1136/annrheumdis-2020-218412,33148701,True
190,&lt;p&gt;Emerging Role of Fractalkine in the Treatment of Rheumatic Diseases&lt;/p&gt;,2020,https://doi.org/10.2147/itt.s277991,33178636,False
191,Changes in the pharmacological management of rheumatoid arthritis over two decades,2021,https://doi.org/10.1093/rheumatology/keaa892,33404652,False
192,"Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment",2021,https://doi.org/10.3390/cells10020323,33557301,False
193,Serum levels of the soluble urokinase plasminogen activator receptor (suPAR) correlates with disease activity in early rheumatoid arthritis and reflects joint damage over time,2021,https://doi.org/10.1016/j.trsl.2021.02.007,33582243,False
194,Clinical evidence of an interferon–glucocorticoid therapeutic synergy in COVID-19,2021,https://doi.org/10.1038/s41392-021-00496-5,33658482,False
195,Change in dietary inflammatory index score is associated with control of long-term rheumatoid arthritis disease activity in a Japanese cohort: the TOMORROW study,2021,https://doi.org/10.1186/s13075-021-02478-y,33832530,False
196,Bioflavonoid Robinin from Astragalus falcatus Lam. Mildly Improves the Effect of Metothrexate in Rats with Adjuvant Arthritis,2021,https://doi.org/10.3390/nu13041268,33924354,False
197,Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape Analysis,2021,https://doi.org/10.3389/fphar.2021.644187,33953678,False
198,Comparative efficacy of subcutaneous (CT-P13) and intravenous infliximab in adult patients with rheumatoid arthritis: a network meta-regression of individual patient data from two randomised trials,2021,https://doi.org/10.1186/s13075-021-02487-x,33863352,True
199,Shield and sword nano-soldiers ameliorate rheumatoid arthritis by multi-stage manipulation of neutrophils,2021,https://doi.org/10.1016/j.jconrel.2021.05.008,33965503,False
200,Short-term glucocorticoids reduce risk of chronic NSAID and analgesic use in early methotrexate-treated rheumatoid arthritis patients with favourable prognosis: subanalysis of the CareRA randomised controlled trial,2021,https://doi.org/10.1136/rmdopen-2021-001615,34031262,True
201,Identification and prediction of difficult-to-treat rheumatoid arthritis patients in structured and unstructured routine care data: results from a hackathon,2021,https://doi.org/10.1186/s13075-021-02560-5,34238346,False
202,Switching between reference adalimumab and biosimilars in chronic immune‐mediated inflammatory diseases: A systematic literature review,2021,https://doi.org/10.1111/bcp.15101,34622969,False
203,"Recent progress in treatments of rheumatoid arthritis: an overview of developments in biologics and small molecules, and remaining unmet needs",2021,https://doi.org/10.1093/rheumatology/keab609,34951925,False
204,Lipidome profile predictive of disease evolution and activity in rheumatoid arthritis,2022,https://doi.org/10.1038/s12276-022-00725-z,35169224,False
205,Perspectives of JAK Inhibitors for Large Vessel Vasculitis,2022,https://doi.org/10.3389/fimmu.2022.881705,35432355,False
206,Focus on Sex and Gender: What We Need to Know in the Management of Rheumatoid Arthritis,2022,https://doi.org/10.3390/jpm12030499,35330498,False
207,The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era,2022,https://doi.org/10.1007/s00296-022-05136-x,35503130,False
208,Rheumatoid arthritis: advances in treatment strategies,2022,https://doi.org/10.1007/s11010-022-04492-3,35725992,False
209,Ozoralizumab: First Approval,2022,https://doi.org/10.1007/s40265-022-01821-0,36509938,False
210,Patient global assessment to define remission in rheumatoid arthritis:quo vadis?,2020,https://doi.org/10.1136/annrheumdis-2020-218802,33158884,False
211,OUP accepted manuscript,2021,https://doi.org/10.1093/rheumatology/keaa834,33432358,False
212,"Drug retention of sarilumab, baricitinib, and tofacitinib in patients with rheumatoid arthritis: the ANSWER cohort study",2021,https://doi.org/10.1007/s10067-021-05609-7,33515115,False
213,Diagnostic issues in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis,2021,https://doi.org/10.1136/rmdopen-2020-001511,33514671,False
214,The role of extracellular vesicles in rheumatoid arthritis: a systematic review,2021,https://doi.org/10.1007/s10067-021-05614-w,33544235,False
215,Does exercise therapy improve patient-reported outcomes in rheumatoid arthritis? A systematic review and meta-analysis for the update of the 2020 JCR guidelines for the management of rheumatoid arthritis,2021,https://doi.org/10.1080/14397595.2021.1886653,33565350,False
216,Mini-Review: The Administration of Apoptotic Cells for Treating Rheumatoid Arthritis: Current Knowledge and Clinical Perspectives,2021,https://doi.org/10.3389/fimmu.2021.630170,33717160,False
217,Patients with rheumatoid arthritis have impaired long-term outcomes after myocardial infarction: a nationwide case-control registry study,2021,https://doi.org/10.1093/rheumatology/keab204,33667301,False
218,"Rheumatoid cachexia: the underappreciated role of myoblast, macrophage and fibroblast interplay in the skeletal muscle niche",2021,https://doi.org/10.1186/s12929-021-00714-w,33658022,False
219,Abatacept in monotherapy <i>vs</i> combined in interstitial lung disease of rheumatoid arthritis—multicentre study of 263 Caucasian patients,2021,https://doi.org/10.1093/rheumatology/keab317,33779697,False
220,Predictors of drug survival for biologic and targeted synthetic DMARDs in rheumatoid arthritis: Analysis from the TRA Clinical Electronic Registry,2021,https://doi.org/10.1371/journal.pone.0250877,33930048,False
221,Treatment journey in rheumatoid arthritis with biosimilars: from better access to good disease control through cost savings and prevention of nocebo effects,2021,https://doi.org/10.1136/rmdopen-2021-001637,34099538,False
222,Influence of glucocorticoid treatment on trabecular bone score and bone remodeling regulators in early rheumatoid arthritis,2021,https://doi.org/10.1186/s13075-021-02562-3,34229744,False
223,Prophylaxis against pneumocystis pneumonia in rheumatoid arthritis patients treated with b/tsDMARDs: insights from 3787 cases in the FIRST registry,2021,https://doi.org/10.1093/rheumatology/keab647,34382090,False
224,Multi-omics approach to precision medicine for immune-mediated diseases,2021,https://doi.org/10.1186/s41232-021-00173-8,34332645,False
225,Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis,2021,https://doi.org/10.1186/s13075-021-02651-3,34782022,False
226,Torque Teno Virus quantification for monitoring of immunomodulation with biologic compounds in the treatment of rheumatoid arthritis,2021,https://doi.org/10.1093/rheumatology/keab839,34792562,True
227,Evaluation of Ruthenium-Based Assemblies as Carriers of Photosensitizers to Treat Rheumatoid Arthritis by Photodynamic Therapy,2021,https://doi.org/10.3390/pharmaceutics13122104,34959385,False
228,Glycerophospholipid metabolism is involved in rheumatoid arthritis pathogenesis by regulating the IL-6/JAK signaling pathway,2022,https://doi.org/10.1016/j.bbrc.2022.02.003,35219101,False
229,Challenges in the management of older patients with inflammatory rheumatic diseases,2022,https://doi.org/10.1038/s41584-022-00768-6,35314796,False
230,APLAR recommendations on the practice of telemedicine in rheumatology,2022,https://doi.org/10.1111/1756-185x.14286,35043576,False
231,JAK inhibitors in difficult-to-treat adult-onset Still’s disease and systemic-onset juvenile idiopathic arthritis,2022,https://doi.org/10.1093/rheumatology/keac440,35920788,False
232,2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases,2022,https://doi.org/10.1136/ard-2022-223335,36328476,False
233,Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis,2022,https://doi.org/10.1136/ard-2022-223365,36368906,False
234,Therapeutic Options and Cost-Effectiveness for Rheumatoid Arthritis Treatment,2020,https://doi.org/10.1007/s11926-020-00921-8,32591916,False
235,Does periodontitis affect the treatment response of biologics in the treatment of rheumatoid arthritis?,2020,https://doi.org/10.1186/s13075-020-02269-x,32711580,False
236,Systematic review of recommendations on the use of methotrexate in rheumatoid arthritis,2020,https://doi.org/10.1007/s10067-020-05363-2,32876784,False
237,Therapeutic Cytokine Inhibition Modulates Activation and Homing Receptors of Peripheral Memory B Cell Subsets in Rheumatoid Arthritis Patients,2020,https://doi.org/10.3389/fimmu.2020.572475,33042152,False
238,Validation of a Prognostic Multivariable Prediction Model for Insufficient Clinical Response to Methotrexate in Early Rheumatoid Arthritis and Its Clinical Application in Evidencio,2020,https://doi.org/10.1007/s40744-020-00230-7,32926395,False
239,The prospects for targeting FcR as a novel therapeutic strategy in rheumatoid arthritis,2021,https://doi.org/10.1016/j.bcp.2020.114360,33301760,False
240,The Story Behind the Use of Glucocorticoids in the Treatment of Rheumatoid Arthritis,2021,https://doi.org/10.1016/j.semarthrit.2020.09.016,33360225,False
241,Glucocorticoid and opioid use in rheumatoid arthritis management,2021,https://doi.org/10.1097/bor.0000000000000788,33625045,False
242,Systematic Review of Outcomes and Patient Experience With Virtual Care in Rheumatoid Arthritis,2022,https://doi.org/10.1002/acr.24586,33650316,False
243,Role of Janus Kinase inhibitors in rheumatoid arthritis treatment,2021,https://doi.org/10.1097/bor.0000000000000792,33769360,False
244,Prediction of disease flare by biomarkers after discontinuing biologics in patients with rheumatoid arthritis achieving stringent remission,2021,https://doi.org/10.1038/s41598-021-86335-7,33767314,False
245,Doppler ultrasound predicts successful discontinuation of biological DMARDs in rheumatoid arthritis patients in clinical remission,2021,https://doi.org/10.1093/rheumatology/keab276,33748831,False
246,Cycling of tumor necrosis factor inhibitors <i>versus</i> switching to different mechanism of action therapy in rheumatoid arthritis patients with inadequate response to tumor necrosis factor inhibitors: a Bayesian network meta-analysis,2021,https://doi.org/10.1177/1759720x211002682,33854570,False
247,Comparison of the drug retention and reasons for discontinuation of tumor necrosis factor inhibitors and interleukin-6 inhibitors in Japanese patients with elderly-onset rheumatoid arthritis—the ANSWER cohort study,2021,https://doi.org/10.1186/s13075-021-02496-w,33858490,False
248,Effect of nurse-led care on outcomes in patients with ACPA/RF-positive rheumatoid arthritis with active disease undergoing treat-to-target: a multicentre randomised controlled trial,2021,https://doi.org/10.1136/rmdopen-2021-001627,33863842,True
249,MicroRNA Expression Differences in Blood-Derived CD19+ B Cells of Methotrexate Treated Rheumatoid Arthritis Patients,2021,https://doi.org/10.3389/fimmu.2021.663736,33897713,False
250,COVID‐19 in DMARD‐treated patients with inflammatory rheumatic diseases: Insights from an analysis of the World Health Organization pharmacovigilance database,2021,https://doi.org/10.1111/fcp.12695,33973280,False
251,Patient Preference for Treatment Mode of Biologics in Rheumatoid Arthritis: A 2020 Web-based Survey in Japan,2021,https://doi.org/10.1007/s40744-021-00325-9,34089509,False
252,"Association between serum bone biomarker levels and therapeutic response to abatacept in patients with rheumatoid arthritis (RA): a multicenter, prospective, and observational RA ultrasound cohort study in Japan",2021,https://doi.org/10.1186/s12891-021-04392-5,34074293,False
253,Double-blinded randomized controlled trial to reveal the effects of Brazilian propolis intake on rheumatoid arthritis disease activity index; BeeDAI,2021,https://doi.org/10.1371/journal.pone.0252357,34043719,True
254,Association between inflammatory cytokines and immune–checkpoint molecule in rheumatoid arthritis,2021,https://doi.org/10.1371/journal.pone.0260254,34793561,False
255,Changes in the use patterns of bDMARDs in patients with rheumatic diseases over the past 13 years,2021,https://doi.org/10.1038/s41598-021-94504-x,34302036,False
256,Has the incidence of total joint arthroplasty in rheumatoid arthritis decreased in the era of biologics use? A population-based cohort study,2021,https://doi.org/10.1093/rheumatology/keab643,34373899,False
257,Biological Therapies for Rheumatoid Arthritis: An Overview for the Clinician,2021,https://doi.org/10.2147/btt.s252575,34413630,False
258,Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo or Adalimumab: Results from SELECT-PsA 1,2021,https://doi.org/10.1007/s40744-021-00379-9,34636026,False
259,Risk of Cardiovascular and Venous Thromboembolic Events Associated With Janus Kinase Inhibitors in Rheumatoid Arthritis,2021,https://doi.org/10.1097/rhu.0000000000001804,34741000,False
260,Treatment strategies for elderly-onset rheumatoid arthritis in the new era,2021,https://doi.org/10.1093/mr/roab087,34791359,False
261,Undifferentiated arthritis: a changing population who did not benefit from enhanced disease-modifying anti-rheumatic drug strategies—results from a 25 year longitudinal inception cohort,2021,https://doi.org/10.1093/rheumatology/keab880,34850952,True
262,Off‐Label Use of Hydroxychloroquine in COVID‐19: Analysis of Reports of Suspected Adverse Reactions From the Italian National Network of Pharmacovigilance,2022,https://doi.org/10.1002/jcph.2006,34802170,False
263,Toward Individualized Prediction of Response to Methotrexate in Early Rheumatoid Arthritis: A <scp>Pharmacogenomics‐Driven</scp> Machine Learning Approach,2022,https://doi.org/10.1002/acr.24834,34902228,False
264,Psychosocial Burden Predicts Sustained Remission in Early Rheumatoid Arthritis: Unraveling the Complex Interplay of <scp>Well‐Being</scp> and Disease Activity,2022,https://doi.org/10.1002/acr.24847,34931480,False
265,Call for action: incorporating wellness practices into a holistic management plan for rheumatoid arthritis—going beyond treat to target,2021,https://doi.org/10.1136/rmdopen-2021-001959,34893537,False
266,Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data,2021,https://doi.org/10.1007/s40744-021-00361-5,34519964,False
267,Cellular and molecular diversity in Rheumatoid Arthritis,2021,https://doi.org/10.1016/j.smim.2021.101519,35033462,False
268,Safety of JAK inhibitors: focus on cardiovascular and thromboembolic events,2022,https://doi.org/10.1080/1744666x.2022.2039630,35129033,False
269,Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria,2022,https://doi.org/10.1136/lupus-2021-000634,35346982,False
270,"Safety and efficacy of the miR-124 upregulator ABX464 (obefazimod, 50 and 100 mg per day) in patients with active rheumatoid arthritis and inadequate response to methotrexate and/or anti-TNFα therapy: a placebo-controlled phase II study",2022,https://doi.org/10.1136/annrheumdis-2022-222228,35641124,False
271,Patient‐centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis,2022,https://doi.org/10.1111/all.15439,35837880,False
272,'Difficult to treat' rheumatoid arthritis: current position and considerations for next steps,2022,https://doi.org/10.1136/rmdopen-2022-002387,35896282,False
273,American College of Rheumatology/EULAR remission criteria for rheumatoid arthritis: 2022 revision,2022,https://doi.org/10.1136/ard-2022-223413,36280238,False
274,Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Another Biologic,2020,https://doi.org/10.1007/s40744-020-00201-y,32227284,False
275,Traditional Chinese medicine on treating active rheumatoid arthritis,2020,https://doi.org/10.1097/md.0000000000020642,32541503,False
276,Disease-specific factors associated with cardiovascular events in patients with Takayasu arteritis,2020,https://doi.org/10.1186/s13075-020-02275-z,32736654,False
277,Unlocking the Value of Anti-TNF Biosimilars: Reducing Disease Burden and Improving Outcomes in Chronic Immune-Mediated Inflammatory Diseases: A Narrative Review,2020,https://doi.org/10.1007/s12325-020-01437-4,32915410,False
278,A systematic review on the effect of DMARDs on fertility in rheumatoid arthritis,2020,https://doi.org/10.1016/j.semarthrit.2020.07.003,32896703,False
279,Revisiting the cardiovascular risk of hydroxychloroquine in RA,2020,https://doi.org/10.1038/s41584-020-00521-x,32999492,False
280,The patient perspective of nurse‐led care in early rheumatoid arthritis: A systematic review of qualitative studies with thematic analysis,2020,https://doi.org/10.1111/jocn.15531,33125809,False
281,Glucocorticoids: surprising new findings on their mechanisms of actions,2020,https://doi.org/10.1136/annrheumdis-2020-218798,33162396,False
282,Identification of Common Differentially Expressed Genes and Potential Therapeutic Targets in Ulcerative Colitis and Rheumatoid Arthritis,2020,https://doi.org/10.3389/fgene.2020.572194,33262784,False
283,An umbrella review of systematic reviews with meta-analyses evaluating positive and negative outcomes of Hydroxychloroquine and chloroquine therapy,2021,https://doi.org/10.1016/j.ijid.2020.12.018,33316389,False
284,Conventional disease-modifying agents in rheumatoid arthritis – a review of their current use and role in treatment algorithms,2020,https://doi.org/10.5114/reum.2020.101400,33456082,False
285,Effect of significant weight loss on disease activity: reason to implement this non-pharmaceutical intervention in daily clinical practice,2021,https://doi.org/10.1136/rmdopen-2020-001498,33504577,False
286,Validity and reliability of the EULAR instrument RAID.7 as a tool to assess individual domains of impact of disease in rheumatoid arthritis: a cross-sectional study of 671 patients,2021,https://doi.org/10.1136/rmdopen-2020-001539,33547229,False
287,Four-year follow-up of atherogenicity in rheumatoid arthritis patients: from the nationwide Korean College of Rheumatology Biologics Registry,2021,https://doi.org/10.1007/s10067-021-05613-x,33576925,False
288,Dynamical trajectory of glucocorticoids tapering and discontinuation in patients with rheumatoid arthritis commencing glucocorticoids with csDMARDs: a real-world data from 2009 to 2020,2021,https://doi.org/10.1136/annrheumdis-2021-220112,33811037,False
289,Primary and secondary non-response: in need of operational definitions in observational studies,2021,https://doi.org/10.1136/annrheumdis-2021-220202,33883161,False
290,An IgD-Fc-Ig fusion protein restrains the activation of T and B cells by inhibiting IgD-IgDR-Lck signaling in rheumatoid arthritis,2021,https://doi.org/10.1038/s41401-021-00665-w,33864023,False
291,Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs,2021,https://doi.org/10.1097/md.0000000000025481,33907096,False
292,Current and Emerging DMARDs for the Treatment of Rheumatoid Arthritis,2021,https://doi.org/10.2147/oarrr.s282627,34104009,False
293,Low-dose oral glucocorticoid therapy and risk of osteoporotic fractures in patients with rheumatoid arthritis: a cohort study using the Clinical Practice Research Datalink,2021,https://doi.org/10.1093/rheumatology/keab548,34255815,False
294,Tofacitinib: Real-World Data and Treatment Persistence in Rheumatoid Arthritis,2021,https://doi.org/10.2147/oarrr.s322086,34349573,False
295,Filgotinib in Rheumatoid Arthritis: A Profile of Its Use,2021,https://doi.org/10.1007/s40261-021-01055-0,34304373,False
296,Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3,2021,https://doi.org/10.1136/rmdopen-2021-001621,34385364,True
297,Fatigue in patients with early rheumatoid arthritis undergoing treat-to-target therapy: predictors and response to treatment,2021,https://doi.org/10.1136/annrheumdis-2021-220750,34389605,False
298,Network Pharmacology and Molecular Docking-Based Prediction of the Mechanism of Qianghuo Shengshi Decoction against Rheumatoid Arthritis,2021,https://doi.org/10.1155/2021/6623912,34527739,False
299,Shikonin induces programmed death of fibroblast synovial cells in rheumatoid arthritis by inhibiting energy pathways,2021,https://doi.org/10.1038/s41598-021-97713-6,34521930,False
300,Influence of anti‐rheumatic agents on the periodontal condition of patients with rheumatoid arthritis and periodontitis: A systematic review and meta‐analysis,2021,https://doi.org/10.1111/jre.12925,34514591,False
301,"Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trial",2021,https://doi.org/10.1016/s2665-9913(21)00220-4,,False
302,Serious infections in patients with rheumatoid arthritis and psoriatic arthritis treated with tumour necrosis factor inhibitors: data from register linkage of the NOR-DMARD study,2021,https://doi.org/10.1136/annrheumdis-2021-221007,34625404,False
303,Pain Management Strategies in Rheumatoid Arthritis: A Narrative Review,2021,https://doi.org/10.1080/15360288.2021.1973647,34623946,False
304,Risk of venous thromboembolism associated with methotrexate versus hydroxychloroquine for rheumatoid arthritis: A propensity score-matched cohort study,2021,https://doi.org/10.1016/j.semarthrit.2021.10.001,34757241,False
305,Predictors of response to TNF inhibitors in rheumatoid arthritis: an individual patient data pooled analysis of randomised controlled trials,2021,https://doi.org/10.1136/rmdopen-2021-001882,34789535,False
306,Restoring the Balance between Pro-Inflammatory and Anti-Inflammatory Cytokines in the Treatment of Rheumatoid Arthritis: New Insights from Animal Models,2021,https://doi.org/10.3390/biomedicines10010044,35052724,False
307,"TELERA—Asynchronous TELEmedicine for Patients With Rheumatoid Arthritis: Study Protocol for a Prospective, Multi-Center, Randomized Controlled Trial",2021,https://doi.org/10.3389/fmed.2021.791715,34966765,False
308,Fc receptors gone wrong: A comprehensive review of their roles in autoimmune and inflammatory diseases,2022,https://doi.org/10.1016/j.autrev.2021.103016,34915182,False
309,Nanoengineered therapy aiming at the etiology of rheumatoid arthritis,2022,https://doi.org/10.1016/j.nantod.2021.101367,,False
310,EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology,2022,https://doi.org/10.1136/annrheumdis-2021-221307,35058229,False
311,"Janus Kinase Inhibitors Improve Disease Activity and Patient-Reported Outcomes in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of 24,135 Patients",2022,https://doi.org/10.3390/ijms23031246,35163173,False
312,The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience,2022,https://doi.org/10.3389/fped.2022.820586,35211430,False
313,Management of patients with rheumatoid arthritis by telemedicine: connected monitoring. A randomized controlled trial,2022,https://doi.org/10.1016/j.jbspin.2022.105368,35248737,True
314,Exploring drug cost and disease outcome in rheumatoid arthritis patients treated with biologic and targeted synthetic DMARDs in Norway in 2010–2019 – a country with a national tender system for prescription of costly drugs,2022,https://doi.org/10.1186/s12913-021-07425-w,35012522,False
315,New Insights in the Treatment of SAPHO Syndrome and Medication Recommendations,2022,https://doi.org/10.2147/jir.s353539,35444448,False
316,N-Acetyl-L-cysteine in human rheumatoid arthritis and its effects on nitric oxide (NO) and malondialdehyde (MDA): analytical and clinical considerations,2022,https://doi.org/10.1007/s00726-022-03185-x,35829920,False
317,Epidemiology of rheumatoid arthritis: genetic and environmental influences,2022,https://doi.org/10.1080/1744666x.2022.2106970,35904251,False
318,Risk of major adverse cardiovascular and venous thromboembolism events in patients with rheumatoid arthritis exposed to JAK inhibitors versus adalimumab: a nationwide cohort study,2022,https://doi.org/10.1136/ard-2022-222824,36198438,False
319,The development of COVID-19 treatment,2023,https://doi.org/10.3389/fimmu.2023.1125246,36776881,False
320,Patient Global Assessment of Disease Activity and Radiographic Progression in Early Arthritis: Three‐Year Results From the ESPOIR Cohort,2021,https://doi.org/10.1002/acr.24237,32339449,False
321,Psoriatic arthritis: still room for improvement,2020,https://doi.org/10.1016/s0140-6736(20)30800-x,32386578,False
322,Prevalence of Elbow Joint Arthritis and Enthesitis in Rheumatoid Arthritis,2020,https://doi.org/10.3390/jcm9051590,32456283,False
323,Update on the treatment of nonsystemic juvenile idiopathic arthritis including treatment-to-target: is (drug-free) inactive disease already possible?,2020,https://doi.org/10.1097/bor.0000000000000727,32657803,False
324,The Influence of Different Disease States on Rituximab Pharmacokinetics,2020,https://doi.org/10.2174/1389200221666200719004035,32682367,False
325,Leflunomide monotherapy versus combination therapy with conventional synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis: a retrospective study,2020,https://doi.org/10.1038/s41598-020-69309-z,32704073,True
326,Does healthcare regime affiliation influence the clinical outcomes of patients with rheumatoid arthritis?,2020,https://doi.org/10.1007/s10067-020-05347-2,32813188,False
327,Disparities in Rheumatoid Arthritis Care and Health Service Solutions to Equity,2020,https://doi.org/10.1016/j.rdc.2020.07.005,32981645,False
328,"Prevalence, Predictors, and Prognostic Benefits of Remission Achievement in Patients With Systemic Lupus Erythematosus: A Systematic Review",2022,https://doi.org/10.1002/acr.24464,32986933,False
329,Upadacitinib versus placebo or adalimumab with background methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate: a subgroup analysis of a phase III randomized controlled trial in Central and Eastern European patients,2020,https://doi.org/10.7573/dic.2020-7-5,33123205,False
330,The progress of rheumatology in the 21st century potential uses of upadacitinib in rheumatoid arthritis and other inflammatory rheumatic diseases,2020,https://doi.org/10.47360/1995-4484-2020-532-543,,False
331,The impact of different (rheumatoid) arthritis phenotypes on patients’ lives,2020,https://doi.org/10.1093/rheumatology/keaa845,33237330,False
332,Immunosuppressive agents for rheumatoid arthritis: a systematic review of clinical trials and their current development stage,2020,https://doi.org/10.1177/1759720x20959971,33403019,False
333,Factors that influence biological survival in rheumatoid arthritis: results of a real-world academic cohort from the Netherlands,2021,https://doi.org/10.1007/s10067-020-05567-6,33415451,False
334,Impact of the HLA-DRB1 shared epitope on responses to treatment with tofacitinib or abatacept in patients with rheumatoid arthritis,2021,https://doi.org/10.1186/s13075-021-02612-w,34465391,False
335,Having a co-morbidity predicts worse outcome in early rheumatoid arthritis despite intensive treatment: a post hoc evaluation of the pragmatic randomized controlled CareRA trial,2020,https://doi.org/10.1093/rheumatology/keaa841,33434277,True
336,Mesenchymal Stem Cells Enhance Therapeutic Effect and Prevent Adverse Gastrointestinal Reaction of Methotrexate Treatment in Collagen-Induced Arthritis,2021,https://doi.org/10.1155/2021/8850820,33505476,False
337,Treat-to-Target Strategies in Rheumatoid Arthritis: a Systematic Review and Cost-Effectiveness Analysis,2021,https://doi.org/10.1007/s42399-021-00727-4,,False
338,Methotrexate does not increase the risk of liver fibrosis in patients with rheumatoid arthritis: assessment by ultrasound elastography (ARFI-MetRA study),2021,https://doi.org/10.1007/s00296-021-04804-8,33608744,False
339,Sustained Remission in Patients With Rheumatoid Arthritis Receiving Triple Therapy Compared to Biologic Therapy: A Swedish Nationwide Register Study,2021,https://doi.org/10.1002/art.41720,33682353,False
340,In vitro and ex vivo functional characterization of human HLA-DRB1∗04 restricted T cell receptors,2021,https://doi.org/10.1016/j.jtauto.2021.100087,33768201,False
341,COVID-19 infection and rheumatoid arthritis: mutual outburst cytokines and remedies,2021,https://doi.org/10.1080/03007995.2021.1906637,33754931,False
342,Soufeng sanjie formula alleviates collagen-induced arthritis in mice by inhibiting Th17 cell differentiation,2021,https://doi.org/10.1186/s13020-021-00448-9,33985537,False
343,The Role of Natural Products in Rheumatoid Arthritis: Current Knowledge of Basic In Vitro and In Vivo Research,2021,https://doi.org/10.3390/antiox10040599,33924632,False
344,Current favourable 10-year outcome of patients with early rheumatoid arthritis: data from the ESPOIR cohort,2021,https://doi.org/10.1093/rheumatology/keab398,33961011,False
345,"Safety of the Methotrexate–leflunomide Combination in Rheumatoid Arthritis: Results of a Multicentric, Registry-based, Cohort Study (BiobadaBrasil)",2021,https://doi.org/10.3899/jrheum.201248,33934077,False
346,"Intermetatarsal Bursitis, a Novel Feature of Juxtaarticular Inflammation in Early Rheumatoid Arthritis Related to Clinical Signs: Results of a Longitudinal Magnetic Resonance Imaging Study",2022,https://doi.org/10.1002/acr.24640,33973415,False
347,"Association of first, second, and third-line bDMARDs and tsDMARD with drug survival among seropositive rheumatoid arthritis patients: Cohort study in A real world setting",2021,https://doi.org/10.1016/j.semarthrit.2021.06.002,34139521,False
348,The Assessment of Muscle Mass and Function in Patients with Long-Standing Rheumatoid Arthritis,2021,https://doi.org/10.3390/jcm10163458,34441751,False
349,"Incidence, sociodemographic factors and treatment penetration of rheumatoid arthritis and psoriatic arthritis in Norway",2021,https://doi.org/10.1016/j.semarthrit.2021.08.006,34450506,False
350,Biologic and Targeted Synthetic DMARD Utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid Arthritis,2021,https://doi.org/10.1007/s40744-021-00357-1,34487340,False
351,Differentiating Psoriatic Arthritis from Osteoarthritis and Rheumatoid Arthritis: A Narrative Review and Guide for Advanced Practice Providers,2021,https://doi.org/10.1007/s40744-021-00365-1,34519965,False
352,In Silico Identification and Evaluation of Natural Products as Potential Tumor Necrosis Factor Function Inhibitors Using Advanced Enalos Asclepios KNIME Nodes,2021,https://doi.org/10.3390/ijms221910220,34638561,False
353,Tumour necrosis factor inhibitor dose adaptation in psoriatic arthritis and axial spondyloarthritis (TAPAS): a retrospective cohort study,2021,https://doi.org/10.1093/rheumatology/keab741,34599803,False
354,"18F-FDG PET-CT in rheumatoid arthritis patients tapering TNFi: reliability, validity and predictive value",2021,https://doi.org/10.1093/rheumatology/keab842,34791068,True
355,Natural and iatrogenic ocular manifestations of rheumatoid arthritis: a systematic review,2021,https://doi.org/10.1007/s10792-021-02058-8,34802085,False
356,Treatment of Cardiovascular Disease in Rheumatoid Arthritis: A Complex Challenge with Increased Atherosclerotic Risk,2021,https://doi.org/10.3390/ph15010011,35056068,False
357,Toward Overcoming Treatment Failure in Rheumatoid Arthritis,2021,https://doi.org/10.3389/fimmu.2021.755844,35003068,False
358,Methotrexate in early rheumatoid arthritis: Is the anchor drug still holding?,2022,https://doi.org/10.1016/j.autrev.2022.103031,34995761,False
359,Phytochemicals targeting JAK/STAT pathway in the treatment of rheumatoid arthritis: Is there a future?,2022,https://doi.org/10.1016/j.bcp.2022.114929,35065024,False
360,Unraveling heterogeneity within ACPA-negative rheumatoid arthritis: the subgroup of patients with a strong clinical and serological response to initiation of DMARD treatment favor disease resolution,2022,https://doi.org/10.1186/s13075-021-02671-z,34980246,False
361,COVID-19—A Trigger Factor for Severe Immune-Mediated Thrombocytopenia in Active Rheumatoid Arthritis,2022,https://doi.org/10.3390/life12010077,35054471,False
362,Pharmacogenomics of Anti-TNF Treatment Response Marks a New Era of Tailored Rheumatoid Arthritis Therapy,2022,https://doi.org/10.3390/ijms23042366,35216481,False
363,Mechanisms underlying DMARD inefficacy in difficult-to-treat rheumatoid arthritis: a narrative review with systematic literature search,2022,https://doi.org/10.1093/rheumatology/keac114,35238332,False
364,Comparison of Efficacy of Acupuncture-Related Therapy in the Treatment of Rheumatoid Arthritis: A Network Meta-Analysis of Randomized Controlled Trials,2022,https://doi.org/10.3389/fimmu.2022.829409,35320944,False
365,Interstitial Lung Disease in Rheumatoid Arthritis: A Practical Review,2022,https://doi.org/10.3389/fmed.2022.837133,35646974,False
366,Rheumatoid arthritis and osteoimmunology: The adverse impact of a deregulated immune system on bone metabolism,2022,https://doi.org/10.1016/j.bone.2022.116468,35688359,False
367,Effectiveness and Safety of JAK Inhibitors in Autoinflammatory Diseases: A Systematic Review,2022,https://doi.org/10.3389/fmed.2022.930071,35833101,False
368,Treatment Guidelines in Rheumatoid Arthritis,2022,https://doi.org/10.1016/j.rdc.2022.03.005,35953230,False
369,The effect of disease-modifying anti-rheumatic drugs on skeletal muscle mass in rheumatoid arthritis patients: a systematic review with meta-analysis,2022,https://doi.org/10.1186/s13075-022-02858-y,35854372,False
370,"Targeting the interleukin-5 pathway in EGPA: evidence, uncertainties and opportunities",2022,https://doi.org/10.1136/ard-2022-223044,36357156,False
371,"Microbes, helminths, and rheumatic diseases",2020,https://doi.org/10.1016/j.berh.2020.101528,32448639,False
372,Intensive therapy alleviates subclinical synovitis on ultrasound and disease activity and reduces flare in rheumatoid arthritis patients who have achieved clinical target – a randomized controlled trial,2020,https://doi.org/10.1016/j.semarthrit.2020.05.014,32512262,True
373,Safety of repository corticotropin injection as an adjunctive therapy for the treatment of rheumatoid arthritis,2020,https://doi.org/10.1080/14740338.2020.1779219,32497440,False
374,Comparison of the efficacy and safety of biologic agents between elderly-onset and young-onset RA patients: the ANSWER cohort study,2020,https://doi.org/10.1007/s00296-020-04660-y,32728836,False
375,Anti-TNF biosimilars in rheumatology: the end of an era?,2020,https://doi.org/10.1080/14712598.2020.1802421,32735158,False
376,Multidisciplinary Approach to Prevent &lt;i&gt;de novo&lt;/i&gt; Hepatitis B in Patients with Rheumatoid Arthritis,2020,https://doi.org/10.1620/tjem.252.133,33028756,False
377,Patient‐Reported Outcomes in Rheumatology Patients With Limited English Proficiency and Limited Health Literacy,2020,https://doi.org/10.1002/acr.24243,33091257,False
378,Tailoring biologic therapy for real-world rheumatoid arthritis patients,2020,https://doi.org/10.1080/14712598.2021.1847268,33147106,False
379,Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis: Subgroup analyses of a global phase 3 study (FINCH 2),2021,https://doi.org/10.1080/14397595.2020.1859675,33274687,True
380,Protein array-based companion diagnostics in precision medicine,2020,https://doi.org/10.1080/14737159.2020.1857734,33315478,False
381,How to Define Boolean Low Disease Activity in Rheumatoid Arthritis: Experience from a Large Real-world Cohort,2020,https://doi.org/10.1007/s40744-020-00270-z,33355913,False
382,Switching first-line targeted therapy after not reaching low disease activity within 6 months is superior to conservative approach: a propensity score-matched analysis from the ATTRA registry,2021,https://doi.org/10.1186/s13075-020-02393-8,33407803,False
383,Low-dose rituximab protocol in rheumatoid arthritis—outcome and economic impact,2021,https://doi.org/10.1093/rap/rkaa077,33605940,False
384,Patient Characteristics and Indicators of Treatment Initiation with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis: A Claims Database Analysis,2021,https://doi.org/10.1007/s40744-020-00272-x,33400194,False
385,"Characteristics of rheumatoid arthritis with immunodeficiency-associated lymphoproliferative disorders to regress spontaneously by the withdrawal of methotrexate and their clinical course: A retrospective, multicenter, case–control study",2021,https://doi.org/10.1080/14397595.2021.1879362,33496194,False
386,Long‐term safety of combination treatment with methotrexate and tumor necrosis factor (TNF)‐α antagonists versus TNF‐α antagonists alone in psoriatic patients,2021,https://doi.org/10.1111/1346-8138.15754,33470023,False
387,Technological Advancements in Monoclonal Antibodies,2021,https://doi.org/10.1155/2021/6663708,33628140,False
388,Changes in the Penetration Rate of Biosimilar Infliximab Within Japan Using a Japanese Claims Database,2021,https://doi.org/10.2147/ceor.s293698,33658813,False
389,"Type 2 diabetes mellitus, glycaemic control, associated therapies and risk of rheumatoid arthritis: a retrospective cohort study",2021,https://doi.org/10.1093/rheumatology/keab148,33590842,False
390,Epigenome wide association study of response to methotrexate in early rheumatoid arthritis patients,2021,https://doi.org/10.1371/journal.pone.0247709,33690661,False
391,"Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study)",2021,https://doi.org/10.1093/rheumatology/keab153,33738492,True
392,Rheumatoid arthritis in Colombia: a clinical profile and prevalence from a national registry,2021,https://doi.org/10.1007/s10067-021-05710-x,33772350,False
393,Comparative Efficacy and Safety of Peficitinib Versus Tofacitinib and Baricitinib for Treatment of Rheumatoid Arthritis: A Systematic Review and Network Meta-Analysis,2021,https://doi.org/10.1007/s40744-021-00284-1,33725321,False
394,Clinical management of patients with rheumatoid arthritis during the COVID-19 pandemic,2021,https://doi.org/10.1080/1744666x.2021.1908887,33787418,False
395,Tofacitinib in the Treatment of Moderate-to-Severe Rheumatoid Arthritis in China: A Cost-Effectiveness Analysis Based on a Mapping Algorithm Derived from a Chinese Population,2021,https://doi.org/10.1007/s12325-021-01733-7,33837917,False
396,Signalling and putative therapeutic molecules on the regulation of synoviocyte signalling in rheumatoid arthritis,2021,https://doi.org/10.1302/2046-3758.104.bjr-2020-0331.r1,33890482,False
397,The sonographic identification of cortical bone interruptions in rheumatoid arthritis: a morphological approach,2021,https://doi.org/10.1177/1759720x211004326,33948124,False
398,Patient and rheumatologist perspectives on tapering DMARDs in rheumatoid arthritis: a qualitative study,2021,https://doi.org/10.1093/rheumatology/keab330,33878168,False
399,Efficacy and safety of levilimab in combination with methotrexate in subjects with rheumatoid arthritis: Results of phase II AURORA study,2021,https://doi.org/10.47360/1995-4484-2021-141-151,,False
400,Association Between Baseline Anti-cyclic Citrullinated Peptide Antibodies and 6-Month Clinical Response Following Abatacept or TNF Inhibitor Treatment: A Real-World Analysis of Biologic-Experienced Patients with RA,2021,https://doi.org/10.1007/s40744-021-00310-2,34047953,False
401,"Traditional Chinese Medicine Qingre Huoxue Treatment vs. the Combination of Methotrexate and Hydroxychloroquine for Active Rheumatoid Arthritis: A Multicenter, Double-Blind, Randomized Controlled Trial",2021,https://doi.org/10.3389/fphar.2021.679588,34113254,False
402,Targeted literature review of current treatments and unmet need in moderate rheumatoid arthritis in the United Kingdom,2021,https://doi.org/10.1093/rheumatology/keab464,34080612,False
403,Impact of Anti-Citrullinated Protein Antibodies on Progressive Systemic Bone Mineral Density Loss in Patients With Early Rheumatoid Arthritis After Two Years of Treat-to-Target,2021,https://doi.org/10.3389/fimmu.2021.701922,34194443,False
404,"In Rheumatoid Arthritis Patients, HLA-DRB1*04:01 and Rheumatoid Nodules Are Associated With ACPA to a Particular Fibrin Epitope",2021,https://doi.org/10.3389/fimmu.2021.692041,34248985,False
405,Influence of the FCGR2A rs1801274 and FCGR3A rs396991 Polymorphisms on Response to Abatacept in Patients with Rheumatoid Arthritis,2021,https://doi.org/10.3390/jpm11060573,34207385,False
406,Cardiovascular risk comorbidities in rheumatoid arthritis patients and the use of anti-rheumatic drugs: a cross-sectional real-life study,2021,https://doi.org/10.1186/s42358-021-00186-4,34172097,False
407,Biomaterial-based immunotherapeutic strategies for rheumatoid arthritis,2021,https://doi.org/10.1007/s13346-021-01038-w,34414564,False
408,Tapering of Etanercept is feasible in patients with Rheumatoid Arthritis in sustained remission: a pragmatic randomized controlled trial,2021,https://doi.org/10.1080/03009742.2021.1955467,34514929,True
409,Factors Associated with &lt;i&gt;Pneumocystis jirovecii&lt;/i&gt; Pneumonia in Patients with Rheumatoid Arthritis Receiving Methotrexate: A Single-center Retrospective Study,2022,https://doi.org/10.2169/internalmedicine.8205-21,34511571,False
410,"How to taper glucocorticoids in inflammatory rheumatic diseases? A narrative review of novel evidence in rheumatoid arthritis, systemic lupus erythematosus, and giant cell arteritis",2022,https://doi.org/10.1016/j.jbspin.2021.105285,34601110,False
411,Pyridinone Derivatives as Interesting Formyl Peptide Receptor (FPR) Agonists for the Treatment of Rheumatoid Arthritis,2021,https://doi.org/10.3390/molecules26216583,34770992,False
412,"Upadacitinib in patients from China, Brazil, and South Korea with rheumatoid arthritis and an inadequate response to conventional therapy",2021,https://doi.org/10.1111/1756-185x.14235,34779576,True
413,Baseline Anti-Citrullinated Protein Antibody Status and Response to Abatacept or Non-TNFi Biologic/Targeted-Synthetic DMARDs: US Observational Study of Patients with RA,2021,https://doi.org/10.1007/s40744-021-00401-0,34940957,False
414,Machine learning approaches to improve disease management of patients with rheumatoid arthritis: review and future directions,2021,https://doi.org/10.1080/1744666x.2022.2017773,34890271,False
415,Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 1),2021,https://doi.org/10.1093/mr/roab030,34910188,True
416,Treating-to-target in rheumatology: Theory and practice,2022,https://doi.org/10.1016/j.berh.2021.101735,34980566,False
417,Rates and predictors of methotrexate-related adverse events in patients with early rheumatoid arthritis: results from a nationwide UK study,2022,https://doi.org/10.1093/rheumatology/keab917,35078225,False
418,Effectiveness of baricitinib and tofacitinib compared with bDMARDs in RA: results from a cohort study using nationwide Swedish register data,2022,https://doi.org/10.1093/rheumatology/keac068,35134119,False
419,Risk of flare after tapering or withdrawal of biologic/targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis or axial spondyloarthritis: a systematic review and meta-analysis,2021,https://doi.org/10.1093/rheumatology/keab902,34864896,False
420,Dietary polyphenols for management of rheumatoid arthritis: Pharmacotherapy and novel delivery systems,2022,https://doi.org/10.1002/ptr.7444,35318759,False
421,New indicator for discordance between patient-reported and traditional disease activity outcomes in patients with early rheumatoid arthritis,2022,https://doi.org/10.1093/rheumatology/keac213,35416951,False
422,Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis,2022,https://doi.org/10.1136/annrheumdis-2022-222338,35470162,False
423,"Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapy",2022,https://doi.org/10.1093/rheumatology/keac285,35579338,False
424,Caffeine and rheumatoid arthritis: A complicated relationship,2022,https://doi.org/10.1016/j.autrev.2022.103117,35595049,False
425,Total-Body <sup>18</sup>F-FDG PET/CT in Autoimmune Inflammatory Arthritis at Ultra-Low Dose: Initial Observations,2022,https://doi.org/10.2967/jnumed.121.263774,35589405,False
426,Methotrexate use reduces mortality risk in rheumatoid arthritis: A systematic review and meta-analysis of cohort studies,2022,https://doi.org/10.1016/j.semarthrit.2022.152031,35671648,False
427,"Association between Endodontic Infection, Its Treatment and Systemic Health: A Narrative Review",2022,https://doi.org/10.3390/medicina58070931,35888650,False
428,Predictors of remission in rheumatoid arthritis patients treated with biologics: a systematic review and meta-analysis,2022,https://doi.org/10.1007/s10067-022-06307-8,35974226,False
429,"2019 update: EULAR RA management recommendations, efficacy and safety systematic literature reviews",2020,https://doi.org/10.1136/annrheumdis-2019-216821,32033940,False
430,Actual Persistence of Abatacept in Rheumatoid Arthritis: Results of the French-Ric Network,2020,https://doi.org/10.3390/jcm9051528,32438597,False
431,Indicators of rheumatoid arthritis disease activity. An association with a patient’s psychological status,2020,https://doi.org/10.14412/1996-7012-2020-2-27-34,,False
432,What value do JAK inhibitors have in treating rheumatoid arthritis?,2020,https://doi.org/10.1080/14656566.2020.1779703,32584622,False
433,Methotrexate: what are the true risks of treatment?,2020,https://doi.org/10.1136/annrheumdis-2020-217207,32611600,False
434,Predictors of long‐term clinical remission in rheumatoid arthritis,2020,https://doi.org/10.1111/eci.13363,32725883,False
435,Multidisciplinary collaboration among young specialists: results of an international survey by the emerging EULAR network and other young organisations,2020,https://doi.org/10.1136/rmdopen-2020-001398,32934010,False
436,Real-World Evidence to Contextualize Clinical Trial Results and Inform Regulatory Decisions: Tofacitinib Modified-Release Once-Daily vs Immediate-Release Twice-Daily for Rheumatoid Arthritis,2020,https://doi.org/10.1007/s12325-020-01501-z,33034006,False
437,Investigating the safety and compliance of using csDMARDs in rheumatoid arthritis treatment through face-to-face interviews: a cross-sectional study in China,2020,https://doi.org/10.1007/s10067-020-05458-w,33058034,False
438,Efficacy of Tocilizumab Monotherapy Versus Tocilizumab and Methotrexate Combination Therapy in the Prevention of Radiographic Progression in Rheumatoid Arthritis: An Analysis Using Individual Patient Data From Multiple Clinical Trials,2022,https://doi.org/10.1002/acr.24524,33253497,False
439,&lt;p&gt;Methotrexate (MTX) Plus Hydroxychloroquine versus MTX Plus Leflunomide in Patients with MTX-Resistant Active Rheumatoid Arthritis: A 2-Year Cohort Study in Real World&lt;/p&gt;,2020,https://doi.org/10.2147/jir.s282249,33376379,False
440,Marine-Derived Biologically Active Compounds for the Potential Treatment of Rheumatoid Arthritis,2020,https://doi.org/10.3390/md19010010,33383638,False
441,DiR-labeled tolerogenic dendritic cells for targeted imaging in collagen- induced arthritis rats,2021,https://doi.org/10.1016/j.intimp.2020.107273,33360828,False
442,"Good response to methotrexate is associated with a decrease in the gene expression of ABCG2, a drug transporter, in patients with rheumatoid arthritis",2021,https://doi.org/10.1080/14397595.2021.1879429,33492182,False
443,Psoas abscess during treatment with intravenous tocilizumab in a patient with rheumatoid arthritis: a case-based review,2021,https://doi.org/10.1007/s00296-021-04800-y,33576887,False
444,Should we use glucocorticoids in early rheumatoid arthritis? Results at 5 years from the early RA UCLouvain Brussels cohort,2021,https://doi.org/10.1093/rheumatology/keab151,33605405,False
445,Similarity of Response to Biologics Between Elderly-onset Rheumatoid Arthritis (EORA) and Non-EORA Elderly Patients: From the FIRST Registry,2021,https://doi.org/10.3899/jrheum.201135,33589546,False
446,Effectiveness of a Second Biologic After Failure of a Non–tumor Necrosis Factor Inhibitor As First Biologic in Rheumatoid Arthritis,2021,https://doi.org/10.3899/jrheum.201467,33649069,False
447,Healthcare Costs of Not Achieving Remission in Patients with Rheumatoid Arthritis in the United States: A Retrospective Cohort Study,2021,https://doi.org/10.1007/s12325-021-01730-w,33837497,False
448,Cut-off value to identify a flare using the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire: analysis of the TOSCA study,2021,https://doi.org/10.1093/rheumatology/keab261,33788913,True
449,Systematic review for the treatment of older rheumatoid arthritis patients informing the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis,2021,https://doi.org/10.1080/14397595.2021.1912922,33853484,False
450,Elderly patients with comorbidities in the definition of difficult-to-treat rheumatoid arthritis,2021,https://doi.org/10.1136/annrheumdis-2021-220315,33962961,False
451,Current and innovative therapeutic strategies for the treatment of giant cell arteritis,2021,https://doi.org/10.1080/21678707.2021.1932458,,False
452,A systematic review and network meta-analysis of the safety of early interventional treatments in rheumatoid arthritis,2021,https://doi.org/10.1093/rheumatology/keab429,34003970,False
453,Glucocorticoid discontinuation in patients with early rheumatoid and undifferentiated arthritis: a post-hoc analysis of the BeSt and IMPROVED studies,2021,https://doi.org/10.1136/annrheumdis-2021-220403,34049858,False
454,Limiting factors to Boolean remission differ between autoantibody-positive and -negative patients in early rheumatoid arthritis,2021,https://doi.org/10.1177/1759720x211011826,34093745,False
455,Burden and cost of comorbidities in patients with neuromyelitis optica spectrum disorder,2021,https://doi.org/10.1016/j.jns.2021.117530,34111762,False
456,Adrenocortical dysfunction in rheumatoid arthritis: Α narrative review and future directions,2021,https://doi.org/10.1111/eci.13635,34097322,False
457,"Comparison of two dose escalation strategies of methotrexate in active rheumatoid arthritis: a multicentre, parallel group, randomised controlled trial",2021,https://doi.org/10.1136/annrheumdis-2021-220512,34112656,True
458,Efficacy and safety of tofacitinib modified-release 11 mg once daily plus methotrexate in adult patients with rheumatoid arthritis: 24-week open-label phase results from a phase 3b/4 methotrexate withdrawal non-inferiority study (ORAL Shift),2021,https://doi.org/10.1136/rmdopen-2021-001673,34103405,True
459,Anti-Inflammatory Effects of Low-Dose Glucocorticoids Compensate for Their Detrimental Effects on Bone Mineral Density in Patients with Rheumatoid Arthritis,2021,https://doi.org/10.3390/jcm10132944,34209074,False
460,What dose of folic acid to use with methotrexate in rheumatoid arthritis?,2021,https://doi.org/10.1136/dtb.2020.000061,34162667,False
461,Hyperbilirubinemia Maintained by Chronic Supplementation of Unconjugated Bilirubin Improves the Clinical Course of Experimental Autoimmune Arthritis,2021,https://doi.org/10.3390/ijms22168662,34445367,False
462,Clinical remission of rheumatoid arthritis in a multicenter real-world study in Asia-Pacific region,2021,https://doi.org/10.1016/j.lanwpc.2021.100240,34528015,False
463,"Abatacept is Efficacious in the Treatment of Older Patients with csDMARD-Refractory Rheumatoid Arthritis: A Prospective, Multicenter, Observational Study",2021,https://doi.org/10.1007/s40744-021-00356-2,34448173,False
464,"Exploring the macro-level, meso-level and micro-level barriers and facilitators to the provision of good quality early inflammatory arthritis (EIA) care in England and Wales",2021,https://doi.org/10.1136/rmdopen-2021-001616,34400579,False
465,Risk of Heart Failure in Rheumatoid Arthritis Patients Treated with Tumor Necrosis Factor‐α Inhibitors,2021,https://doi.org/10.1002/cpt.2415,34496051,False
466,"Long-term efficacy, safety, and immunogenicity of the adalimumab biosimilar, PF-06410293, in patients with rheumatoid arthritis after switching from reference adalimumab (Humira®) or continuing biosimilar therapy: week 52–92 data from a randomized, double-blind, phase 3 trial",2021,https://doi.org/10.1186/s13075-021-02626-4,34563243,True
467,Possibilities for personalised medicine in rheumatoid arthritis: hype or hope,2021,https://doi.org/10.1136/rmdopen-2021-001653,34649986,False
468,Methotrexate Alters the Expression of microRNA in Fibroblast-like Synovial Cells in Rheumatoid Arthritis,2021,https://doi.org/10.3390/ijms222111561,34768991,False
469,A Bridge Too Far? Real‐World Practice Patterns of Early Glucocorticoid Use in the Canadian Early Arthritis Cohort,2021,https://doi.org/10.1002/acr2.11334,34708574,False
470,The Macrophage Reprogramming Ability of Antifolates Reveals Soluble CD14 as a Potential Biomarker for Methotrexate Response in Rheumatoid Arthritis,2021,https://doi.org/10.3389/fimmu.2021.776879,34804067,False
471,"A double-blind, double-dummy, randomized controlled, multicenter trial of 99Tc-methylene diphosphonate in patients with moderate to severe rheumatoid arthritis",2021,https://doi.org/10.1097/cm9.0000000000001527,34039871,True
472,"The Relationship between Platelet Indices and Ultrasound, Clinical, Laboratory Parameters of Disease Activity in Patients with Rheumatoid Arthritis",2021,https://doi.org/10.3390/jcm10225259,34830541,False
473,Advances in Use of Nanomaterials for Musculoskeletal Regeneration,2021,https://doi.org/10.3390/pharmaceutics13121994,34959276,False
474,"Trend in prescription and treatment retention of molecular-targeted drugs in 121,131 Japanese patients with rheumatoid arthritis: A population-based real-world study",2021,https://doi.org/10.1093/mr/roab126,34907436,False
475,Usefulness of noninvasive diagnostic procedures for assessment of methotrexate hepatotoxicity in patients with rheumatoid arthritis,2021,https://doi.org/10.1007/s00296-021-05059-z,34870735,False
476,Pre-RA: Can early diagnosis lead to prevention?,2022,https://doi.org/10.1016/j.berh.2021.101737,34991984,False
477,"Drug levels, anti-drug antibodies and B-cell counts were not predictive of response in rheumatoid arthritis patients on (ultra-)low-dose rituximab",2022,https://doi.org/10.1093/rheumatology/keac024,35022672,False
478,Biologikatherapie von rheumatoider Arthritis und Spondyloarthritiden,2022,https://doi.org/10.1007/s00108-021-01248-x,35029702,False
479,Effectiveness of Baricitinib in Refractory Seronegative Rheumatoid Arthritis and Uveitis: A Case Report,2022,https://doi.org/10.3389/fmed.2021.764067,35096866,False
480,Applying Early Intervention Strategies to Autoimmune Skin Diseases. Is the Window of Opportunity Preclinical? A Dermato-Rheumatology Perspective,2022,https://doi.org/10.1016/j.jid.2021.11.018,35034771,False
481,Factors affecting drug retention of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study,2022,https://doi.org/10.1038/s41598-021-04075-0,34997059,False
482,A Narrative Literature Review Comparing the Key Features of Musculoskeletal Involvement in Rheumatoid Arthritis and Systemic Lupus Erythematosus,2022,https://doi.org/10.1007/s40744-022-00442-z,35359260,False
483,"Using real-world data to dynamically predict flares during tapering of biological DMARDs in rheumatoid arthritis: development, validation, and potential impact of prediction-aided decisions",2022,https://doi.org/10.1186/s13075-022-02751-8,35321739,False
484,"Factors affecting patient satisfaction related to cost and treatment effectiveness in rheumatoid arthritis: results from the multicenter observational cohort study, FRANK Registry",2022,https://doi.org/10.1186/s13075-022-02746-5,35193646,False
485,"Discovery of novel non-steroidal selective glucocorticoid receptor modulators by structure- and IGN-based virtual screening, structural optimization, and biological evaluation",2022,https://doi.org/10.1016/j.ejmech.2022.114382,35483323,False
486,Effects of Biological/Targeted Therapies on Bone Mineral Density in Inflammatory Arthritis,2022,https://doi.org/10.3390/ijms23084111,35456929,False
487,Perspectives of at-Risk Individuals on Preventive Intervention for Rheumatoid Arthritis: A Mini Review,2022,https://doi.org/10.3389/fimmu.2022.883287,35572603,False
488,Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis,2022,https://doi.org/10.3390/jpm12030353,35330353,False
489,"Pharmacokinetics and pharmacodynamics of a proposed tocilizumab biosimilar MSB11456 versus both the US-licensed and EU-approved products: a randomized, double-blind trial",2022,https://doi.org/10.1080/1744666x.2022.2060204,35354411,True
490,Janus kinase versus TNF inhibitors: where we stand today in rheumatoid arthritis,2022,https://doi.org/10.1080/1744666x.2022.2064275,35535405,False
491,"Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission",2020,https://doi.org/10.1016/j.semarthrit.2020.03.022,32504990,False
492,Dynamics of Type I and Type II Interferon Signature Determines Responsiveness to Anti-TNF Therapy in Rheumatoid Arthritis,2022,https://doi.org/10.3389/fimmu.2022.901437,35734167,False
493,Synchronous Investigation of the Mechanism and Substance Basis of Tripterygium Glycosides Tablets on Anti-rheumatoid Arthritis and Hepatotoxicity,2022,https://doi.org/10.1007/s12010-022-04011-6,35763252,False
494,Clinical predictors of response to methotrexate in patients with rheumatoid arthritis: a machine learning approach using clinical trial data,2022,https://doi.org/10.1186/s13075-022-02851-5,35778714,True
495,Evaluation of the Therapeutic Potential of Mesenchymal Stem Cells (MSCs) in Preclinical Models of Autoimmune Diseases,2022,https://doi.org/10.1155/2022/6379161,35935180,False
496,Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update,2022,https://doi.org/10.1136/ard-2022-222784,35953263,False
497,Non-pharmacological treatment in difficult-to-treat rheumatoid arthritis,2022,https://doi.org/10.3389/fmed.2022.991677,36106320,False
498,Association Between Low-Dose Methotrexate Exposure and Melanoma,2022,https://doi.org/10.1001/jamadermatol.2022.3337,36044236,False
499,"After JAK inhibitor failure: to cycle or to switch, that is the question – data from the JAK-pot collaboration of registries",2022,https://doi.org/10.1136/ard-2022-222835,36100351,False
500,"Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor inhibitor therapy: efficacy and safety results of a randomised controlled phase III study",2022,https://doi.org/10.1136/ard-2022-222630,36109142,True
501,The monocyte-to-osteoclast transition in rheumatoid arthritis: Recent findings,2022,https://doi.org/10.3389/fimmu.2022.998554,36172385,False
502,Safety and efficacy of fecal microbiota transplantation for autoimmune diseases and autoinflammatory diseases: A systematic review and meta-analysis,2022,https://doi.org/10.3389/fimmu.2022.944387,36248877,False
503,The change of plasma metabolic profile and gut microbiome dysbiosis in patients with rheumatoid arthritis,2022,https://doi.org/10.3389/fmicb.2022.931431,36329847,False
504,Prevention of rheumatoid arthritis: A systematic literature review of preventive strategies in at-risk individuals,2023,https://doi.org/10.1016/j.autrev.2022.103217,36280095,False
505,"A meta‐analysis of methotrexate polyglutamates in relation to efficacy and toxicity of methotrexate in inflammatory arthritis, colitis and dermatitis",2022,https://doi.org/10.1111/bcp.15579,36326810,False
506,"The Effect of Meditation, Mindfulness, and Yoga in Patients with Rheumatoid Arthritis",2022,https://doi.org/10.3390/jpm12111905,36422081,False
507,"Interactions between NSAIDs, opioids and the gut microbiota - Future perspectives in the management of inflammation and pain",2023,https://doi.org/10.1016/j.pharmthera.2022.108327,36473615,False
508,Autoantibodies to disease‐related proteins in joints as novel biomarkers for the diagnosis of rheumatoid arthritis,2023,https://doi.org/10.1002/art.42463,36718635,False
509,Are treat-to-target and dose tapering strategies for rheumatoid arthritis possible during the COVID-19 pandemic?,2020,https://doi.org/10.1016/s2665-9913(20)30175-2,32835250,False
510,Beyond Methotrexate and Biologics in RA – Efficacy of JAK Inhibitors and their Place in the Current Treatment Armamentarium,2020,https://doi.org/10.31138/mjr.31.1.120,32676570,False
511,Validation of the Italian Version of the Educational Needs Assessment Tool in Rheumatoid Arthritis Patients and Factors Associated with Educational Needs,2020,https://doi.org/10.3390/jpm10040150,33019610,False
512,Chinese registry of rheumatoid arthritis (CREDIT): III. The transition of disease activity during follow‐ups and predictors of achieving treatment target,2020,https://doi.org/10.1111/1756-185x.13996,33034424,False
513,Radiographic remission in rheumatoid arthritis quantified by computer-aided joint space analysis (CASJA): a post hoc analysis of the RAPID 1 trial,2020,https://doi.org/10.1186/s13075-020-02322-9,33023661,True
514,Methotrexate use does not increase the prevalence of hepatic steatosis: a real-world retrospective nested case-control study,2020,https://doi.org/10.1007/s10067-020-05456-y,33078254,False
515,The role of rehabilitation and apparatus physiotherapy in rheumatic disease treatment strategies,2020,https://doi.org/10.17116/kurort20209705192,33054013,False
516,Therapeutic Maintenance of Baricitinib and Tofacitinib in Real Life,2020,https://doi.org/10.3390/jcm9103319,33081099,False
517,"Impact of Single-Nucleotide Polymorphisms of CTLA-4, CD80 and CD86 on the Effectiveness of Abatacept in Patients with Rheumatoid Arthritis",2020,https://doi.org/10.3390/jpm10040220,33187286,False
518,Neglected extra-articular manifestations in rheumatoid arthritis patients with normal body mass index: reduced skeletal muscle overlapping overfat,2020,https://doi.org/10.1177/2040622320975241,33294150,False
519,Rapid Onset of Efficacy of Baricitinib in Chinese Patients with Moderate to Severe Rheumatoid Arthritis: Results from Study RA-BALANCE,2020,https://doi.org/10.1007/s12325-020-01572-y,33237533,False
520,Comparative Efficacy (DAS28 Remission) of Targeted Immune Modulators for Rheumatoid Arthritis: A Network Meta-Analysis,2021,https://doi.org/10.1007/s40744-021-00322-y,34037968,False
521,Associations between an expanded autoantibody profile and treatment responses to biologic therapies in patients with rheumatoid arthritis,2021,https://doi.org/10.1016/j.intimp.2020.107260,33360371,False
522,The role of ixekizumab in non-radiographic axial spondyloarthritis,2021,https://doi.org/10.1177/1759720x20986734,33488787,False
523,"To apply the recent EULAR recommendations, more knowledge on adherence patterns to medication and to physical activity is needed",2021,https://doi.org/10.1016/j.jbspin.2021.105137,33484861,False
524,Non-adherence in difficult-to-treat rheumatoid arthritis from the perspectives of patients and rheumatologists: a concept mapping study,2021,https://doi.org/10.1093/rheumatology/keab130,33560301,False
525,"Association between Health Literacy, Patient Activation, and Functional Capacity in Individuals with Rheumatoid Arthritis",2021,https://doi.org/10.2174/1874312902115010001,,False
526,Role of comorbidities on therapeutic persistence of biological agents in rheumatoid arthritis: results from the RECord-linkage On Rheumatic Disease study on administrative healthcare databases,2021,https://doi.org/10.1080/03009742.2020.1855365,33660559,False
527,Operationalizing Treat-to-Target for Osteoporosis,2021,https://doi.org/10.3803/enm.2021.970,33761232,False
528,Comparing cost-utility of DMARDs in autoantibody-negative rheumatoid arthritis patients,2021,https://doi.org/10.1093/rheumatology/keab251,33725091,True
529,"Estado, control, impacto y manejo actual de la artritis reumatoide según los pacientes: encuesta nacional AR 2020",2022,https://doi.org/10.1016/j.reuma.2020.10.006,,False
530,Geographic variations in rheumatoid arthritis treatment in Japan: A nationwide retrospective study using the national database of health insurance claims and specific health checkups of Japan,2021,https://doi.org/10.1080/14397595.2021.1910615,33818268,False
531,Effectiveness and tolerability of oral <i>vs</i> subcutaneous methotrexate in patients with rheumatoid arthritis,2021,https://doi.org/10.1093/rheumatology/keab313,33788911,False
532,Evaluation Method of Rheumatoid Arthritis by the X-ray Photograph using Deep Learning,2021,https://doi.org/10.1109/lifetech52111.2021.9391953,,False
533,Rheumatoid Arthritis Relapse and Remission – Advancing Our Predictive Capability Using Modern Imaging,2021,https://doi.org/10.2147/jir.s284405,34163211,False
534,Abrupt change to telephone follow‐up clinics in a regional rheumatology service during <scp>COVID</scp> ‐19: analysis of treatment decisions,2021,https://doi.org/10.1111/imj.15336,34155761,False
535,Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis,2021,https://doi.org/10.1371/journal.pone.0253793,34170978,True
536,A comparison of Janus kinase inhibitor safety in rheumatoid arthritis,2021,https://doi.org/10.1111/1756-185x.14127,,False
537,Plasma interferon-alpha is associated with double-positivity for autoantibodies but is not a predictor of remission in early rheumatoid arthritis—a spin-off study of the NORD-STAR randomized clinical trial,2021,https://doi.org/10.1186/s13075-021-02556-1,34256800,True
538,Delayed diagnosis in axial spondyloarthritis—how can we do better?,2021,https://doi.org/10.1093/rheumatology/keab496,34244705,False
539,Neutrophil count reduction 1 month after initiating tocilizumab can predict clinical remission within 1 year in rheumatoid arthritis patients,2021,https://doi.org/10.1007/s00296-021-04944-x,34241658,False
540,"Real-world evaluation of effectiveness, persistence, and usage patterns of monotherapy and combination therapy tofacitinib in treatment of rheumatoid arthritis in Australia",2021,https://doi.org/10.1007/s10067-021-05853-x,34370130,False
541,The susceptibility of attaining and maintaining DMARD-free remission in different (rheumatoid) arthritis phenotypes,2021,https://doi.org/10.1093/rheumatology/keab631,34352094,False
542,Evaluating filgotinib for the treatment of rheumatoid arthritis,2021,https://doi.org/10.1080/14656566.2021.1967929,34402699,False
543,Cryptococcal pneumonia in a patient with rheumatoid arthritis treated with baricitinib,2021,https://doi.org/10.1093/rheumatology/keab658,34424311,False
544,A Cross-Sectional and Longitudinal Study to Define Alarmins and A-SAA Variants as Companion Markers in Early Rheumatoid Arthritis,2021,https://doi.org/10.3389/fimmu.2021.638814,34489924,False
545,Multiple time-point assessment of lncRNA <i>MEG3</i> shows potential to monitor treatment efficacy in rheumatoid arthritis patients,2021,https://doi.org/10.2217/bmm-2021-0070,34488430,False
546,"The temporal association between hospital admissions, biological therapy usage and direct health care costs in rheumatoid arthritis patients",2021,https://doi.org/10.1007/s00296-021-04985-2,34536090,False
547,Favorable clinical response and drug retention of anti-IL-6 receptor inhibitor in rheumatoid arthritis with high CRP levels: the ANSWER cohort study,2021,https://doi.org/10.1080/03009742.2021.1947005,34511031,False
548,‘More than just chitchat’: a qualitative study concerning the need and potential format of a peer mentor programme for patients with early rheumatoid arthritis,2021,https://doi.org/10.1136/rmdopen-2021-001795,34611049,False
549,Back to Basics: Prioritizing Communication as a Key Instrument in Managing Rheumatoid Arthritis,2021,https://doi.org/10.3899/jrheum.210984,34599049,False
550,"Prospective, simultaneous assessment of joint and vascular inflammation by PET/CT in tofacitinib-treated patients with rheumatoid arthritis: associations with vascular and bone status",2021,https://doi.org/10.1136/rmdopen-2021-001804,34740980,False
551,Identification of Five Quality Needs for Rheumatology (Text Analysis and Literature Review),2021,https://doi.org/10.3389/fmed.2021.757102,34760902,False
552,"Patient satisfaction, preferences, expectations, characteristics, and impact of suboptimal control of rheumatoid arthritis: A subgroup analysis of Japanese patients from a large international cohort study (SENSE)",2021,https://doi.org/10.1371/journal.pone.0259389,34780502,False
553,The perception of stakeholders on the applicability of nurse-led clinics in the management of rheumatoid arthritis,2021,https://doi.org/10.1093/rap/rkab052,34755028,False
554,Recommendations of the Brazilian Society of Rheumatology for the use of JAK inhibitors in the management of rheumatoid arthritis,2021,https://doi.org/10.1186/s42358-021-00228-x,34819172,False
555,MicroRNA-106b overexpression suppresses synovial inflammation and alleviates synovial damage in patients with rheumatoid arthritis,2021,https://doi.org/10.1093/mr/roab108,34850088,False
556,The effectiveness of e-learning in patient education delivered to patients with rheumatoid arthritis: The WebRA study—protocol for a pragmatic randomised controlled trial,2021,https://doi.org/10.1186/s41927-021-00226-y,34924034,False
557,Differential Changes in ACPA Fine Specificity and Gene Expression in a Randomized Trial of Abatacept and Adalimumab in Rheumatoid Arthritis,2021,https://doi.org/10.1007/s40744-021-00404-x,34878629,False
558,"Geranium wilfordii maxim.: A review of its traditional uses, phytochemistry, pharmacology, quality control and toxicology",2022,https://doi.org/10.1016/j.jep.2021.114907,34896206,False
559,Intravenous pegylated liposomal prednisolone outperforms intramuscular methylprednisolone in treating rheumatoid arthritis flares: A randomized controlled clinical trial,2022,https://doi.org/10.1016/j.jconrel.2021.12.007,34896445,True
560,Current evidence on the use of the adalimumab biosimilar SB5 (Imraldi<sup>TM</sup>): a multidisciplinary perspective,2021,https://doi.org/10.1080/14712598.2022.2012146,34918591,False
561,Therapeutic efficacy of denosumab for rheumatoid arthritis: a systematic review and meta-analysis,2021,https://doi.org/10.1093/rap/rkab099,34988358,False
562,Efficacy and safety of filgotinib alone and in combination with methotrexate in Japanese patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 3),2021,https://doi.org/10.1093/mr/roab021,34910203,True
563,"Real-World Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis Patients in Spain: Results of a Multicenter, Observational Study in Routine Clinical Practice (The ORBIT-RA Study)",2022,https://doi.org/10.1007/s40744-021-00423-8,35041155,False
564,Clinical features of methotrexate osteopathy in rheumatic musculoskeletal disease: A systematic review,2022,https://doi.org/10.1016/j.semarthrit.2022.151952,35038641,False
565,Cost-effectiveness of a telehealth intervention in rheumatoid arthritis: economic evaluation of the Telehealth in RA (TeRA) randomized controlled trial,2022,https://doi.org/10.1080/03009742.2021.2008604,35048793,True
566,Effectiveness and safety of aerobic exercise for rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials,2022,https://doi.org/10.1186/s13102-022-00408-2,35123568,False
567,Biological Disease-Modifying Antirheumatic Drugs and Osteoporotic Fracture Risk in Patients with Rheumatoid Arthritis: A Danish Cohort Study,2022,https://doi.org/10.1016/j.amjmed.2022.01.017,35134369,False
568,Selection of treatment regimens based on shared decision-making in patients with rheumatoid arthritis on remission in the FREE-J study,2022,https://doi.org/10.1093/rheumatology/keac075,35136990,False
569,Sarilumab reduces disease activity in rheumatoid arthritis patients with inadequate response to janus kinase inhibitors or tocilizumab in regular care in Germany,2022,https://doi.org/10.1093/rap/rkac002,35146322,False
570,Decreased chronic kidney disease in rheumatoid arthritis in the era of biologic disease-modifying anti-rheumatic drugs,2022,https://doi.org/10.1093/ckj/sfac036,35756739,False
571,The role of antifibrotics in the treatment of rheumatoid arthritis–associated interstitial lung disease,2022,https://doi.org/10.1177/1759720x221074457,35186127,False
572,Baricitinib further enhances disease-modifying effects by uncoupling the link between disease activity and joint structural progression in patients with rheumatoid arthritis,2022,https://doi.org/10.1136/annrheumdis-2021-221323,35193872,False
573,"Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 study",2022,https://doi.org/10.1016/s2665-9913(22)00008-x,,False
574,Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis,2022,https://doi.org/10.1371/journal.pone.0264628,35213675,False
575,Clinical worsening following discontinuation of tocilizumab in diffuse cutaneous systemic sclerosis: a single-centre experience in Japan,2022,https://doi.org/10.1093/rheumatology/keac136,35258561,False
576,Treatment of Giant Cell Arteritis (GCA),2022,https://doi.org/10.3390/jcm11071799,35407411,False
577,Differential efficacy of TNF inhibitors with or without the immunoglobulin fragment crystallizable (Fc) portion in rheumatoid arthritis: the ANSWER cohort study,2022,https://doi.org/10.1007/s00296-021-05086-w,35266034,False
578,Towards a Better Implementation of Treat-to-Target Strategy in Rheumatoid Arthritis: A Comparison of Two Real-World Cohorts,2022,https://doi.org/10.1007/s40744-022-00441-0,35347662,False
579,Metabolic reprogramming of synovial fibroblasts in osteoarthritis by inhibition of pathologically overexpressed pyruvate dehydrogenase kinases,2022,https://doi.org/10.1016/j.ymben.2022.03.006,35296430,False
580,"Safety and efficacy of elsubrutinib or upadacitinib alone or in combination (ABBV-599) in patients with rheumatoid arthritis and inadequate response or intolerance to biological therapies: a multicentre, double-blind, randomised, controlled, phase 2 trial",2022,https://doi.org/10.1016/s2665-9913(22)00092-3,,False
581,Sensory testing and topical capsaicin can characterize patients with rheumatoid arthritis,2022,https://doi.org/10.1007/s10067-022-06185-0,35499773,False
582,Patient perspectives on biological treatments for inflammatory arthritis: A multi-center study in Korea,2021,https://doi.org/10.46497/archrheumatol.2021.8524,35382362,False
583,"Are Cannabis, Cannabis-Derived Products, and Synthetic Cannabinoids a Therapeutic Tool for Rheumatoid Arthritis? A Friendly Summary of the Body of Evidence",2021,https://doi.org/10.1097/rhu.0000000000001745,33859125,True
584,Risk of Serious Infection With Low-dose Glucocorticoids in Patients With Rheumatoid Arthritis,2021,https://doi.org/10.1097/ede.0000000000001422,34561348,False
585,Sex difference in disease burden of inflammatory arthritis patients treated with tumor necrosis factor inhibitors as part of standard care,2022,https://doi.org/10.1371/journal.pone.0266816,35511905,False
586,Biochanin A as a modulator of the inflammatory response: An updated overview and therapeutic potential,2022,https://doi.org/10.1016/j.phrs.2022.106246,35562014,False
587,Janus kinase inhibitors in immunoinflammatory diseases: 10 years of clinical practice in rheumatology,2022,https://doi.org/10.47360/1995-4484-2022-131-148,,False
588,Australian recommendations on tapering of biologic and targeted synthetic disease‐modifying anti‐rheumatic drugs in inflammatory arthritis,2022,https://doi.org/10.1111/imj.15816,35567366,False
589,Treatment strategies of COVID-19: A rheumatology perspective,2022,https://doi.org/10.1016/j.ejim.2022.05.014,35610165,False
590,Semaphorin 3G exacerbates joint inflammation through the accumulation and proliferation of macrophages in the synovium,2022,https://doi.org/10.1186/s13075-022-02817-7,35659346,False
591,Unincreased risk of hospitalized infection under targeted therapies versus methotrexate in elderly patients with rheumatoid arthritis: a retrospective cohort study,2022,https://doi.org/10.1186/s13075-022-02807-9,35689250,False
592,"The Efficacy of <scp>Short‐Term</scp> Bridging Strategies With High‐ and <scp>Low‐Dose</scp> Prednisolone on Radiographic and Clinical Outcomes in Active Early Rheumatoid Arthritis: A <scp>Double‐Blind</scp> , Randomized, <scp>Placebo‐Controlled</scp> Trial",2022,https://doi.org/10.1002/art.42245,35643951,True
593,Pulmonary fibrosis associated with rheumatoid arthritis: from pathophysiology to treatment strategies,2022,https://doi.org/10.1080/17476348.2022.2089116,35695895,False
594,Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: A multinational real-world cohort analysis,2022,https://doi.org/10.1016/j.semarthrit.2022.152050,35728447,False
595,Vasculitogenic T Cells in Large Vessel Vasculitis,2022,https://doi.org/10.3389/fimmu.2022.923582,35784327,False
596,"Longitudinal trajectories of fatigue in early RA: the role of inflammation, perceived disease impact and early treatment response",2022,https://doi.org/10.1136/annrheumdis-2022-222517,35725296,False
597,Impact of pre-existing background therapy on placebo responses in randomised controlled clinical trials of rheumatoid arthritis,2022,https://doi.org/10.1136/annrheumdis-2021-221807,35725294,False
598,Patient-reported outcomes of upadacitinib versus abatacept in patients with rheumatoid arthritis and an inadequate response to biologic disease-modifying antirheumatic drugs: 12- and 24-week results of a phase 3 trial,2022,https://doi.org/10.1186/s13075-022-02813-x,35751108,True
599,"Gut Microbiota Structure and Metabolites, Before and After Treatment in Early Rheumatoid Arthritis Patients: A Pilot Study",2022,https://doi.org/10.3389/fmed.2022.921675,35872763,False
600,Hit-hard and early versus step-up treatment in severe sarcoidosis,2022,https://doi.org/10.1097/mcp.0000000000000906,35869744,False
601,Trends in risks of malignancies in Japanese patients with rheumatoid arthritis: Analyses from a 14-year observation of the IORRA cohort,2022,https://doi.org/10.1093/mr/roac085,35920098,False
602,Outcomes of coronavirus disease 19 patients with a history of rheumatoid arthritis: A retrospective registry‐based study in Iran,2022,https://doi.org/10.1111/1756-185x.14405,35920406,False
603,Comparative safety of Janus kinase inhibitors and tumor necrosis factor inhibitors in patients undergoing treatment for rheumatoid arthritis,2022,https://doi.org/10.1111/1756-185x.14414,35923107,False
604,Janus kinase (JAK) inhibitors significantly reduce the humoral vaccination response against SARS-CoV-2 in patients with rheumatoid arthritis,2022,https://doi.org/10.1007/s10067-022-06329-2,35965290,False
605,Disease mechanisms in preclinical rheumatoid arthritis: A narrative review,2022,https://doi.org/10.3389/fmed.2022.689711,36059838,False
606,-Omic Approaches and Treatment Response in Rheumatoid Arthritis,2022,https://doi.org/10.3390/pharmaceutics14081648,36015273,False
607,The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls—a prospective cohort study,2022,https://doi.org/10.1186/s12916-022-02587-8,36199139,False
608,American College of Rheumatology/ <scp>EULAR</scp> Remission Criteria for Rheumatoid Arthritis: 2022 Revision,2022,https://doi.org/10.1002/art.42347,36274193,False
609,"Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications",2022,https://doi.org/10.2147/oarrr.s285407,36388145,False
610,Articular Tissue-Mimicking Organoids Derived from Mesenchymal Stem Cells and Induced Pluripotent Stem Cells,2022,https://doi.org/10.3390/organoids1020011,,False
611,Applications and prospects of intra-articular drug delivery system in arthritis therapeutics,2022,https://doi.org/10.1016/j.jconrel.2022.11.018,36375618,False
612,Discovery and Optimization of <i>N</i>-Acyl-6-sulfonamide-tetrahydroquinoline Derivatives as Novel Non-Steroidal Selective Glucocorticoid Receptor Modulators,2022,https://doi.org/10.1021/acs.jmedchem.2c01082,36399795,False
613,"Characterisation of the safety profile of evobrutinib in over 1000 patients from phase II clinical trials in multiple sclerosis, rheumatoid arthritis and systemic lupus erythematosus: an integrated safety analysis",2022,https://doi.org/10.1136/jnnp-2022-328799,36418156,True
614,IgD enhances the release of neutrophil extracellular traps (NETs) via FcδR in rheumatoid arthritis patients,2023,https://doi.org/10.1016/j.intimp.2022.109484,36450207,False
615,Cytokines and cytokine receptors as targets of immune-mediated inflammatory diseases—RA as a role model,2022,https://doi.org/10.1186/s41232-022-00221-x,36451227,False
616,Anti-Arthritic and Anti-Cancer Activities of Polyphenols: A Review of the Most Recent In Vitro Assays,2023,https://doi.org/10.3390/life13020361,36836717,False
617,A guide to managing reproductive health in rheumatology,2020,https://doi.org/10.1038/s41584-020-0443-z,32518414,False
618,"An updated review of infliximab biosimilar, CT-P13, in the treatment of immune-mediated inflammatory diseases",2020,https://doi.org/10.2217/imt-2020-0086,32517574,False
619,Adoptive Treg cell-based immunotherapy: Frontier therapeutic aspects in rheumatoid arthritis,2020,https://doi.org/10.2217/imt-2020-0071,32635779,False
620,Recognition System of Positions of Joints of Hands in an X-ray photograph to Develop an Automatic Evaluation System for Rheumatoid Arthritis Using Machine Learning,2020,https://doi.org/10.1109/hsi49210.2020.9142640,,False
621,Pharmacokinetics and Bioequivalence of 2 Immediate‐Release Tofacitinib Tablet Formulations in Chinese Healthy Volunteers Under Fasting and Fed Conditions,2020,https://doi.org/10.1002/cpdd.864,32770665,True
622,The perennial search for alternatives to corticosteroids in rheumatology: is there light at the end of the tunnel?,2020,https://doi.org/10.1007/s10067-020-05357-0,32827282,False
623,Clinical markers combined with HMGB1 polymorphisms to predict efficacy of conventional DMARDs in rheumatoid arthritis patients,2020,https://doi.org/10.1016/j.clim.2020.108592,32920213,False
624,Rethinking the Balance of Risks and Rewards of Chronic Low-Dose Glucocorticoids in Rheumatoid Arthritis,2020,https://doi.org/10.7326/m20-6010,32956596,False
625,Analysis of Killer Cell Immunoglobulin-Like Receptor Genes and Their HLA Ligands in Inflammatory Bowel Diseases,2020,https://doi.org/10.1155/2020/4873648,33015197,False
626,Predictors of Flares in Patients with Rheumatoid Arthritis Who Exhibit Low Disease Activity: A Nationwide Cohort Study,2020,https://doi.org/10.3390/jcm9103219,33036446,False
627,Cost-effectiveness analysis of tofacitinib compared with adalimumab and etanercept in the treatment of severe active rheumatoid arthritis; Iranian experience,2020,https://doi.org/10.1080/14737167.2021.1834384,33043757,False
628,What Next after Biologic Therapy Fails in Rheumatoid Arthritis?,2020,https://doi.org/10.1056/nejme2026142,33053290,False
629,High prevalence of steroid-induced glucose intolerance with normal fasting glycaemia during low-dose glucocorticoid therapy: an oral glucose tolerance test screening study,2020,https://doi.org/10.1093/rheumatology/keaa724,33254223,False
630,Introductory Chapter: Rheumatoid Arthritis - Overview of Current Facts and Strategies,2020,https://doi.org/10.5772/intechopen.92771,,False
631,Biomechanical Particularities in the Therapy of the Rheumatic Knee,2020,https://doi.org/10.3390/app10238600,,False
632,Topical issues of perioperative management of patients with rheumatoid arthritis during arthroplasty of large joints in conditions of orthopedic department (literature review),2021,https://doi.org/10.33667/2078-5631-2020-31-43-47,,False
633,Consideration of differences in drug usage between young-onset and elderly-onset rheumatoid arthritis with target of low disease activity,2021,https://doi.org/10.1080/14397595.2021.1883251,33538619,False
634,Long-term methotrexate use in rheumatoid arthritis patients: real-world data from the MARTE study,2021,https://doi.org/10.23736/s0026-4806.21.06902-0,33555152,False
635,Utility of the HandScan in monitoring disease activity and prediction of clinical response in rheumatoid arthritis patients: an explorative study,2021,https://doi.org/10.1093/rap/rkab004,33693304,False
636,Outcomes in rheumatoid arthritis patients treated with abatacept: a UK multi-centre observational study,2021,https://doi.org/10.1186/s41927-020-00173-0,33536080,False
637,The unsustainable bubble of disease-modifying antirheumatic drugs in rheumatology,2021,https://doi.org/10.1016/s2665-9913(21)00013-8,,False
638,Janus kinase inhibitors for the treatment of rheumatoid arthritis,2021,https://doi.org/10.5124/jkma.2021.64.2.105,,False
639,Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review,2021,https://doi.org/10.1007/s40259-021-00467-w,33595833,False
640,Antirheumatic drugs for cardiovascular disease prevention: the case for colchicine,2021,https://doi.org/10.1136/rmdopen-2020-001560,33727219,False
641,Is There a Symmetry in Disease Control and Quality of Life of Patients with Rheumatoid Arthritis Treated with Biological Therapy?,2021,https://doi.org/10.3390/sym13040538,,False
642,"The clinical efficacy of Rituximab administration in autoimmunity disorders, primary immunodeficiency diseases and malignancies",2021,https://doi.org/10.1016/j.intimp.2021.107565,33773205,False
643,Assessing the risk of rapid radiographic progression in Hungarian rheumatoid arthritis patients,2021,https://doi.org/10.1186/s12891-021-04192-x,33794855,False
644,MTX optimization or adding bDMARD equally improve disease activity in rheumatoid arthritis: results from the prospective study STRATEGE,2021,https://doi.org/10.1093/rheumatology/keab274,33774669,False
645,Polymorphism of genes involved in methotrexate pathway: Predictors of response to methotrexate therapy in Indian rheumatoid arthritis patients,2021,https://doi.org/10.1111/1756-185x.14100,33780152,False
646,The synergistic efficacy of hydroxychloroquine with methotrexate is accompanied by increased erythrocyte mean corpuscular volume,2021,https://doi.org/10.1093/rheumatology/keab403,33944915,False
647,Factors affecting persistence with biologic treatments in patients with rheumatoid arthritis: a systematic literature review,2021,https://doi.org/10.1080/14740338.2021.1924146,33926364,False
648,Tofacitinib versus tocilizumab in the treatment of biological-naïve or previous biological-failure patients with methotrexate-refractory active rheumatoid arthritis,2021,https://doi.org/10.1136/rmdopen-2021-001601,33958440,False
649,Positive rate and prognostic significance of the superb microvascular imaging signal in joints of rheumatoid arthritis patients in remission with normal C-reactive protein levels and erythrocyte sedimentation rates,2021,https://doi.org/10.1007/s10396-021-01102-5,34014426,False
650,Joint tenderness and ultrasound inflammation in DMARD-naïve patients with early rheumatoid arthritis,2021,https://doi.org/10.1136/annrheumdis-2021-220265,34083205,False
651,Treatment Patterns and Pharmacoutilization in Patients Affected by Rheumatoid Arthritis in Italian Settings,2021,https://doi.org/10.3390/ijerph18115679,34073179,False
652,Gastric Adenocarcinoma Presenting as a Rheumatoid Factor and Anti-cyclic Citrullinated Protein Antibody-Positive Polyarthritis: A Case Report and Review of Literature,2021,https://doi.org/10.3389/fmed.2021.627004,34109188,False
653,Sonographic assessment of cartilage damage at the metacarpal head in rheumatoid arthritis: qualitative versus quantitative methods,2021,https://doi.org/10.1093/rheumatology/keab472,34097001,False
654,Comparison of the effects of baricitinib and tocilizumab on disease activity in patients with rheumatoid arthritis: a propensity score matching analysis,2021,https://doi.org/10.1007/s10067-021-05815-3,34136969,False
655,Cross-Cultural Validation of the 5-Item Compliance Questionnaire for Rheumatology to the Arabic Language in Patients with Rheumatoid Arthritis,2021,https://doi.org/10.2147/ppa.s316263,34234419,False
656,Adalimumab-Induced Rhupus Syndrome in a Female Patient Affected with Anti-Citrullinated Protein Antibody (ACPA)-Positive Rheumatoid Arthritis (RA): A Case Report and Review of Literature,2021,https://doi.org/10.3390/clinpract11030055,34287248,False
657,Real-world data on MTX tolerance with regimens used in children versus adults,2021,https://doi.org/10.1007/s10067-021-05802-8,34218394,False
658,Effectiveness of iguratimod as monotherapy or combined therapy in patients with rheumatoid arthritis: a systematic review and meta-analysis of RCTs,2021,https://doi.org/10.1186/s13018-021-02603-2,34271950,False
659,Effect of abatacept treatment on serum osteoclast-related biomarkers in patients with rheumatoid arthritis (RA),2021,https://doi.org/10.1097/md.0000000000026592,34260539,False
660,2021 ACR guideline reflects changes in RA treatment,2021,https://doi.org/10.1038/s41584-021-00667-2,34272518,False
661,"Switching from originator adalimumab to biosimilar SB5 in a rheumatology cohort: persistence on treatment, predictors of drug interruption and safety analysis",2021,https://doi.org/10.1177/1759720x211033679,35116080,False
662,Frailty as a novel predictor of achieving comprehensive disease control (CDC) in rheumatoid arthritis,2021,https://doi.org/10.1007/s10067-021-05744-1,34283332,False
663,"Budget Impact of Sequential Treatment with Biologics, Biosimilars, and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Thai Patients with Rheumatoid Arthritis",2021,https://doi.org/10.1007/s12325-021-01867-8,34370276,False
664,Influence of Multimorbidity on New Treatment Initiation and Achieving Target Disease Activity Thresholds in Active Rheumatoid Arthritis: A Cohort Study Using the Rheumatology Informatics System for Effectiveness Registry,2022,https://doi.org/10.1002/acr.24762,34338449,False
665,Sequences of biological treatments for patients with moderate-to-severe rheumatoid arthritis in the era of treat-to-target in China: a cost-effectiveness analysis,2021,https://doi.org/10.1007/s10067-021-05876-4,34373933,False
666,Patient involvement in rheumatoid arthritis care to improve disease activity-based management in daily practice: A randomized controlled trial,2022,https://doi.org/10.1016/j.pec.2021.08.013,34465495,True
667,"SM03, an anti-human CD22 monoclonal antibody, for active rheumatoid arthritis: a phase II, randomized, double-blind, placebo-controlled study",2021,https://doi.org/10.1093/rheumatology/keab699,34508557,True
668,Sarilumab monotherapy <i>vs</i> sarilumab and methotrexate combination therapy in patients with rheumatoid arthritis,2021,https://doi.org/10.1093/rheumatology/keab676,34508594,False
669,Treatment patterns and sequencing in patients with rheumatic diseases: a retrospective claims data analysis,2021,https://doi.org/10.1080/03007995.2021.1981278,34544301,False
670,“Ways in which the neonatal Fc-receptor is involved in autoimmunity”,2021,https://doi.org/10.1016/j.jtauto.2021.100122,34568803,False
671,Subclinical synovitis detected by magnetic resonance imaging and ultrasonography following clinical remission in patients with rheumatoid arthritis: A retrospective study,2021,https://doi.org/10.1002/rai2.12006,,False
672,Validity of Remission Criteria in Rheumatoid Arthritis Compared to Ultrasound-Defined Remission,2022,https://doi.org/10.18295/squmj.9.2021.128,36407714,False
673,"Real-Life Retention Rates and Reasons for Switching of Biological DMARDs in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis",2021,https://doi.org/10.3389/fmed.2021.708168,34646840,False
674,Functional capacity vs side effects: treatment attributes to consider when individualising treatment for patients with rheumatoid arthritis,2021,https://doi.org/10.1007/s10067-021-05961-8,34655004,False
675,Molecular Changes in the Adipose Tissue Induced by Rheumatoid Arthritis: Effects of Disease-Modifying Anti-Rheumatic Drugs,2021,https://doi.org/10.3389/fimmu.2021.744022,34721412,False
676,"Analytical and clinical validation of an RNA sequencing-based assay for quantitative, accurate evaluation of a molecular signature response classifier in rheumatoid arthritis",2021,https://doi.org/10.1080/14737159.2021.2000394,34727834,False
677,Nxhl Controls Angiogenesis by Targeting VE-PTP Through Interaction With Nucleolin,2021,https://doi.org/10.3389/fcell.2021.728821,34733844,False
678,Decentralizing healthcare in Norway to improve patient-centered outpatient clinic management of rheumatoid arthritis – a conceptual model,2021,https://doi.org/10.1186/s41927-021-00215-1,34743757,False
679,Short-term glucocorticoids for flares in people with rheumatoid arthritis receiving disease-modifying anti-rheumatic drugs (DMARDs),2021,https://doi.org/10.1002/14651858.cd014898,,False
680,A Serious Puzzle Game to Enhance Adherence to Antirheumatic Drugs in Patients With Rheumatoid Arthritis: Systematic Development Using Intervention Mapping,2022,https://doi.org/10.2196/31570,35179510,False
681,Hematological parameters as a predictor of disease remission in patients with rheumatoid arthritis,2021,https://doi.org/10.1016/j.amsu.2021.103085,34868575,False
682,Fine Comparison of the Efficacy and Safety Between GB242 and Infliximab in Patients with Rheumatoid Arthritis: A Phase III Study,2021,https://doi.org/10.1007/s40744-021-00396-8,34806155,False
683,Prediction of sustained biologic and targeted synthetic DMARD-free remission in rheumatoid arthritis patients,2021,https://doi.org/10.1093/rap/rkab087,34888435,False
684,Long-term glucocorticoids for rheumatoid arthritis,2021,https://doi.org/10.1002/14651858.cd014899,,False
685,Inhibition of structural joint damage progression with upadacitinib in rheumatoid arthritis: 1-year outcomes from the SELECT phase 3 program,2021,https://doi.org/10.1093/rheumatology/keab861,34897366,True
686,Initial Preserved Renal Function as a Predictor of Favorable Renal Response to Rituximab in Refractory or Relapsing Lupus Nephritis: A Single-center Cohort Study in Korea,2022,https://doi.org/10.4078/jrd.2022.29.1.22,,False
687,Post Hoc Analysis of the Correlation Between Patient-Reported Outcomes and Clinical Response to Repository Corticotropin Injection for Persistently Active Rheumatoid Arthritis,2021,https://doi.org/10.1007/s40744-021-00412-x,34919213,False
688,Implications of a diagnosis of rheumatoid arthritis in resource-poor countries,2022,https://doi.org/10.1016/j.berh.2021.101725,34906416,False
689,Real-world effectiveness and safety of golimumab in rheumatoid arthritis treatment: A two-center study in Taiwan,2022,https://doi.org/10.1097/jcma.0000000000000673,34882100,False
690,Defining the Optimal Strategies for Achieving Drug-Free Remission in Rheumatoid Arthritis: A Narrative Review,2021,https://doi.org/10.3390/healthcare9121726,34946453,False
691,Tailored first-line biologic and targeted synthetic disease modifying anti-rheumatic drugs therapy in patients with rheumatoid arthritis: 2021 updated ITABIO statements,2021,https://doi.org/10.1080/14740338.2022.2020247,34937466,False
692,Short-term induction glucocorticoids and disease-modifying anti-rheumatic drugs (DMARD) therapy for rheumatoid arthritis,2021,https://doi.org/10.1002/14651858.cd014897,,False
693,Role of Suppressor of cytokine signaling 2 during the development and resolution of an experimental arthritis,2022,https://doi.org/10.1016/j.cellimm.2021.104476,35033752,False
694,"Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel)",2022,https://doi.org/10.1007/s10067-021-05908-z,34973077,False
695,Prediction of treatment response: Personalized medicine in the management of rheumatoid arthritis,2022,https://doi.org/10.1016/j.berh.2021.101741,35063347,False
696,Risk of adrenal insufficiency in patients with polymyalgia rheumatica versus patients with rheumatoid arthritis: A cross-sectional study,2022,https://doi.org/10.1093/mr/roab091,35041750,False
697,Clinical-Like Cryotherapy in Acute Knee Arthritis Protects Neuromuscular Junctions of Quadriceps and Reduces Joint Inflammation in Mice,2022,https://doi.org/10.1155/2022/7442289,35103239,False
698,Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration,2022,https://doi.org/10.1093/rheumatology/keac081,35139178,False
699,Nucleic Acids for Potential Treatment of Rheumatoid Arthritis,2022,https://doi.org/10.1021/acsabm.1c01205,35118863,False
700,Development of an UPLC-MS/MS Method for the Quantitative Analysis of Upadacitinib in Beagle Dog Plasma and Pharmacokinetics Study,2021,https://doi.org/10.2147/dddt.s332282,34629864,False
701,Increased remission with fewer corticosteroids and more biologics in rheumatoid arthritis at 7-year follow-up in real-life conditions,2022,https://doi.org/10.1038/s41598-022-06584-y,35169251,False
702,Factors influencing clinician prescribing of disease-modifying anti-rheumatic drugs for inflammatory arthritis: A systematic review and thematic synthesis of qualitative studies,2022,https://doi.org/10.1016/j.semarthrit.2022.151988,35286905,False
703,The Role of Autoantibody Testing in Modern Personalized Medicine,2022,https://doi.org/10.1007/s12016-021-08918-6,35244870,False
704,Herpes zoster meningitis in a rheumatoid arthritis patient treated with tofacitinib,2022,https://doi.org/10.1136/bcr-2021-247276,35236687,False
705,Interleukin-17 as a predictor of subclinical synovitis in the remission state of rheumatoid arthritis,2022,https://doi.org/10.1016/j.cyto.2022.155837,35255378,False
706,The beneficial effect of csDMARDs co-medication on drug persistence of first-line TNF inhibitor in rheumatoid arthritis patients: data from Czech ATTRA registry,2022,https://doi.org/10.1007/s00296-021-05072-2,35338383,False
707,Using patient-reported data from a smartphone app to capture and characterize real-time patient-reported flares in rheumatoid arthritis,2022,https://doi.org/10.1093/rap/rkac021,35392426,False
708,Integrated safety analysis of filgotinib treatment for rheumatoid arthritis in patients from Japan over a median of 1.5 years,2022,https://doi.org/10.1093/mr/roac020,35365828,False
709,Improvement in clinical disease activity index when treatment selection is informed by the tumor necrosis factor-ɑ inhibitor molecular signature response classifier: analysis from the study to accelerate information of molecular signatures in rheumatoid arthritis,2022,https://doi.org/10.1080/14712598.2022.2066972,35442122,False
710,Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents,2022,https://doi.org/10.3390/medicina58050571,35629988,False
711,The RAPID3 questionnaire as a screening tool to reduce the number of outpatient clinic visits: a retrospective cohort study,2022,https://doi.org/10.1007/s10067-022-06162-7,35469354,False
712,Short interruptions of TNF-inhibitor treatment can be associated with treatment failure in patients with immune-mediated diseases,2022,https://doi.org/10.1080/08916934.2022.2067985,35481450,False
713,SYSADOA place in degenerative-dystrophic joints diseases treatment of neurological practice from the standpoint of evidence-based medicine,2022,https://doi.org/10.17116/jnevro202212203138,35394718,False
714,Mucosa‐associated lymphoid tissue lymphoma translocation protein 1 in rheumatoid arthritis: Longitudinal change after treatment and correlation with treatment efficacy of tumor necrosis factor inhibitors,2022,https://doi.org/10.1002/jcla.24449,35500150,False
715,Musculoskeletal ultrasound for treating rheumatoid arthritis to target—a systematic literature review,2022,https://doi.org/10.1093/rheumatology/keac261,35512175,False
716,Associations Between Genetic Polymorphisms Within Transporter Genes and Clinical Response to Methotrexate in Chinese Rheumatoid Arthritis Patients: A Pilot Study,2022,https://doi.org/10.2147/pgpm.s350417,35437350,False
717,The safety of glucocorticoids in the treatment of inflammatory rheumatic disease: new evidence,2022,https://doi.org/10.1097/bor.0000000000000870,35238807,False
718,Targets Exploration of Hydroxychloroquine for Pigmentation and Cell Protection Effect in Melanocytes: The Clue for Vitiligo Treatment,2022,https://doi.org/10.2147/dddt.s350387,35411132,False
719,"Combination Therapy With Tofacitinib and IL-12/23, IL-23, or IL-17A Inhibition for the Treatment of Refractory Psoriatic Arthritis",2021,https://doi.org/10.1097/rhu.0000000000001767,34176886,False
720,How effective are JAK-inhibitors? Perspectives from clinical trials and real-world studies,2021,https://doi.org/10.1080/1744666x.2021.1982383,34528855,False
721,Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational study,2022,https://doi.org/10.1007/s10067-022-06176-1,35536413,False
722,"Real-world evidence of the effectiveness and safety of generic tofacitinib in rheumatoid arthritis patients: a retrospective, single-centre analysis from Western India",2022,https://doi.org/10.1007/s10067-022-06205-z,35596818,False
723,Risk of Severe Infection among Rheumatoid Arthritis Patients on Biological DMARDs: A Population-Based Cohort Study,2022,https://doi.org/10.3390/jcm11112955,35683344,False
724,Increasing trend of radiographic features of knee osteoarthritis in rheumatoid arthritis patients before total knee arthroplasty,2022,https://doi.org/10.1038/s41598-022-14440-2,35729263,False
725,The Effect of Anti-rheumatic Drugs on the Skeleton,2022,https://doi.org/10.1007/s00223-022-01001-y,35771255,False
726,Tumour necrosis factor inhibitor use during pregnancy is associated with increased birth weight of rheumatoid arthritis patients’ offspring,2022,https://doi.org/10.1136/ard-2022-222679,35817469,False
727,Biosimilar Use and Switching in Belgium: Avenues for Integrated Policymaking,2022,https://doi.org/10.3389/fphar.2022.821616,35903323,False
728,Canadian Rheumatology Association Living Guidelines for the Pharmacological Management of Rheumatoid Arthritis With Disease-Modifying Antirheumatic Drugs,2022,https://doi.org/10.3899/jrheum.220209,35840155,False
729,Assessment of inflammation in patients with rheumatoid arthritis using thermography and machine learning: a fast and automated technique,2022,https://doi.org/10.1136/rmdopen-2022-002458,35840312,False
730,Optimal Biologic Drugs for the Treatment of Ankylosing Spondylitis: Results from a Network Meta-Analysis and Network Metaregression,2022,https://doi.org/10.1155/2022/8316106,35845959,False
731,Upadacitinib for the Treatment of Rheumatoid Arthritis: An Extensive Review,2022,https://doi.org/10.1177/10600280221113092,35919945,False
732,Safety and effectiveness of baricitinib for rheumatoid arthritis in Japanese clinical practice: 24-week results of all-case post-marketing surveillance,2022,https://doi.org/10.1093/mr/roac089,35932218,False
733,Real-world effectiveness of biological therapy in patients with rheumatoid arthritis: Systematic review and meta-analysis,2022,https://doi.org/10.3389/fphar.2022.927179,36034836,False
734,Machine learning predicts response to TNF inhibitors in rheumatoid arthritis: results on the ESPOIR and ABIRISK cohorts,2022,https://doi.org/10.1136/rmdopen-2022-002442,35999028,False
735,Therapeutic drug monitoring of teriflunomide: do plasma concentrations predict response to leflunomide in patients with rheumatoid arthritis?,2022,https://doi.org/10.1515/dmpt-2021-0236,35998916,False
736,Physical activity assessment with wearable devices in rheumatic diseases: a systematic review and meta-analysis,2022,https://doi.org/10.1093/rheumatology/keac476,36005834,False
737,The economic burden of biologic disease-modifying antirheumatic drugs in rheumatoid arthritis patients in the United States,2022,https://doi.org/10.1080/14737167.2022.2117690,36004551,False
738,Secondary Failure of Tocilizumab in Treating Elderly-Onset Rheumatoid Arthritis With Systemic Symptoms Complicated by Diverticulum Perforation,2022,https://doi.org/10.7759/cureus.28357,36168347,False
739,High plasma homocysteine level is associated with increased prevalence of the non-remission state in rheumatoid arthritis: Findings from the KURAMA cohort,2022,https://doi.org/10.1093/mr/roac106,36069659,False
740,Role of IL6R Genetic Variants in Predicting Response to Tocilizumab in Patients with Rheumatoid Arthritis,2022,https://doi.org/10.3390/pharmaceutics14091942,36145690,False
741,Dynamics of patient reported outcomes during the use various biological disease-modifying antirheumatic drugs for rheumatoid arthritis,2022,https://doi.org/10.47360/1995-4484-2022-427-437,,False
742,Rheumatoid arthritis and mitochondrial homeostasis: The crossroads of metabolism and immunity,2022,https://doi.org/10.3389/fmed.2022.1017650,36213670,False
743,"The RA-BE-REAL Multinational, Prospective, Observational Study in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic, or Biologic Disease-Modifying Therapies: a 6-Month Interim Analysis",2022,https://doi.org/10.1007/s40744-022-00500-6,36227530,False
744,Differences in trajectory of disease activity according to biologic and targeted synthetic disease-modifying anti-rheumatic drug treatment in patients with rheumatoid arthritis,2022,https://doi.org/10.1186/s13075-022-02918-3,36242075,False
745,Tapering biologic DMARDs in rheumatoid arthritis,2022,https://doi.org/10.1016/j.coph.2022.102308,36274358,False
746,Difficult-to-treat rheumatoid arthritis: Current concept and unsolved problems,2022,https://doi.org/10.3389/fmed.2022.1049875,36353219,False
747,Reduced prescription of TNF-inhibitors in chronic arthritis based on therapeutic drug monitoring: A randomized controlled trial,2022,https://doi.org/10.1080/03009742.2022.2121081,36315419,False
748,A novel anti-TNF-α drug ozoralizumab rapidly distributes to inflamed joint tissues in a mouse model of collagen induced arthritis,2022,https://doi.org/10.1038/s41598-022-23152-6,36302840,False
749,Tissue-resident memory T cells: The key frontier in local synovitis memory of rheumatoid arthritis,2022,https://doi.org/10.1016/j.jaut.2022.102950,36356551,False
750,Therapeutic Utility and Adverse Effects of Biologic Disease-Modifying Anti-Rheumatic Drugs in Inflammatory Arthritis,2022,https://doi.org/10.3390/ijms232213913,36430392,False
751,The prospects of interleukin-6 inhibition in rheumatoid arthritis: Olokizumab (novel monoclonal antibodies to IL-6),2022,https://doi.org/10.47360/1995-4484-2022-505-518,,False
752,Who stop telemonitoring disease activity and who adhere: a prospective cohort study of patients with inflammatory arthritis,2022,https://doi.org/10.1186/s41927-022-00303-w,36447263,False
753,"The Association of uPA, uPAR, and suPAR System with Inflammation and Joint Damage in Rheumatoid Arthritis: suPAR as a Biomarker in the Light of a Personalized Medicine Perspective",2022,https://doi.org/10.3390/jpm12121984,36556207,False
754,Kinins and their B1 and B2 receptors as potential therapeutic targets for pain relief,2023,https://doi.org/10.1016/j.lfs.2022.121302,36535404,False
755,Cost-effectiveness of janus kinase inhibitors for rheumatoid arthritis: A systematic review and meta-analysis of cost-utility studies,2022,https://doi.org/10.3389/fphar.2022.1090361,36582538,False
756,Retinal microvascular density analysis in patients with rheumatoid arthritis treated with hydroxychloroquine,2022,https://doi.org/10.1007/s00417-022-05946-6,36580078,False
757,Erosion-free rheumatoid arthritis: clinical and conceptional implications—a BARFOT study,2022,https://doi.org/10.1186/s41927-022-00317-4,36581910,False
758,A Case of Capillary Leak Syndrome and Intestinal Ischemia Caused by Rheumatoid Vasculitis,2023,https://doi.org/10.7759/cureus.33404,36751197,False
759,A comprehensive review of COVID-19 symptoms and treatments in the setting of autoimmune diseases,2023,https://doi.org/10.1186/s12985-023-01967-7,36611166,False
760,A multidisciplinary lifestyle program for rheumatoid arthritis: the ‘Plants for Joints’ randomized controlled trial,2023,https://doi.org/10.1093/rheumatology/keac693,36617162,False
761,Facilitators and barriers to adhere to monitoring disease activity with ePROs: a focus group study in patients with inflammatory arthritis,2023,https://doi.org/10.1007/s00296-022-05263-5,36627396,False
762,Treatment in Patients with Psoriatic Disease and Rheumatoid Arthritis: Seven Case Reports,2023,https://doi.org/10.3390/clinpract13010016,36826158,False
763,<scp>COVID</scp> ‐19 Vaccination and the Incidence of <i>De Novo</i> or Recurrent Rheumatoid Arthritis: A French and International ( <scp>VigiBase</scp> ) Signal Detection Study,2023,https://doi.org/10.1002/cpt.2866,36752604,False
764,Expected impact of immunomodulatory agents during pregnancy: A newborn's perspective,2023,https://doi.org/10.1111/pai.13911,36825745,False
765,Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis,2023,https://doi.org/10.1007/s40744-022-00519-9,36869251,False
766,Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES study,2023,https://doi.org/10.3389/fimmu.2023.1150162,37122713,False
767,EULAR updates its RA management recommendations,2020,https://doi.org/10.1038/s41584-020-0385-5,32001826,False
768,A Network Meta-Analysis to Compare Effectiveness of Baricitinib and Other Treatments in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate,2020,https://doi.org/10.36469/jheor.2020.12273,32685594,False
769,Response to lower dose TNF inhibitors in axial spondyloarthritis; a real-world multicentre observational study,2020,https://doi.org/10.1093/rap/rkaa015,32793854,False
770,Effectiveness of duloxetine for remnant pain relief in patients with rheumatoid arthritis despite remission,2020,https://doi.org/10.1007/s40267-020-00739-5,,False
771,Lower concentration of vitamin D is associated with lower DAS28 and VAS-pain scores in patients with inflammatory rheumatic diseases treated with infliximab: a pilot study,2020,https://doi.org/10.1007/s00296-020-04607-3,32462255,False
772,Evaluating upadacitinib for the treatment of rheumatoid arthritis.,2020,https://doi.org/10.1080/14656566.2020.1774555,32515665,False
773,Renal disorders in rheumatologic diseases: the spectrum is changing (part 2. Arthridides),2020,https://doi.org/10.1007/s40620-020-00776-3,32548773,False
774,Twenty years’ follow-up of radiocarpal arthrodesis for rheumatoid wrists,2020,https://doi.org/10.1080/14397595.2020.1782565,32530346,False
775,Problems of pain and quality of life in rheumatoid arthritis: focus on baricitinib,2020,https://doi.org/10.47360/1995-4484-2020-420-427,,False
776,Elderly-onset rheumatoid arthritis: an outlook from a practicing rheumatologist,2020,https://doi.org/10.47360/1995-4484-2020-447-450,,False
777,Recommendations for the Management of Patients With Systemic Rheumatic Diseases During the Coronavirus Disease Pandemic,2020,https://doi.org/10.4078/jrd.2020.27.4.218,,False
778,A pharmacokinetic evaluation of the rituximab biosimilar CT-P10 in the treatment of rheumatoid arthritis,2020,https://doi.org/10.1080/17425255.2020.1832082,33012214,False
779,Clinical conditions needed to acquire sustained functional remission in rheumatoid arthritis patients,2020,https://doi.org/10.1007/s10067-020-05451-3,33040232,False
780,"Current state, control, impact and management of rheumatoid arthritis according to patient: AR 2020 national survey",2022,https://doi.org/10.1016/j.reumae.2021.03.002,35277215,False
781,Perspectives of Methotrexate-Based Radioagents for Application in Nuclear Medicine,2020,https://doi.org/10.1021/acs.molpharmaceut.0c00740,33251808,False
782,Response to interleukin-6 receptor antagonists in patients with rheumatoid arthritis is independent of the number of prior used TNF inhibitors: A systematic review and metaanalysis,2021,https://doi.org/10.1016/j.jbspin.2020.105112,33276135,False
783,Effectiveness of initial methotrexate-based treatment approaches in early rheumatoid arthritis: an elicitation of rheumatologists’ beliefs,2020,https://doi.org/10.1093/rheumatology/keaa803,33367919,False
784,The results of investigating the efficacy and safety of non-medical switching from the original rituximab to its biosimilar in rheumatoid arthritis patients (AMBIRA study),2021,https://doi.org/10.47360/1995-4484-2020-663-672,,False
785,"Correspondence on ‘Cardiovascular effects of biological versus csDMARD therapy in treatment naive, early rheumatoid arthritis’",2021,https://doi.org/10.1136/annrheumdis-2021-219891,33558259,False
786,Monitoring of Peripheral Blood Leukocytes and Plasma Samples: A Pilot Study to Examine Treatment Response to Leflunomide in Rheumatoid Arthritis,2021,https://doi.org/10.3390/ph14020106,33573015,False
787,Insulin resistance in patients with rheumatoid arthritis,2021,https://doi.org/10.1007/s00296-021-04814-6,33635386,False
788,Musculoskeletal ultrasound using superb microvascular imaging documents treatment response to biosimilar infliximab in rheumatoid arthritis,2021,https://doi.org/10.1136/bcr-2020-239112,33602763,False
789,Discrepancy Between Multibiomarker Disease Activity and Clinical Disease Activity Scores in Patients With Persistently Active Rheumatoid Arthritis,2022,https://doi.org/10.1002/acr.24583,33644992,True
790,"Effect of total glucosides of paeony and Tripterygium wilfordii polyglycosides on erythrocyte methotrexate polyglutamates in rats, analysed using ultra-high-performance liquid chromatography-tandem mass spectrometry",2021,https://doi.org/10.1093/jpp/rgab025,33749788,False
791,Quality evaluation of the underlying evidence in the updated treatment recommendations for systemic lupus erythematosus,2021,https://doi.org/10.1093/rheumatology/keab306,33764408,False
792,Use of Janus kinase inhibitors in the treatment of immunoinflammatory rheumatic diseases: safety issues,2021,https://doi.org/10.21518/2079-701x-2021-2-76-84,,False
793,Artritis reumatoide: Tratamiento,2021,https://doi.org/10.1016/j.med.2021.03.028,,False
794,Biomarkers of tolerance in immune-mediated inflammatory diseases: a new era in clinical management?,2021,https://doi.org/10.1016/s2665-9913(21)00069-2,,False
795,Diagnosing and managing patients with rheumatoid arthritis,2021,https://doi.org/10.1097/01.jaa.0000742944.34230.87,33870928,False
796,Clinical pharmacology of filgotinib in the treatment of rheumatoid arthritis: current insights,2021,https://doi.org/10.1080/17512433.2021.1913050,33847204,False
797,Frecuencia de positividad de la prueba de intradermorreacción a tuberculina en una cohorte de pacientes con artritis reumatoide,2021,https://doi.org/10.7705/biomedica.5416,34559494,False
798,The role of imaging in predicting the development of rheumatoid arthritis,2021,https://doi.org/10.2478/rir-2021-0007,36467903,False
799,Comment on: Telemedicine in the management of rheumatoid arthritis: maintaining disease control with less health-care utilization,2021,https://doi.org/10.1093/rap/rkab032,34124537,False
800,Increased disease activity in early arthritis patients with anti-carbamylated protein antibodies,2021,https://doi.org/10.1038/s41598-021-89502-y,33976334,False
801,Nurse‐Led Consultation for Patients With Rheumatoid Arthritis at Low Disease Activity: A Randomized Noninferiority Trial,2022,https://doi.org/10.1002/acr.24625,33973407,True
802,Minicircles for Investigating and Treating Arthritic Diseases,2021,https://doi.org/10.3390/pharmaceutics13050736,34067675,False
803,A Critical Look at Race‐Based Practices in Rheumatology Guidelines,2022,https://doi.org/10.1002/acr.24645,33973416,False
804,Correspondence on ‘Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study’,2021,https://doi.org/10.1136/annrheumdis-2021-220494,34039620,False
805,Therapeutic education improves rheumatoid arthritis patients’ knowledge about methotrexate: a single center retrospective study,2021,https://doi.org/10.1007/s00296-021-04893-5,34050794,False
806,"Disease Activity Indices in Rheumatoid Arthritis: Comparative Performance to Detect Changes in Function, IL-6 Levels, and Radiographic Progression",2021,https://doi.org/10.3389/fmed.2021.669688,34136506,False
807,Does opioid-based pharmacotherapy have a place in rheumatoid arthritis therapy?,2021,https://doi.org/10.1080/14656566.2021.1940136,34129419,False
808,Initial methotrexate dosage is not associated with an increased risk of liver toxicity in patients with rheumatoid arthritis,2021,https://doi.org/10.1007/s10067-021-05811-7,34115231,False
809,A musculoskeletal ultrasound program as an intervention to improve disease modifying anti-rheumatic drugs adherence in rheumatoid arthritis: a randomized controlled trial,2021,https://doi.org/10.1080/03009742.2021.1901416,34107851,True
810,Targeted and biological drugs in the treatment of inflammatory rheumatic diseases,2021,https://doi.org/10.36290/vnl.2021.052,34275303,False
811,Methotrexate Reduces the Probability of Discontinuation of TNF Inhibitors in Seropositive Patients With Rheumatoid Arthritis. A Real-World Data Analysis,2021,https://doi.org/10.3389/fmed.2021.692557,34268325,False
812,Long-Term Maintenance of Golimumab Effectiveness for Injection Spacing in Rheumatoid Arthritis Patients with Low Disease Activity Who Previously Received Other TNF Inhibitors: Minimum 2-year Data From an Observational Study,2021,https://doi.org/10.1007/s40268-021-00355-2,34173221,False
813,Cost per responder for upadacitinib vs abatacept in patients with moderate-to-severe Rheumatoid Arthritis in Italy,2021,https://doi.org/10.33393/grhta.2021.2267,36627881,False
814,Corticosteroid injections in the temporomandibular joint temporarily alleviate pain and improve function in rheumatoid arthritis,2021,https://doi.org/10.1007/s10067-021-05860-y,34287722,False
815,Artritis reumatoide: manifestaciones extraarticulares y comorbilidades,2022,https://doi.org/10.1016/j.rcreu.2021.03.015,,False
816,Application of Automated Hand Ultrasound Scanning and a Simplified Three-Joint Scoring System for Assessment of Rheumatoid Arthritis Activity,2021,https://doi.org/10.1016/j.ultrasmedbio.2021.06.007,34315618,False
817,Treatment of moderate rheumatoid arthritis,2021,https://doi.org/10.1093/rheumatology/keab582,34289023,False
818,The impact of T2T therapy on the treatment of the patients with the early rheumatoid arthritis (data from OREL registry),2021,https://doi.org/10.47360/1995-4484-2021-269-274,,False
819,Tapering of disease-modifying antirheumatic drugs: an overview for daily practice,2021,https://doi.org/10.1016/s2665-9913(21)00224-1,,False
820,The effect of nurse‐led care on fatigue in patients with rheumatoid arthritis: A systematic review and meta‐analysis of randomised controlled studies,2021,https://doi.org/10.1111/jocn.16003,34396605,False
821,Patterns of Response to Different Treatment Strategies in Seropositive Rheumatoid Arthritis Patients in a Tertiary Hospital in South‐Western Saudi Arabia: A Retrospective Study,2021,https://doi.org/10.2147/oarrr.s322833,34429668,False
822,Association between 9-month isoniazid prophylaxis of latent tuberculosis and severe hepatitis in patients treated with TNF inhibitors,2021,https://doi.org/10.1038/s41598-021-97444-8,34504225,False
823,Genetic Polymorphisms of GGH and ABCC2 Are Associated with Methotrexate Intolerance in Patients with Rheumatoid Arthritis,2021,https://doi.org/10.3390/jcm10184070,34575187,False
824,Systemic inflammatory responses after orthopedic surgery in patients with rheumatoid arthritis treated with tofacitinib,2021,https://doi.org/10.1007/s10067-021-05914-1,34545450,False
825,Methotrexat-Versorgung vor dem Einsatz von Biologika bei rheumatoider Arthritis,2021,https://doi.org/10.1007/s00393-021-01086-0,34545429,False
826,New Insights into Bone Loss in RA,2021,https://doi.org/10.1055/a-1577-2719,,False
827,Atypical Cogan's Syndrome Mimicking Giant Cell Arteritis Successfully Treated with Early Administration of Tocilizumab,2022,https://doi.org/10.2169/internalmedicine.7674-21,34615818,False
828,Monitoring of rheumatoid arthritis: a patient survey on disease insight and possible added value of an innovative inflammation monitoring device,2021,https://doi.org/10.1007/s00296-021-05026-8,34676427,False
829,Retention of golimumab treatment following discontinuation of non‐TNF inhibitors in patients with inflammatory rheumatic diseases: An analysis of the Spanish BIOBADASER registry,2021,https://doi.org/10.1002/msc.1595,34668303,False
830,Effect of TNF inhibitors with bisphosphonates vs bisphosphonates alone on bone mineral density and bone and cartilage biomarkers at 1 year in patients with rheumatoid arthritis: A prospective study,2021,https://doi.org/10.1093/mr/roab037,34910195,False
831,Certolizumab Can Also Be Effective in Monotherapy for the Treatment of Rheumatoid Arthritis Patients,2021,https://doi.org/10.2147/btt.s322860,34712042,False
832,Correlation and agreement between physical and ultrasound examination after a training session dedicated to the standardization of synovitis assessment in rheumatoid arthritis patients,2021,https://doi.org/10.1186/s42358-021-00227-y,34794509,False
833,Clinical utility of therapy selection informed by predicted non-response to tumor necrosis factor-ɑ inhibitors: an analysis from the Study to Accelerate Information of Molecular Signatures (AIMS) in Rheumatoid Arthritis,2021,https://doi.org/10.1080/14737159.2022.2020648,34937469,False
834,Paradoxical Reactions to Biologicals in Chronic Inflammatory Systemic Diseases.,2022,https://doi.org/10.3238/arztebl.m2022.0067,34939919,False
835,"Development, psychometric evaluation and cognitive debriefing of the rheumatoid arthritis symptom and impact questionnaire (RASIQ)",2021,https://doi.org/10.1186/s41687-021-00400-3,34894330,False
836,"European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response",2021,https://doi.org/10.1093/rheumatology/keab945,34940840,False
837,Frequency and Duration of Early Non-serious Adverse Events in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Treated with Tofacitinib,2021,https://doi.org/10.1007/s40744-021-00405-w,34921355,False
838,Clinical efficacy and safety of methotrexate compared with leflunomide in the treatment of rheumatoid arthritis,2021,https://doi.org/10.1097/md.0000000000028285,34941113,False
839,Predictive factors for achievement of treatment goals in patients with postmenopausal osteoporosis treated with denosumab,2021,https://doi.org/10.1093/mr/roab129,34939114,False
840,Rheumatoid arthritis and myasthenia gravis: a case-based review of the therapeutic options,2022,https://doi.org/10.1007/s10067-022-06062-w,35031874,False
841,Predictive factors for retention of golimumab over a median 4‐year duration in Japanese patients with rheumatoid arthritis in a real‐world setting: A retrospective study and literature review,2022,https://doi.org/10.1111/1756-185x.14281,34989482,False
842,Implementing a <scp>Treat‐to‐Target</scp> Approach for Rheumatoid Arthritis During the <scp>COVID</scp> ‐19 Pandemic: Results of a Virtual Learning Collaborative Program,2022,https://doi.org/10.1002/acr.24830,35119779,False
843,Disease modification in gout: a qualitative study of gout expert rheumatologists,2022,https://doi.org/10.1093/rap/rkab107,35028499,False
844,Drug efficacy and safety of biologics and Janus kinase inhibitors in elderly patients with rheumatoid arthritis,2021,https://doi.org/10.1093/mr/roab003,34894239,False
845,Research advances in the role and pharmaceuticals of ATP-binding cassette transporters in autoimmune diseases,2022,https://doi.org/10.1007/s11010-022-04354-y,35034257,False
846,Persistence of bDMARD therapy in Rheumatoid Arthritis after first-line TNF-inhibitor failure: the RECORD study of the Italian Society for Rheumatology,2022,https://doi.org/10.1080/03009742.2021.2003033,35023421,False
847,High Sensitivity C Reactive Protein in Patients with Rheumatoid Arthritis Treated with Antibodies against IL-6 or Jak Inhibitors: A Clinical and Ultrasonographic Study,2022,https://doi.org/10.3390/diagnostics12010182,35054349,False
848,Angiotensin Converting Enzyme Activity in Anti-TNF-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients,2022,https://doi.org/10.3389/fmed.2021.785744,35155468,False
849,A Patient with Symmetrical Polyarthritis. The Value of Conventional Radiography for a Correct Diagnosis,2022,https://doi.org/10.1007/s40744-022-00426-z,35113362,False
850,Conversion of the MDHAQ to the HAQ score: a simple algorithm developed and validated in a cohort of 13 391 real-world patients,2022,https://doi.org/10.1093/rheumatology/keac040,35108380,False
851,Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes,2022,https://doi.org/10.1007/s40744-021-00418-5,35113363,False
852,Impact of lifestyle and comorbidities on seropositive rheumatoid arthritis risk from Korean health insurance data,2022,https://doi.org/10.1038/s41598-022-06194-8,35140294,False
853,Pathogenesis of follicular thymic hyperplasia associated with rheumatoid arthritis,2022,https://doi.org/10.1111/pin.13212,35147259,False
854,The Role of Shared Epitope in Rheumatoid Arthritis Prognosis in Relation to Anti-Citrullinated Protein Antibody Positivity,2022,https://doi.org/10.1007/s40744-022-00427-y,35174462,False
855,Population Pharmacokinetic and Exposure–Response Model Simulations: Predicted Exposure and Efficacy for Maintenance Doses of Intravenous Golimumab Every 6 or 8 Weeks in Patients With Moderately to Severely Active Rheumatoid Arthritis,2022,https://doi.org/10.1016/j.clinthera.2022.01.015,35183373,True
856,Factors influencing the Sharp score of 1057 patients with rheumatoid arthritis and anemia: a retrospective study,2022,https://doi.org/10.1177/03000605221088560,35345929,False
857,Current status of shared decision making for rheumatoid arthritis treatment in Japan: a web-based survey on physicians and patients,2022,https://doi.org/10.1080/03007995.2022.2050108,35260022,False
858,Ultrasound scoring systems for evaluation of synovitis and tenosynovitis in patients with rheumatoid arthritis,2022,https://doi.org/10.4103/jmu.jmu_146_21,35465587,False
859,Interruptions of biological and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: a descriptive cohort study assessing trends in patient characteristics in Switzerland,2022,https://doi.org/10.1136/bmjopen-2021-056352,35292498,False
860,Lymphocyte activation gene-3 (LAG-3) regulatory T cells: An evolving biomarker for treatment response in autoimmune diseases,2022,https://doi.org/10.1016/j.autrev.2022.103085,35341974,False
861,"Unmet Needs in Rheumatoid Arthritis: A Subgroup of Patients With High Levels of Pain, Fatigue, and Psychosocial Distress 3 Years After Diagnosis",2022,https://doi.org/10.1002/acr2.11422,35262276,False
862,Gut microbial dysbiosis in rheumatoid arthritis: a systematic review protocol of case-control studies,2022,https://doi.org/10.1136/bmjopen-2021-052021,35365513,False
863,"Real-World Evidence of the Effectiveness and Safety of Generic Tofacitinib in Rheumatoid Arthritis Patients: A Retrospective, Single-Centre Analysis from Western India",2022,https://doi.org/10.1101/2022.04.08.22273582,,False
864,Identification of poor prognostic joint locations in an early rheumatoid arthritis cohort at risk of rapidly progressing disease: a post-hoc analysis of the Phase III AGREE study,2022,https://doi.org/10.1186/s41927-022-00252-4,35418172,False
865,Genetic and Clinical Factors Associated with Olokizumab Treatment in Russian Patients with Rheumatoid Arthritis,2022,https://doi.org/10.3390/jpm12040641,35455757,False
866,Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy and Control of Immune-Mediated Inflammatory Diseases—Reply,2022,https://doi.org/10.1001/jama.2022.2938,35438729,False
867,Enhanced In Vitro Antiviral Activity of Hydroxychloroquine Ionic Liquids against SARS-CoV-2,2022,https://doi.org/10.3390/pharmaceutics14040877,35456711,False
868,Male Sex Predicts a Favorable Outcome in Early ACPA-Negative Rheumatoid Arthritis: Data From an Observational Study,2022,https://doi.org/10.3899/jrheum.211199,35501149,False
869,Real-world evidence of tofacitinib in rheumatoid arthritis patients in Spain,2022,https://doi.org/10.5582/ddt.2022.01028,35491233,False
870,"Comparison of Teleconsultations and In-Person Consultations from Outpatients with Rheumatoid Arthritis, During the COVID-19 Pandemic: An Internal Audit of Medical Notes",2022,https://doi.org/10.1089/tmj.2022.0078,35506921,False
871,Development and validation of a self-administered questionnaire measuring essential knowledge in patients with rheumatoid arthritis,2022,https://doi.org/10.1007/s00296-022-05090-8,35389078,False
872,The Aftermath of Tapering Tocilizumab After Achieving Treatment Target in Patients With Rheumatoid Arthritis: A Nationwide Cohort Study,2022,https://doi.org/10.3389/fmed.2022.839206,35211491,False
873,Pharmacoeconomic analysis of biologics and methotrexate for rheumatoid arthritis from the standpoint of the number needed to treat concept under the Japanese health insurance system,2022,https://doi.org/10.1186/s12962-022-00347-2,35331233,False
874,Does tenosynovitis of the hand detected by B-mode ultrasound predict loss of clinical remission in rheumatoid arthritis? Results from a real-life cohort,2022,https://doi.org/10.15557/jou.2022.0004,35449701,False
875,"Treatment Satisfaction, Patient Preferences, and the Impact of Suboptimal Disease Control in Rheumatoid Arthritis Patients in Greece: Analysis of the Greek Cohort of SENSE study",2022,https://doi.org/10.31138/mjr.33.1.14,35611113,False
876,When topical therapy of atopic dermatitis fails: a guide for the clinician,2021,https://doi.org/10.1080/1744666x.2021.2000390,34720031,False
877,Difficult-to-treat rheumatoid arthritis in the clinical practice of a rheumatological hospital. First look,2022,https://doi.org/10.14412/1996-7012-2022-2-13-20,,False
878,Pharmacokinetics and Safety of Single and Multiple Doses of Peficitinib (ASP015K) in Healthy Chinese Subjects,2022,https://doi.org/10.2147/dddt.s359501,35586186,True
879,Implementation of the treat-to-target approach and treatment satisfaction in patients with rheumatoid arthritis: perspectives of Chinese rheumatologists,2022,https://doi.org/10.1007/s10067-022-06187-y,35579773,False
880,Long-term drug effectiveness and survival for reference rituximab in rheumatoid arthritis patients in an ordinary outpatient clinic,2022,https://doi.org/10.1038/s41598-022-12271-9,35585215,False
881,"Surgical intervention for patients with rheumatoid arthritis is declining except for foot and ankle surgery: A single-centre, 20-year observational cohort study",2022,https://doi.org/10.1093/mr/roac042,35536604,False
882,Identification of novel off targets of baricitinib and tofacitinib by machine learning with a focus on thrombosis and viral infection,2022,https://doi.org/10.1038/s41598-022-11879-1,35551258,False
883,Real-world evidence on methotrexate-free subcutaneous tocilizumab therapy in patients with rheumatoid arthritis: 24-week data from the SIMPACT study,2022,https://doi.org/10.1093/rap/rkac038,35663154,False
884,Remission and Low Disease Activity in Granulomatosis With Polyangiitis and Microscopic Polyangiitis: Prevalence and Impact on Damage Accrual,2022,https://doi.org/10.1002/acr.24958,35604889,False
885,Efficacy and safety of HLX01 in patients with moderate-to-severe rheumatoid arthritis despite methotrexate therapy: a phase 3 study,2022,https://doi.org/10.1186/s13075-022-02821-x,35689239,True
886,Oral methotrexate at doses 15–25 mg/week is non-inferior to parenteral regarding efficacy and safety in the treatment of rheumatoid arthritis: a systematic review and meta-analysis,2022,https://doi.org/10.1007/s10067-022-06221-z,35672619,False
887,Making space for patients’ preferences in precision medicine: a qualitative study exploring perspectives of patients with rheumatoid arthritis,2022,https://doi.org/10.1136/bmjopen-2021-058303,35649604,False
888,Immune‐related conditions and cancer‐specific mortality among older adults with cancer in the United States,2022,https://doi.org/10.1002/ijc.34140,35633044,False
889,Assessing acceptability and identifying barriers and facilitators to implementation of the EULAR recommendations for patient education in inflammatory arthritis: a mixed-methods study with rheumatology professionals in 23 European and Asian countries,2022,https://doi.org/10.1136/annrheumdis-2022-222253,35676076,False
890,Three Months of Glucocorticoids in Rheumatoid Arthritis: A Bridge Too Short?,2022,https://doi.org/10.1002/art.42249,35643954,False
891,Difficult-to-treat rheumatoid arthritis in real clinical practice. Preliminary results,2022,https://doi.org/10.26442/00403660.2022.05.201489,36286966,False
892,Efficacy of Abatacept Versus Tumor Necrosis Factor Inhibitors in Anti-citrullinated Protein Antibody-Positive Patients with Rheumatoid Arthritis: Results from a Korean Nationwide Biologics Registry,2022,https://doi.org/10.1007/s40744-022-00467-4,35716235,False
893,Trends of adverse events and mortality after DMARDs in patients with rheumatoid arthritis: Interrupted time‐series analysis,2022,https://doi.org/10.1002/iid3.630,35759234,False
894,Can we finally exonerate methotrexate as a factor in causing or exacerbating fibrotic interstitial lung disease in patients with rheumatoid arthritis?,2022,https://doi.org/10.1007/s10067-022-06245-5,35729371,False
895,"Serum Amyloid A Protein–Associated Kidney Disease: Presentation, Diagnosis, and Management",2022,https://doi.org/10.1016/j.xkme.2022.100504,35879979,False
896,Lessons learned from the preclinical discovery and development of sarilumab for the treatment of rheumatoid arthritis,2022,https://doi.org/10.1080/17460441.2022.2093852,35757853,False
897,Safety and effectiveness of certolizumab pegol in Japanese patients with rheumatoid arthritis: Results from a 24-week post-marketing surveillance study,2022,https://doi.org/10.1093/mr/roac073,35822806,False
898,"Pharmacokinetic Characteristics, Safety, and Tolerability of Telitacicept, an Injectable Recombinant Human B‐Lymphocyte Stimulating Factor Receptor‐Antibody Fusion Protein, in Healthy Chinese Subjects",2022,https://doi.org/10.1002/cpdd.1136,35844038,True
899,"Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study",2022,https://doi.org/10.3390/jcm11144178,35887946,False
900,Subcutaneous panniculitis‐like <scp>T‐cell</scp> lymphoma associated with methotrexate treatment,2022,https://doi.org/10.1111/1346-8138.16524,35892130,False
901,Clinical prediction models for methotrexate treatment outcomes in patients with rheumatoid arthritis: A systematic review and meta-analysis,2022,https://doi.org/10.1016/j.semarthrit.2022.152076,35921745,False
902,Probability of Medication Intensifications in Rheumatoid Arthritis Patients With Low Disease Activity Scores on Their Patient-Reported Outcomes,2022,https://doi.org/10.1097/rhu.0000000000001883,35905459,False
903,"Dantrolene, a stabilizer of the ryanodine receptor, prevents collagen-induced arthritis",2022,https://doi.org/10.1016/j.bbrc.2022.07.111,35940127,False
904,"A Multicenter, Prospective, Randomized, <scp>Parallel‐Group</scp> Trial on the Effects of Temporary Methotrexate Discontinuation for One Week Versus Two Weeks on Seasonal Influenza Vaccination in Patients With Rheumatoid Arthritis",2022,https://doi.org/10.1002/art.42318,35930728,True
905,Early persistence on therapy impacts drug-free remission: a case-control study in a cohort of Hispanic patients with recent-onset rheumatoid arthritis,2022,https://doi.org/10.1186/s13075-022-02884-w,35962421,False
906,Managing inadequate response to initial anti-TNF therapy in rheumatoid arthritis: optimising treatment outcomes,2022,https://doi.org/10.1177/1759720x221114101,35991524,False
907,Validation of the Simplified Disease Activity Index (SDAI) with a quick quantitative C-reactive protein assay (SDAI-Q) in patients with rheumatoid arthritis: a prospective multicenter cross-sectional study,2022,https://doi.org/10.1177/1759720x221114107,36003590,False
908,Reasons and risk factors for discontinuation of treatment with any biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: A long-term observational study,2022,https://doi.org/10.1093/mr/roac090,35975317,False
909,Validity and Reliability of the Thai Version of the 19-Item Compliance-Questionnaire-Rheumatology,2022,https://doi.org/10.2147/ppa.s374445,36003800,False
910,"The long‐term persistence of <scp>tumor necrosis factor</scp> inhibitors in patients with moderate to severe immune‐mediated rheumatic diseases: A nation‐wide, population‐based real‐world study",2022,https://doi.org/10.1111/1756-185x.14423,35975402,False
911,Emerging story of gut dysbiosis in spondyloarthropathy: From gastrointestinal inflammation to spondyloarthritis,2022,https://doi.org/10.3389/fcimb.2022.973563,36072223,False
912,Sex differences in remission rates over 24 weeks among three different biological treatments compared to conventional therapy in patients with early rheumatoid arthritis (NORD-STAR): a post-hoc analysis of a randomised controlled trial,2022,https://doi.org/10.1016/s2665-9913(22)00186-2,,False
913,Specific enterotype of gut microbiota predicted clinical effect of methotrexate in patients with rheumatoid arthritis,2022,https://doi.org/10.1093/rheumatology/keac458,35946529,False
914,PHARAO-Studie: Arzneimittelversorgung entzündlich rheumatischer Erkrankungen,2022,https://doi.org/10.1007/s00393-022-01259-5,36006471,False
915,Impact of initial therapy with upadacitinib or adalimumab on achievement of 48-week treatment goals in patients with rheumatoid arthritis: <i>post hoc</i> analysis of SELECT-COMPARE,2022,https://doi.org/10.1093/rheumatology/keac477,36018230,True
916,Basic Methods of Physical Rehabilitation of Patients with Rheumatoid Arthritis,2022,https://doi.org/10.26693/jmbs07.04.019,,False
917,"Quality of life, disease activity and preferences for administration routes in rheumatoid arthritis: a multicentre, prospective, observational study",2022,https://doi.org/10.1093/rap/rkac071,36133962,False
918,"Mindfulness-based stress reduction to improve depression, pain and high patient global assessment in controlled rheumatoid arthritis",2022,https://doi.org/10.1093/rap/rkac074,36157617,False
919,Nano-Based Co-Delivery System for Treatment of Rheumatoid Arthritis,2022,https://doi.org/10.3390/molecules27185973,36144709,False
920,Development and real-life use assessment of a self-management smartphone application for patients with inflammatory arthritis. A user-centred step-by-step approach,2022,https://doi.org/10.1371/journal.pone.0272235,36107954,False
921,An intersectional analysis of LncRNAs and mRNAs reveals the potential therapeutic targets of Bi Zhong Xiao Decoction in collagen-induced arthritis rats,2022,https://doi.org/10.1186/s13020-022-00670-z,36109779,False
922,Plasma calprotectin as a biomarker of ultrasound synovitis in rheumatoid arthritis patients receiving IL-6 antagonists or JAK inhibitors,2022,https://doi.org/10.1177/1759720x221114105,36148395,False
923,"Remission or Not Remission, That’s the Question: Shedding Light on Remission and the Impact of Objective and Subjective Measures Reflecting Disease Activity in Rheumatoid Arthritis",2022,https://doi.org/10.1007/s40744-022-00490-5,36129667,False
924,Management of chronic rheumatic diseases in women 18–45 years of age in Asia Pacific: insights from patient and clinician surveys,2022,https://doi.org/10.1007/s00296-022-05206-0,36163594,False
925,Potential of Disease-Modifying Anti-Rheumatic Drugs to Limit Abdominal Aortic Aneurysm Growth,2022,https://doi.org/10.3390/biomedicines10102409,36289670,False
926,Determinants of prescribing decisions for off-patent biological medicines in Belgium: a qualitative study,2022,https://doi.org/10.1186/s12913-022-08591-1,36175885,False
927,Real-world effectiveness and persistence of reference etanercept versus biosimilar etanercept GP2015 among rheumatoid arthritis patients: A cohort study,2022,https://doi.org/10.3389/fphar.2022.980832,36263118,False
928,Egyptian guidelines for the treatment of Rheumatoid Arthritis — 2022 update,2022,https://doi.org/10.1186/s43166-022-00153-x,,False
929,Adiponectin and Leptin as Biomarkers of Disease Activity and Metabolic Disorders in Rheumatoid Arthritis Patients,2022,https://doi.org/10.2147/jir.s380642,36247076,False
930,Effects of One-Year Tofacitinib Therapy on Lipids and Adipokines in Association with Vascular Pathophysiology in Rheumatoid Arthritis,2022,https://doi.org/10.3390/biom12101483,36291691,False
931,Management of Axial Spondyloarthritis – Insights into Upadacitinib,2022,https://doi.org/10.2147/dddt.s330413,36268520,False
932,"Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas",2022,https://doi.org/10.5009/gnl210551,36268584,False
933,Diet and the risk of rheumatoid arthritis – A systematic literature review,2023,https://doi.org/10.1016/j.semarthrit.2022.152118,36379128,False
934,Real-World Safety Profile of Biologics Used in Rheumatology: A Six-Year Observational Pharmacovigilance Study in the Calabria Region,2022,https://doi.org/10.3390/pharmaceutics14112328,36365146,False
935,The Stat3 inhibitor F0648-0027 is a potential therapeutic against rheumatoid arthritis,2022,https://doi.org/10.1016/j.bbrc.2022.10.106,36368156,False
936,Sarcopenia in Immune-Mediated Rheumatic Diseases—Review,2022,https://doi.org/10.1097/rhu.0000000000001913,36322934,False
937,The effect of disease-modifying antirheumatic drugs (DMARDs) on bone homeostasis in rheumatoid arthritis (RA) patients,2022,https://doi.org/10.1007/s10787-022-01088-7,36348208,False
938,Effects of tofacitinib therapy on arginine and methionine metabolites in association with vascular pathophysiology in rheumatoid arthritis: A metabolomic approach,2022,https://doi.org/10.3389/fmed.2022.1011734,36438060,False
939,Baseline bony erosions and time-averaged DAS28 predict discontinuation of TNF inhibitors in rheumatoid arthritis,2022,https://doi.org/10.1038/s41598-022-24027-6,36402804,False
940,Identification of SNPs associated with methotrexate treatment outcomes in patients with early rheumatoid arthritis,2022,https://doi.org/10.3389/fphar.2022.1075603,36467057,False
941,Better Clinical Results in Rheumatoid Arthritis Patients Treated Under a Multidisciplinary Care Model When Compared with a National Rheumatoid Arthritis Registry,2022,https://doi.org/10.2147/oarrr.s385423,36426199,False
942,Machine learning identifies a profile of inadequate responder to methotrexate in rheumatoid arthritis,2022,https://doi.org/10.1093/rheumatology/keac645,36416134,False
943,The Effect of Upadacitinib on Lipid Profile and Cardiovascular Events: A Meta-Analysis of Randomized Controlled Trials,2022,https://doi.org/10.3390/jcm11236894,36498468,False
944,An update on thermal imaging in rheumatoid arthritis,2023,https://doi.org/10.1016/j.jbspin.2022.105496,36423780,False
945,Serum proteomics analysis of biomarkers for evaluating clinical response to MTX/IGU therapy in early rheumatoid arthritis,2023,https://doi.org/10.1016/j.molimm.2022.11.016,36462402,False
946,Early intervention in psoriasis: Where do we go from here?,2022,https://doi.org/10.3389/fmed.2022.1027347,36530901,False
947,Patients treated with rituximab are poorly screened for hepatitis B infection: Data from a low-incidence country,2023,https://doi.org/10.1016/j.ejim.2022.11.024,36462966,False
948,Olokizumab's Effectiveness and Safety in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials,2023,https://doi.org/10.1016/j.jocd.2022.12.003,36535857,False
949,Synergistically targeting synovium STING pathway for rheumatoid arthritis treatment,2023,https://doi.org/10.1016/j.bioactmat.2022.12.001,36582350,False
950,Anti-drug antibodies and rheumatoid factor level in patients with rheumatoid arthritis using the infliximab biosimilar CT-P13,2022,https://doi.org/10.1186/s41927-022-00304-9,36474258,False
951,Regulatory Fibroblast‐Like Synoviocytes Cell Membrane Coated Nanoparticles: A Novel Targeted Therapy for Rheumatoid Arthritis,2022,https://doi.org/10.1002/advs.202204998,36509660,False
952,Case report: JAKi and TNFi dual therapy is a potential treatment strategy for difficult-to-treat rheumatoid arthritis,2022,https://doi.org/10.3389/fimmu.2022.1074329,36591263,False
953,Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis,2022,https://doi.org/10.1136/ard-2022-223443,36526336,False
954,Adherence to methotrexate and associated factors considering social desirability in patients with rheumatoid arthritis: a multicenter cross-sectional study,2022,https://doi.org/10.1186/s41927-022-00305-8,36527156,False
955,Controversies in rheumatology: telemedicine—friend or foe?,2022,https://doi.org/10.1093/rheumatology/keac708,36534821,False
956,A common missense variant rs874881 of PADI4 gene and rheumatoid arthritis: Genetic association study and in-silico analysis,2023,https://doi.org/10.1016/j.gene.2022.147123,36535460,False
957,The added value of predictive biomarkers in treat-to-target strategies for rheumatoid arthritis patients: a conceptual modelling study,2022,https://doi.org/10.1093/rheumatology/keac709,36538875,False
958,Association between Rheumatic Disease Comorbidity Index and factors of poor prognosis in a cohort of 280 patients with rheumatoid arthritis,2022,https://doi.org/10.1186/s41927-022-00308-5,36539858,False
959,Factors Associated With Quality Care Among Adults With Rheumatoid Arthritis,2022,https://doi.org/10.1001/jamanetworkopen.2022.46299,36508216,False
960,Incidence of septic arthritis in patients with ankylosing spondylitis and seropositive rheumatoid arthritis following TNF inhibitor therapy,2022,https://doi.org/10.1093/rheumatology/keac721,36562569,False
961,"Late-onset rheumatoid arthritis registry study, LORIS study: study protocol and design",2022,https://doi.org/10.1186/s41927-022-00322-7,36567352,False
962,Association between malignancy risk and Janus kinase inhibitors versus tumour necrosis factor inhibitors in Korean patients with rheumatoid arthritis: a nationwide population-based study,2022,https://doi.org/10.1136/rmdopen-2022-002614,36549855,False
963,Management of autoinflammatory syndromes and periodic fevers,2022,https://doi.org/10.1016/b978-0-323-95061-9.00049-7,,False
964,Janus kinase inhibitors alter NK cell phenotypes and inhibit their antitumour capacity,2022,https://doi.org/10.1093/rheumatology/keac710,36583542,False
965,Comparison of Biological Agent Monotherapy and Associations Including Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis: Literature Review and Meta-Analysis of Randomized Trials,2022,https://doi.org/10.3390/jcm12010286,36615086,False
966,The prevalence of rheumatoid arthritis in Western Australia,2022,https://doi.org/10.1186/s41927-022-00324-5,36585680,False
967,Janus Kinase Inhibitors: A New Tool for the Treatment of Axial Spondyloarthritis,2023,https://doi.org/10.3390/ijms24021027,36674537,False
968,Matrix Metalloproteinase-9 Level in Synovial Fluid—Association with Joint Destruction in Early Rheumatoid Arthritis,2023,https://doi.org/10.3390/medicina59010167,36676791,False
969,Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAM,2023,https://doi.org/10.1093/rheumatology/kead021,36645243,False
970,From Bench to Bedside in Rheumatoid Arthritis from the “2022 GISEA International Symposium”,2023,https://doi.org/10.3390/jcm12020527,36675455,False
971,"First-time adverse drug reactions, survival analysis, and the share of adverse drug reactions in treatment discontinuation in real-world rheumatoid arthritis patients: a comparison of first-time treatment with adalimumab and etanercept",2023,https://doi.org/10.1080/14740338.2023.2172157,36683590,False
972,"Cardiovascular Risk Assessment in Rheumatoid Arthritis: Accelerated Atherosclerosis, New Biomarkers, and the Effects of Biological Therapy",2023,https://doi.org/10.3390/life13020319,36836675,False
973,Baseline erythrocyte sedimentation rate level predicts long-term inhibition of radiographic progression by tocilizumab: the KURAMA cohort,2023,https://doi.org/10.1080/25785826.2023.2170384,36688476,False
974,Patient participation in defining best-practice rheumatology service provision in Aotearoa New Zealand: a qualitative study with service consumers,2023,https://doi.org/10.1186/s41927-022-00319-2,36694263,False
975,Trends in Hospitalization for Tuberculosis and Other Opportunistic Infections in Australian Patients with Inflammatory Joint Diseases,2023,https://doi.org/10.1007/s40744-023-00534-4,36738423,False
976,Prevalence of apical periodontitis in patients with autoimmune diseases: A case‐control study,2023,https://doi.org/10.1111/iej.13902,36747086,False
977,Global trends in research of fibroblasts associated with rheumatoid diseases in the 21st century: A bibliometric analysis,2023,https://doi.org/10.3389/fimmu.2023.1098977,36845163,False
978,Impact of early age at menopause on disease outcomes in postmenopausal women with rheumatoid arthritis: a large observational cohort study of Korean patients with rheumatoid arthritis,2023,https://doi.org/10.1136/rmdopen-2022-002722,36792311,False
979,Olive Oil and Nuts in Rheumatoid Arthritis Disease Activity,2023,https://doi.org/10.3390/nu15040963,36839323,False
980,"Comparison of risks of cancer, infection, and MACEs associated with JAK inhibitor and TNF inhibitor treatment: a multicentre cohort study",2023,https://doi.org/10.1093/rheumatology/kead079,36794922,False
981,"Efficacy, safety and immunogenicity of etanercept biosimilars versus reference biologics in patients with rheumatoid arthritis: A meta-analysis",2023,https://doi.org/10.3389/fphar.2023.1089272,36874005,False
982,Safety and efficacy associated with long-term low dose glucocorticoids in rheumatoid arthritis: a systematic review and meta-analysis,2023,https://doi.org/10.1093/rheumatology/kead088,36810945,False
983,Upadacitinib for Patients with Rheumatoid Arthritis: A Comprehensive Review,2023,https://doi.org/10.3390/jcm12051734,36902522,False
984,Withdrawal of biologic therapy in juvenile idiopathic arthritis due to remission: predictors of flare and outcomes,2023,https://doi.org/10.1080/14712598.2023.2185132,36825474,False
985,Ixekizumab therapy following secukinumab inadequate response in psoriatic arthritis: a case series focusing on axial disease,2023,https://doi.org/10.1007/s00296-023-05289-3,36840819,False
986,<sup>68</sup>Ga-FAPI PET/CT for Rheumatoid Arthritis: A Prospective Study,2023,https://doi.org/10.1148/radiol.222052,36853178,False
987,Sarcopenia in Rheumatoid arthritis. A narrative review,2023,https://doi.org/10.22540/jfsf-08-044,36873824,False
988,Nanomedicine is more than a supporting role in rheumatoid arthritis therapy,2023,https://doi.org/10.1016/j.jconrel.2023.02.035,36863691,False
989,An update on the use of conventional and biological disease-modifying anti-rheumatic drugs in hand osteoarthritis,2023,https://doi.org/10.1177/1759720x231158618,36937821,False
990,"Reduced versus maximum tolerated methotrexate dose concomitant with adalimumab in patients with rheumatoid arthritis (MIRACLE): a randomised, open-label, non-inferiority trial",2023,https://doi.org/10.1016/s2665-9913(23)00070-x,,False
991,How to self-examine for tender and swollen joints: co-producing a training video for people with rheumatoid arthritis,2023,https://doi.org/10.1093/rap/rkad015,36968635,False
992,Management of Rheumatoid Arthritis With a Digital Health Application,2023,https://doi.org/10.1001/jamanetworkopen.2023.8343,37058302,True
993,The role of interleukin 17 in the pathogenesis of rheumatoid arthritis. Are there any prospects for the use of IL-17 inhibitors?,2023,https://doi.org/10.47360/1995-4484-2023-165-180,,False
994,Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK.,2023,https://doi.org/10.1136/bmj-2022-074678,37253479,False
995,Does methotrexate improve TNF inhibitor drug survival in elderly patients with RA?,2020,https://doi.org/10.1038/s41584-020-0411-7,32210391,False
996,Reply,2020,https://doi.org/10.1002/art.41268,32249541,False
997,Diagnostic Challenges and Management Update in Rheumatoid Arthritis,2020,https://doi.org/10.5772/intechopen.91965,,False
998,Biological disease‐modifying drugs for rheumatoid arthritis,2020,https://doi.org/10.1002/psb.1836,,False
999,Response to: ‘Increasing the threshold for patient global assessment in defining remission may have a different impact in patients with early and established rheumatoid arthritis’ by Bugatti et al,2020,https://doi.org/10.1136/annrheumdis-2020-217705,32398283,False
1000,Background Glucocorticoid Therapy Has No Impact on Efficacy and Safety of Abatacept or Adalimumab in Patients with Rheumatoid Arthritis,2020,https://doi.org/10.3390/jcm9062017,32604962,False
1001,Onkologie und Versorgung in Fach- und Publikumsmedien,2020,https://doi.org/10.1007/s00761-020-00801-x,,False
1002,Growing Need for Diagnostic Precision in Rheumatoid Arthritis: Proposal of MR Imaging Criteria for Early Diagnosis,2020,https://doi.org/10.5772/intechopen.92989,,False
1003,Response to: ‘Comment on ‘Implication of baseline levels and early changes of C-reactive protein for subsequent clinical outcomes of patients with rheumatoid arthritis treated with tocilizumab’’ by Pethoe-Schramm et al,2020,https://doi.org/10.1136/annrheumdis-2020-218403,32737110,False
1004,Response to: ‘Tapering antirheumatic drugs in a resource-poor setting: real-world evidence’ by Haroon<i>et al</i>,2020,https://doi.org/10.1136/annrheumdis-2020-218731,32816708,False
1005,Time to remission in swollen joints is far faster than patient reported outcomes in rheumatoid arthritis: results from the Ontario Best Practices Research Initiative (OBRI),2020,https://doi.org/10.1093/rheumatology/keaa343,32789456,False
1006,Comment on: ‘It can’t be zero!’ difficulties in completing patient global assessment in rheumatoid arthritis: a mixed methods study: reply,2020,https://doi.org/10.1093/rheumatology/keaa488,33020820,False
1007,Whole Genome and Embryo Transcriptome Analysis of Vertebrate Identifies nxhl Controlling Angiogenesis by Targeting VE-PTP,2019,https://doi.org/10.1101/804609,,False
1008,Whole Genome and Embryo Transcriptome Analysis of Vertebrate Identifies nxhl Controlling Angiogenesis by Targeting VE-PTP,2019,,,False
1009,Budget impact analysis of an early identification and referral model for diagnosing patients with suspected rheumatoid arthritis in Ireland,2020,https://doi.org/10.1093/rap/rkaa059,33364546,False
1010,Development and Validation of Adherence Score for Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs,2020,https://doi.org/10.3389/fphar.2020.572260,33240088,False
1011,"Les patients atteints d’arthrite inflammatoire qui adhèrent le plus au traitement ne font pas plus d’activité physique : une étude transversale de 152 patients, l’étude ImBAIA",2020,https://doi.org/10.1016/j.rhum.2020.10.075,,False
1012,Tapering and discontinuation of oral glucocorticoids without deterioration of disease status in patients with rheumatoid arthritis under a stable treatment,2021,https://doi.org/10.1080/14397595.2020.1864914,33325280,False
1013,One-year direct costs of biological therapy in rheumatoid arthritis and its predictive factors: data from the Moroccan RBSMR registry,2021,https://doi.org/10.1007/s00296-020-04762-7,33386900,False
1014,Risk of infections and cardiovascular and venous thromboembolic events associated with JAK inhibitors in rheumatoid arthritis: protocols of two systematic reviews and network meta-analyses,2020,https://doi.org/10.1136/bmjopen-2020-041420,33384392,False
1015,Compliance with oral disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a Colombian experience,2021,https://doi.org/10.1016/j.rcreue.2020.06.009,,False
1016,Factors predicting addition of disease-modifying antirheumatic drugs after initial methotrexate monotherapy in patients with rheumatoid arthritis,2021,https://doi.org/10.1007/s10067-021-05599-6,33483918,False
1017,Rheumatoid arthritis relapse in patients with other iatrogenic immunodeficiency-associated lymphoproliferative disorders and its treatment,2021,https://doi.org/10.1080/14397595.2021.1879367,33491519,False
1018,Risikostratifizierung für Therapieentscheidungen bei Rheumatoider Arthritis,2021,https://doi.org/10.1055/a-1340-0000,,False
1019,Successful discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis in real-world settings,2021,https://doi.org/10.1080/14397595.2021.1883252,33538611,False
1020,Biologic therapies for the treatment of rheumatoid arthritis,2021,https://doi.org/10.5124/jkma.2021.64.2.95,,False
1021,"Markers of disease severity and positive family history are associated to significant risk perception in rheumatoid arthritis, while compliance with therapy is not: a cross-sectional study in 415 Mexican outpatients",2021,https://doi.org/10.1186/s13075-021-02440-y,33618752,False
1022,Advantages and disadvantages of targeted therapy in patients with rheumatoid arthritis,2021,https://doi.org/10.5124/jkma.2021.64.2.90,,False
1023,Comment on: Real-world single centre use of JAK inhibitors across the rheumatoid arthritis pathway,2021,https://doi.org/10.1093/rheumatology/keab195,33677502,False
1024,"If You Want to Perform a Cost-effectiveness Trial, First Do a Modeling Study",2021,https://doi.org/10.3899/jrheum.201430,33649068,False
1025,Glukokortikoidfreie und glukokortikoidarme Therapie der rheumatoiden Arthritis,2021,https://doi.org/10.1007/s00393-021-00973-w,33689031,False
1026,Influence of prognosis factors on the prescription of targeted treatments in rheumatoid arthritis: A Delphi survey,2021,https://doi.org/10.1016/j.jbspin.2021.105172,33689842,False
1027,Arthralgien mit Nachweis von Anti-CCP-Antikörpern,2021,https://doi.org/10.1007/s00393-021-00992-7,,False
1028,Current Treatment Strategies in Rheumatoid Arthritis After Methotrexate Are Not Enough to Maintain Sustained Remission: There Is No Holy Grail!,2021,https://doi.org/10.1002/art.41746,33779069,False
1029,Clinical Outcomes in Iraqi Patients with Rheumatoid Arthritis Following Earlier or Later Treatment with Etanercept,2021,https://doi.org/10.2147/oarrr.s300838,33907478,False
1030,Actualités dans la polyarthrite rhumatoïde,2021,https://doi.org/10.1016/s1169-8330(21)00104-6,,False
1031,Performance of a pre‐administration infection screening questionnaire in patients with rheumatoid arthritis administered biological disease‐modifying antirheumatic drugs,2021,https://doi.org/10.1111/1756-185x.14108,33847455,False
1032,Current advances in the treatment of autoimmune-associated interstitial lung diseases,2021,https://doi.org/10.5124/jkma.2021.64.4.264,,False
1033,Behandlungsempfehlungen vs. Real-Life: Therapie der rheumatoiden Arthritis in Österreich,2021,https://doi.org/10.1007/s12688-021-00427-w,,False
1034,Elicitation of Rheumatologist Preferences for the Treatment of Patients with Rheumatoid Arthritis After the Failure of a First Conventional Synthetic Disease-Modifying Anti-Rheumatic Agent,2021,https://doi.org/10.1007/s40744-021-00311-1,33939171,False
1035,How important is JAK1 selectivity?,2021,https://doi.org/10.1093/rheumatology/keaa864,33950227,False
1036,Prévalence du COVID-19 chez les patients atteints de rhumatismes inflammatoires chroniques traités par biothérapies ou inhibiteurs des JAK : une étude basée sur la population au cours des deux premiers mois de l’épidémie de COVID-19 en Italie,2021,https://doi.org/10.1016/j.rhum.2021.05.004,34007141,False
1037,Practical management of patients on anti-TNF therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI),2021,https://doi.org/10.1016/j.jbspin.2021.105174,34183155,False
1038,Rheumatologists at a crossroads: blocking tumour necrosis factor or interleukin 6 in disease-modifying anti-rheumatic drug inadequate responder patients with rheumatoid arthritis,2021,https://doi.org/10.1093/rheumatology/keab425,33974043,False
1039,Efficacy of Bi Qi Capsules in combination with methotrexate in the treatment of rheumatoid arthritis,2021,https://doi.org/10.1097/md.0000000000025790,34011040,False
1040,Response to: ‘Correspondence on ‘Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study’ by Gong and Zhang and Lin<i>et al</i>,2021,https://doi.org/10.1136/annrheumdis-2021-220477,34039619,False
1041,Methotrexate-induced lung damage in a patient with rheumatoid arthritis,2021,https://doi.org/10.26442/00403660.2021.03.200656,36286699,False
1042,Hydroxychloroquine dans les maladies systémiques et auto-immunes : où en sommes-nous ?,2021,https://doi.org/10.1016/j.rhum.2021.05.002,,False
1043,Musculoskeletal Ultrasound of Rheumatologic Conditions,2021,https://doi.org/10.1016/j.yacr.2021.04.001,,False
1044,Novel Immunomodulatory Therapies for Respiratory Pathologies,2022,https://doi.org/10.1016/b978-0-12-820472-6.00073-6,,False
1045,Editorial: Traditional Medicine and Rheumatology,2021,https://doi.org/10.3389/fphar.2021.707811,34248649,False
1046,"Switching from TNFα inhibitor to tacrolimus as maintenance therapy in rheumatoid arthritis after achieving low disease activity with TNFα inhibitors and methotrexate: 24-week result from a non-randomized, prospective, active-controlled trial",2021,https://doi.org/10.1186/s13075-021-02566-z,34233727,True
1047,"In the era of disease-modifying antirheumatic drugs, how close are we to treating rheumatoid arthritis without the use of glucocorticoids?",2021,https://doi.org/10.1007/s00296-021-04939-8,34226947,False
1048,Sustained Remission in Rheumatoid Arthritis: Time to Withdraw Treatment?,2021,https://doi.org/10.1002/acr2.11303,34250763,False
1049,AHR-dependent genes and response to MTX therapy in rheumatoid arthritis patients,2021,https://doi.org/10.1038/s41397-021-00238-4,34302046,False
1050,Effect of subcutaneous high-dose methotrexate treatment on the management of rheumatoid arthritis,2021,https://doi.org/10.17826/cumj.914892,,False
1051,ASSOCIATION OF SEROLOGICAL STATUS WITH THE FREQUENCY OF CLINICAL AND RADIOLOGICAL REMISSION IN RHEUMATOID ARTHRITIS,2021,https://doi.org/10.32345/2664-4738.2.2021.09,,False
1052,Heterogeneity in Patient Characteristics and Differences in Treatment Across 4 Canadian Rheumatoid Arthritis Cohorts,2021,https://doi.org/10.3899/jrheum.201688,34334357,False
1053,"Differences and similarities in clinical and functional responses among patients receiving tofacitinib monotherapy, tofacitinib plus methotrexate, and adalimumab plus methotrexate: a post hoc analysis of data from ORAL Strategy",2021,https://doi.org/10.1186/s13075-021-02591-y,34429160,True
1054,Investigating the Causes and Incidence of Mortality in Patients Using Biological Disease Modifying Antirheumatic Drug (DMARD) and the Mortality Rates Thereof Compared to the General Population,2021,https://doi.org/10.20492/aeahtd.894837,,False
1055,The use of biosimilars as a new approach to the treatment of rheumatoid arthritis,2021,https://doi.org/10.21518/2079-701x-2021-10-112-121,,False
1056,Synovial fluid cell count of 84 930/mm3 in adult-onset Still’s disease,2021,https://doi.org/10.1136/bcr-2021-243889,34429291,False
1057,Leflunomide: modern look at safety problem (literature review),2021,https://doi.org/10.33667/2078-5631-2021-16-16-19,,False
1058,Effect of initiating biologics compared to intensifying conventional DMARDs on clinical and MRI outcomes in established rheumatoid arthritis patients in clinical remission: Secondary analyses of the IMAGINE-RA trial,2021,https://doi.org/10.1080/03009742.2021.1935312,34474649,True
1059,The Reproducibility of Patient Self-reported Joint Counts in Rheumatoid Arthritis: A Closer Look at the Results of a Review,2021,https://doi.org/10.3899/jrheum.210822,34470794,False
1060,Ultrasound efficacy of targeted-synthetic disease-modifying anti-rheumatic drug treatment in rheumatoid arthritis: a multicenter prospective cohort study in Japan,2021,https://doi.org/10.1080/03009742.2021.1927389,34474646,False
1061,Predictive Role of Ultrasound Remission for Progressive Ultrasonography-Detected Structural Damage in Patients with Rheumatoid Arthritis,2022,https://doi.org/10.1136/jim-2021-001885,34518320,False
1062,Rheumatology: biosimilars are here to stay,2021,https://doi.org/10.1093/rheumatology/keab663,34559204,False
1063,A not-to-miss Cause of Severe Cervical Spine Pain in a Patient with Rheumatoid Arthritis: A Case-Based Review,2021,https://doi.org/10.31138/mjr.32.3.256,34964030,False
1064,Biologics Targeting Immune Modulation in Inflammatory Disorders,2022,https://doi.org/10.1016/b978-0-12-820472-6.00122-5,,False
1065,Modern Genetic Engineering Technology Achievements in Rheumatology,2021,https://doi.org/10.1088/1755-1315/852/1/012075,,False
1066,Rheumatologic Aspects of the COVID-19 Pandemic: A Practical Resource for Physicians in Kuwait and the Gulf region as Recommended by the Kuwait Association of Rheumatology,2022,https://doi.org/10.2174/1573397117666211007091256,34620059,False
1067,Rehabilitation bei rheumatoider Arthritis,2021,https://doi.org/10.1055/a-1275-2657,34655068,False
1068,Impact of age on the efficacy and safety of peficitinib (ASP015K) for the treatment of rheumatoid arthritis,2021,https://doi.org/10.1093/mr/roab058,34850095,True
1069,Belgian rheumatologists’ preferences regarding measures of disease activity in patients with rheumatoid arthritis: results from a mixed-methods study,2021,https://doi.org/10.1007/s00296-021-05020-0,34687348,False
1070,Tacrolimus as an alternative treatment for patients with juvenile idiopathic arthritis,2021,https://doi.org/10.1093/mr/roab055,34918100,False
1071,Diagnosis and management of rheumatoid arthritis,2021,https://doi.org/10.1002/psb.1945,,False
1072,Guided therapy selection in rheumatoid arthritis using a molecular signature response classifier: an assessment of budget impact and clinical utility,2021,https://doi.org/10.18553/jmcp.2021.21120,34669487,False
1073,Real-world Effectiveness and Safety of JAK Inhibitors in Rheumatoid Arthritis: A Single-centre Study,2022,https://doi.org/10.1016/j.reuma.2021.08.001,,False
1074,JAK-Hemmer bei adulter und juveniler Arthritis,2021,https://doi.org/10.1055/a-1578-5513,,False
1075,Development and validation of a prognostic model for leflunomide discontinuation with abnormal blood tests during long-term treatment: cohort study using data from the Clinical Practice Research Datalink Gold and Aurum,2021,https://doi.org/10.1093/rheumatology/keab790,34718430,False
1076,Pregnancy outcomes in patients with rheumatoid arthritis who discontinue methotrexate treatment to conceive,2021,https://doi.org/10.1007/s10067-021-05985-0,34778939,False
1077,Impact of concomitant chronic kidney disease on hospitalised infections and remission in patients with rheumatoid arthritis: results from the IORRA cohort,2021,https://doi.org/10.1093/mr/roab082,34751783,False
1078,"Frequency and impact of DHODH, ABCG2 and CYP2C19 SNPs on the therapeutic efficacy, tolerability and toxicity of leflunomide",2021,https://doi.org/10.2217/pgs-2020-0146,34747629,False
1079,The impact of diabetes mellitus on treatment and outcomes of rheumatoid arthritis at 5-year follow-up: results from a multi-ethnic Asian cohort,2021,https://doi.org/10.1093/rap/rkab077,34778702,False
1080,"Rheumatoid Arthritis, Osteoarthritis, and Gout",2022,https://doi.org/10.1016/b978-0-12-820472-6.00127-4,,False
1081,Intra-articular glucocorticoid injection site: best practice guidelines,2021,https://doi.org/10.21518/2079-701x-2021-19-155-162,,False
1082,Association between ultrasound images and patient-reported outcomes in the treatment of rheumatoid arthritis: a retrospective study,2021,https://doi.org/10.1186/s41927-021-00221-3,34802464,False
1083,Impact du statut sérologique du facteur rhumatoïde (FR) et des anticorps anti-protéines citrullinées (ACPA) sur le maintien thérapeutique de l’abatacept (ABA) à 2 ans chez des patients (pts) atteints de polyarthrite rhumatoïde (PR),2021,https://doi.org/10.1016/j.rhum.2021.10.193,,False
1084,Rheumatoid Arthritis,2021,https://doi.org/10.1007/978-3-030-80699-6_3,,False
1085,Advances with pharmacotherapy for the treatment of interstitial lung disease,2021,https://doi.org/10.1080/14656566.2021.2016697,34907821,False
1086,Dynamics of clinical manifestations and cytokine concentrations in rheumatoid arthritis patients on tofacitinib therapy,2021,https://doi.org/10.47360/1995-4484-2021-693-699,,False
1087,Impact of multimorbidity on disease modifying antirheumatic drug therapy in early rheumatoid arthritis: Data from the ESPOIR cohort,2022,https://doi.org/10.1016/j.jbspin.2021.105326,34906696,False
1088,Clinical Advantage of Attaining Index-Based Remission Prior to Composite Remission in Treating Rheumatoid Arthritis,2022,https://doi.org/10.1016/j.reuma.2021.09.008,,False
1089,Two-year clinical outcomes after discontinuation of long-term golimumab therapy in Korean patients with rheumatoid arthritis,2022,https://doi.org/10.3904/kjim.2021.018,34883551,False
1090,Impact of a clinical pharmacist in a multidisciplinary consultation on the switch to a biosimilar for inflammatory rheumatic diseases,2022,https://doi.org/10.1016/j.jbspin.2021.105322,34896303,False
1091,Extracorporeal Membrane Oxygenation in Immunocompromised Patients With Acute Respiratory Distress Syndrome—A Retrospective Cohort Study,2021,https://doi.org/10.3389/fmed.2021.755147,34926503,False
1092,Importance of baseline musculoskeletal ultrasound findings in the prognosis of rheumatoid arthritis,2022,https://doi.org/10.1007/s10067-021-06017-7,35041111,False
1093,Application of IL-6 antagonists in autoimmune disorders,2022,https://doi.org/10.1016/b978-0-12-824390-9.00002-5,,False
1094,Glukokortikoidfreie und glukokortikoidarme Therapie der rheumatoiden Arthritis,2021,https://doi.org/10.1007/s12688-021-00467-2,,False
1095,Chondroitin sulfate in therapy osteoarthritis chronic pain patients according to actual clinical recommendations,2022,https://doi.org/10.26442/00403660.2021.12.201241,36286687,False
1096,Rheumatologie 2021,2021,https://doi.org/10.1055/a-1469-2433,,False
1097,Neues zu Therapiestrategien bei der rheumatoiden Arthritis,2022,https://doi.org/10.1007/s00393-021-01144-7,34997270,False
1098,So behandle ich – die Polymyalgia rheumatica mit möglichst geringer kumulativer Glukokortikoiddosis,2022,https://doi.org/10.1007/s00393-022-01157-w,35059811,False
1099,Introduction on therapeutic opportunities for autoimmunity,2022,https://doi.org/10.1016/b978-0-12-824390-9.00012-8,,False
1100,Rheumatoid arthritis and HIV-associated arthritis: Two sides of the same coin or different coins,2022,https://doi.org/10.1016/j.berh.2021.101739,34998696,False
1101,Ultrasound remission in patients with rheumatoid arthritis in clinical remission,2021,https://doi.org/10.5114/reum.2021.112237,35079182,False
1102,Autoantibodies in Common Connective Tissue Diseases: A Primer for Laboratory Professionals,2022,https://doi.org/10.1093/jalm/jfab131,34996077,False
1103,"Clinical-like cryotherapy in acute knee arthritis of the knee improves inflammation signs, pain, joint swelling, and motor performance in mice",2022,https://doi.org/10.1371/journal.pone.0261667,35061737,False
1104,Association of cancer with comorbid inflammatory conditions and treatment in patients with Lynch syndrome,2022,https://doi.org/10.5306/wjco.v13.i1.49,35116232,False
1105,Intraindividual Changes in Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody Tests in Korean Patients Visiting Local Clinics and Hospitals,2022,https://doi.org/10.3390/jcm11030832,35160283,False
1106,JAK inhibition and the holy grail for pain control in early RA,2022,https://doi.org/10.1136/rmdopen-2021-002068,35091464,False
1107,Effect of different initial rituximab regimens on B cell depletion in children with autoimmune neurological diseases,2022,https://doi.org/10.1016/j.msard.2022.103510,35114607,False
1108,The effects of golimumab on patient centric outcomes amongst rheumatoid arthritis patients in Greece. The GO-Q study,2022,https://doi.org/10.1007/s00296-021-05073-1,35091757,False
1109,Ultrasound-guided lymph node biopsy sampling to study the immunopathogenesis of rheumatoid arthritis: a well-tolerated valuable research tool,2022,https://doi.org/10.1186/s13075-022-02728-7,35115042,False
1110,Management of rheumatoid arthritis,2022,https://doi.org/10.1016/j.mpmed.2021.12.003,,False
1111,Practical management of patients on anti-IL6R therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI),2021,https://doi.org/10.1016/j.jbspin.2021.105221,,False
1112,Number needed to treat and cost per responder of Janus kinase inhibitors approved for the treatment of moderate-to-severe rheumatoid arthritis in Japan,2022,https://doi.org/10.1093/mr/roac015,35141743,False
1113,Rheumatoid Arthritis,2017,https://doi.org/10.21019/pharmacotherapyfirst.ra_overview,,False
1114,Post Hoc Analysis of Predictors of Clinical Response to Repository Corticotropin Injection in Persistently Active Rheumatoid Arthritis,2022,https://doi.org/10.1007/s40744-022-00429-w,35184268,False
1115,Editorial: Drug Survival: Treatment of Rheumatic Diseases in the Biologic Era,2022,https://doi.org/10.3389/fmed.2022.858817,35252282,False
1116,Exploring Drug Cost and Disease Outcome in Rheumatoid Arthritis Patients Treated With Biologic and Targeted Synthetic DMARDs in Norway from 2010 to 2019 – A Country With a National Tender System for Prescription of Costly Drugs,2021,https://doi.org/10.2139/ssrn.3907252,,False
1117,"Yunpi Qufeng Chushi Formula for Pre-Rheumatoid Arthritis: Study Protocol for a Multiple-Center, Double-Blind, Placebo-Controlled Randomized Controlled Trial",2022,https://doi.org/10.3389/fphar.2022.793394,35237159,False
1118,A Serious Puzzle Game to Enhance Adherence to Antirheumatic Drugs in Patients With Rheumatoid Arthritis: Systematic Development Using Intervention Mapping (Preprint),2021,https://doi.org/10.2196/preprints.31570,,False
1119,Management of rheumatoid arthritis in China: a study of the implementation of 2019 EULAR recommendations,2022,https://doi.org/10.1136/annrheumdis-2021-221841,35168947,False
1120,Validity and risk of adopting PGA ≤ 2 as a remission criteria of Boolean in clinical practice in patient with rheumatoid arthritis,2022,https://doi.org/10.1038/s41598-022-07046-1,35194126,True
1121,"Painkillers in the treatment of inflammatory arthritis: past, present and future",2022,https://doi.org/10.1093/rheumatology/keac153,35266514,False
1122,Methotrexate Pneumonitis After a Low-Dose Medication Error: A Case Report,2022,https://doi.org/10.7759/cureus.23078,35464521,False
1123,Rheumatic side effects of cancer immunotherapy with immune checkpoint inhibitors,2022,https://doi.org/10.36290/far.2021.025,,False
1124,Tapering subcutaneous methotrexate causes more disease flares compared with tapering oral administration in established rheumatoid arthritis patients,2022,https://doi.org/10.1093/rheumatology/keac154,35266525,False
1125,Early diagnosis and therapy of rheumatoid arthritis,2022,https://doi.org/10.36290/med.2022.001,,False
1126,State-of-the-art glucocorticoid-targeted drug therapies for the treatment of rheumatoid arthritis,2022,https://doi.org/10.1080/14656566.2022.2049238,35313795,False
1127,Antimicrobial agents and torsades de pointes,2022,https://doi.org/10.1016/b978-0-12-821446-6.00012-2,,False
1128,Current Status and Future Challenges in the Treatment of Rheumatic Diseases,2022,https://doi.org/10.3389/fdsfr.2022.881556,,False
1129,Semi-automated socio-anthropologic analysis of the<i>medical discourse</i>on rheumatoid arthritis: potential impact in public health,2022,https://doi.org/10.1101/2022.04.05.22273443,,False
1130,Influence of frailty on patient global assessment in rheumatoid arthritis,2022,https://doi.org/10.1111/ggi.14375,35365932,False
1131,Effectiveness of SB4 transition from originator etanercept in rheumatoid arthritis and axial spondyloarthritis: A subgroup analysis from the BENEFIT study,2022,https://doi.org/10.2478/rir-2022-0005,36467021,False
1132,Factors associated with frailty in rheumatoid arthritis patients with decreased renal function,2022,https://doi.org/10.1093/mr/roac018,35459952,False
1133,Combination therapies in rheumatoid arthritis—choose your partner carefully,2022,https://doi.org/10.1016/s2665-9913(22)00108-4,,False
1134,Musculoskeletal ultrasound may narrow the gap between patients and physicians in the assessment of rheumatoid arthritis disease activity,2022,https://doi.org/10.1093/rheumatology/keac255,35482548,False
1135,Patient Experienced Symptom State in rheumatoid arthritis: sensitivity to change in disease activity and impact,2022,https://doi.org/10.1093/rheumatology/keac257,35482485,False
1136,<scp>ABCB1</scp> gene polymorphisms impact the effect of high‐dose intravenous methylprednisolone therapy on optic neuritis associated with <scp>AQP4‐IgG</scp> ‐positive neuromyelitis optica spectrum disorder,2022,https://doi.org/10.1111/jcpt.13675,35488449,False
1137,The Clinical Presentation and Factors Associated with Disease Severity of Rheumatoid Arthritis in Uganda: A Cross-Sectional Study,2022,https://doi.org/10.2147/oarrr.s361454,35535352,False
1138,OSG-Prothesen am arthritischen und arthrotischen Fuß,2022,https://doi.org/10.1055/a-1785-3679,,False
1139,Biologics in Rheumatoid Arthritis,2022,https://doi.org/10.1007/978-981-16-7200-2_2,,False
1140,Patient Consent for Biologics,2022,https://doi.org/10.1007/978-981-16-7200-2_27,,False
1141,Nachrichten des Verbandes Rheumatologischer Akutkliniken e. V.,2021,https://doi.org/10.1055/a-1670-5087,,False
1142,Metagenomics from bench to bedside and from bedside to bench,2022,https://doi.org/10.1016/b978-0-323-91369-0.00006-6,,False
1143,Discontinuation of methotrexate in rheumatoid arthritis patients achieving clinical remission by treatment with upadacitinib plus methotrexate (DOPPLER study),2022,https://doi.org/10.1097/md.0000000000028463,35029189,False
1144,Hyperlipidemia and rheumatoid arthritis,2022,https://doi.org/10.1016/b978-0-323-85857-1.00003-1,,False
1145,Positive impact on 10-year outcome of the window of opportunity for conventional synthetic DMARDs in rheumatoid arthritis: results from the ESPOIR cohort,2022,https://doi.org/10.1136/rmdopen-2021-002040,35534053,False
1146,Des scores élevés d’évaluation globale par le patient en cas de polyarthrite rhumatoïde en rémission ne reflètent pas une inflammation infraclinique,2022,https://doi.org/10.1016/j.rhum.2022.05.003,,False
1147,Rheumatoid Arthritis,2021,https://doi.org/10.1007/978-981-33-4885-1_6,,False
1148,"Efficacy of Raloxifene as Add-on Therapy on Disease Activity of Postmenopausal Women with Rheumatoid Arthritis: A Double-blind, Randomized, Placebo-controlled Clinical Trial",2023,https://doi.org/10.2174/1573397118666220518114415,35585813,True
1149,To choose or not? The value of discrete-choice experiments in rheumatology,2022,https://doi.org/10.1038/s41584-022-00799-z,35680990,False
1150,Re-Routing Infliximab Therapy: Subcutaneous Infliximab Opens a Path Towards Greater Convenience and Clinical Benefit,2022,https://doi.org/10.1007/s40261-022-01162-6,35657560,False
1151,Rheumatoid arthritis: extra articular manifestations and comorbidities,2022,https://doi.org/10.1016/j.rcreue.2021.03.003,,False
1152,Rheumatoid arthritis patients initiating rituximab with low number of previous bDMARDs failures may effectively reduce rituximab dose and experience fewer serious adverse events than patients on full dose: a 5-year cohort study,2022,https://doi.org/10.1186/s13075-022-02826-6,35655317,False
1153,"Impact of Methotrexate Discontinuation, Interruption, or Persistence in US Patients with Rheumatoid Arthritis Initiating Tofacitinib + Oral Methotrexate Combination",2022,https://doi.org/10.1016/j.clinthera.2022.05.002,35667900,False
1154,Meta‐Analyses on the Effects of Disease‐Modifying Antirheumatic Drugs on the Most Relevant Patient‐Reported Outcome Domains in Rheumatoid Arthritis,2023,https://doi.org/10.1002/acr.24965,35657611,False
1155,Digitalization and disruptive change in rheumatology,2022,https://doi.org/10.1007/s00393-022-01222-4,35639150,False
1156,Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational Study,2022,https://doi.org/10.1002/acr.24966,35678771,False
1157,Combined Conventional Synthetic Disease Modifying Therapy vs. Infliximab for Rheumatoid Arthritis: Emulating a Randomized Trial in Observational Data,2022,https://doi.org/10.1002/cpt.2673,35652244,True
1158,Using observational study data as an external control group for a clinical trial: an empirical comparison of methods to account for longitudinal missing data,2022,https://doi.org/10.1186/s12874-022-01639-0,35643430,False
1159,Practices among General Practitioners in Rheumatoid Arthritis (GEPRA-I): results of a region-wide online survey,2022,https://doi.org/10.1186/s12875-022-01744-5,35659194,False
1160,Subcutaneously-Administered Infliximab in the Management of Rheumatoid Arthritis: A Short Narrative Review of Current Clinical Evidence,2022,https://doi.org/10.2147/jir.s240593,35673354,False
1161,The Clinical Impact of Seropositivity on Treatment Response in Patients with Rheumatoid Arthritis Treated with Etanercept: A Real-World Iraqi Experience,2022,https://doi.org/10.2147/oarrr.s368190,35756976,False
1162,Prévenir les complications cardiovasculaires dans les rhumatismes inflammatoires chroniques,2022,https://doi.org/10.1016/j.monrhu.2022.05.006,,False
1163,Impact of continuity of care on risk for major osteoporotic fracture in patients with new onset rheumatoid arthritis,2022,https://doi.org/10.1038/s41598-022-14368-7,35715560,False
1164,Controversies in rheumatology: maintenance therapy with low-dose glucocorticoids in rheumatoid arthritis,2022,https://doi.org/10.1093/rheumatology/keac355,35713511,False
1165,Janus kinase inhibitors in immunoinflammatory rheumatic diseases,2022,https://doi.org/10.26442/00403660.2022.05.201501,36286957,False
1166,IL-10 Induced by mTNF Crosslinking-Mediated Reverse Signaling in a Whole Blood Assay Is Predictive of Response to TNFi Therapy in Rheumatoid Arthritis,2022,https://doi.org/10.3390/jpm12061003,35743787,False
1167,Comparison of the efficacy and safety of the original rituximab and its biosimilar in routine clinical practice,2022,https://doi.org/10.14412/1996-7012-2022-3-21-28,,False
1168,Relationship between laboratory biomarkers and ultrasonographic signs of inflammation in patients with rheumatoid arthritis treated with a rituximab biosimilar,2022,https://doi.org/10.14412/1996-7012-2022-3-29-36,,False
1169,Impact of a pharmaceutical care service for patients with rheumatoid arthritis using a customised mobile device (the PROUD trial): study protocol for a randomised controlled trial,2022,https://doi.org/10.1136/bmjopen-2022-061917,35728909,False
1170,Long-term outcomes after discontinuing biological drugs and tofacitinib in patients with rheumatoid arthritis: A prospective cohort study,2022,https://doi.org/10.1371/journal.pone.0270391,35737642,False
1171,Development of an interdisciplinary early rheumatoid arthritis care pathway,2022,https://doi.org/10.1186/s41927-022-00267-x,35751106,False
1172,Quality of life and disease activity of patients with rheumatoid arthritis on tofacitinib and biologic disease-modifying antirheumatic drug therapies,2022,https://doi.org/10.1007/s00296-022-05163-8,35759028,False
1173,"Clinical variables, including novel joint index, associated with future patient‐physician discordance in global assessment of rheumatoid arthritis ( <scp>RA</scp> ) disease activity based on a large <scp>RA</scp> database in Japan",2022,https://doi.org/10.1111/1756-185x.14374,35754383,False
1174,THE PLACE OF LEFLUNOMIDE IN DISEASE-MODIFYING THERAPY OF RHEUMATOID ARTHRITIS: NEW ASPECTS,2022,https://doi.org/10.25040/ntsh2022.01.16,,False
1175,Analysis of combined deficiency of interleukin-1 and -6 versus single deficiencies in TNF-mediated arthritis and systemic bone loss,2022,https://doi.org/10.1302/2046-3758.117.bjr-2021-0481.r1,35801532,False
1176,Reply,2022,https://doi.org/10.1002/art.42300,35819803,False
1177,"Treatment Patterns among Patients with Atopic Dermatitis in Secondary Care: A National, Observational, Non-interventional, Retrospective Study in Sweden",2022,https://doi.org/10.2340/actadv.v102.1986,35818736,False
1178,Is Tofacitinib Effectiveness in Patients with Rheumatoid Arthritis Better After Conventional Than After Biological Therapy? – A Cohort Study in a Colombian Population,2022,https://doi.org/10.2147/btt.s361164,35860386,False
1179,Real-life experience of tofacitinib in patients with treatment-resistant rheumatoid arthritis: 5 -year follow up: Monocentric experience,2022,https://doi.org/10.14744/nci.2022.05863,36276563,False
1180,Comparison of remission criteria in patients with rheumatoid arthritis treated with biologic or targeted synthetic disease-modifying anti-rheumatic drugs: results from a nationwide registry,2022,https://doi.org/10.1177/1759720x221096363,35586514,False
1181,Measuring Disease Activity and Functional Capacity in Telerheumatology,2022,https://doi.org/10.1007/978-3-031-00936-5_11,,False
1182,Effectiveness and Safety of Golimumab for Patients ≥75 Years Old with Rheumatoid Arthritis,2022,https://doi.org/10.2169/internalmedicine.8497-21,35850986,False
1183,Optimizing the anti-inflammatory strategies in (osteo)arthritis: local or systemic?,2022,https://doi.org/10.23736/s1824-4785.22.03477-x,35838028,False
1184,Leveraging whole blood based functional flow cytometry assays to open new perspectives for rheumatoid arthritis translational research,2022,https://doi.org/10.1038/s41598-022-16622-4,35842449,False
1185,"The Herbal Combination of Radix astragali, Radix angelicae sinensis, and Caulis lonicerae Regulates the Functions of Type 2 Innate Lymphocytes and Macrophages Contributing to the Resolution of Collagen-Induced Arthritis",2022,https://doi.org/10.3389/fphar.2022.964559,35928276,False
1186,Anti-Citrullinated Protein Antibody Titers Are Independently Modulated by Both Disease Activity and Conventional or Biologic Anti-Rheumatic Drugs,2022,https://doi.org/10.3390/diagnostics12071773,35885675,False
1187,Differential diagnosis of inflammatory arthritis from musculoskeletal ultrasound view,2022,https://doi.org/10.2478/rir-2022-0010,36465322,False
1188,Overlap syndrome variant: transformation of adults' Still's disease into rheumatoid arthritis (clinical case),2022,https://doi.org/10.33667/2078-5631-2022-15-7-13,,False
1189,Measuring a grey area in medication deployment reveals delays from invention to clinical use of rheumatoid arthritis medications,2022,https://doi.org/10.21037/atm-22-3234,35965815,False
1190,Efficacy and Safety of JAK Inhibitors for Rheumatoid Arthritis: A Meta-Analysis,2022,https://doi.org/10.3390/jcm11154459,35956078,False
1191,Twenty Years of Targeted and Biologic Immunomodulatory Drugs,2022,https://doi.org/10.1016/j.mayocp.2022.02.018,35933136,False
1192,Pharmacological treatment for connective tissue disease-associated interstitial lung involvement: Protocol for an overview of systematic reviews and meta-analyses,2022,https://doi.org/10.1371/journal.pone.0272327,35921316,False
1193,"Repurposing of Amisulpride, a known antipsychotic drug, to target synovial fibroblasts activation in arthritis",2022,https://doi.org/10.1101/2022.08.02.500956,,False
1194,Investigation of remission with ultrasound in patients with rheumatoid arthritis according to different clinical remission criteria,2022,https://doi.org/10.18621/eurj.1091860,,False
1195,Anti-Rheumatoid Arthritis Potential of Rhododendron Molle G. Don Leaf Extract in Adjuvant Induced Arthritis Rats,2022,https://doi.org/10.2139/ssrn.4176841,,False
1196,Does persistence to methotrexate treatment in early rheumatoid arthritis have a familial component?,2022,https://doi.org/10.1186/s13075-022-02873-z,35933427,False
1197,Validation and predictive capacity of a Dutch version of the FLARE-RA questionnaire within the context of a TNFi-tapering trial,2022,https://doi.org/10.1007/s10067-022-06320-x,35943667,False
1198,Biologic DMARDs and targeted synthetic DMARDs and the risk of all-cause mortality in rheumatoid arthritis: A systematic review and meta-analysis,2022,https://doi.org/10.1097/md.0000000000029838,35960132,False
1199,Predictors of flare in rheumatoid arthritis patients with persistent clinical remission/low disease activity: Data from the TARAC cohort,2022,https://doi.org/10.1097/md.0000000000029974,35960097,False
1200,ROCK inhibition with Y-27632 reduces joint inflammation and damage in serum-induced arthritis model and decreases in vitro osteoclastogenesis in patients with early arthritis,2022,https://doi.org/10.3389/fimmu.2022.858069,36032152,False
1201,Add-on effectiveness of methotrexate or iguratimod in patients with rheumatoid arthritis exhibiting an inadequate response to Janus kinase inhibitors: The ANSWER cohort study,2022,https://doi.org/10.1093/mr/roac092,35962543,False
1202,Abatacept downregulates Fcγ receptor I on circulating monocytes: a potential therapeutic mechanism in patients with rheumatoid arthritis,2022,https://doi.org/10.1186/s13075-022-02886-8,35964055,False
1203,Five cases of seronegative persistent inflammatory monoarthritis improved with biological therapy,2022,https://doi.org/10.1093/mrcr/rxac063,35959594,False
1204,The serum immunoglobulin G titres against <i>Porphyromonas gingivalis</i> as a predictor of clinical response to 1-year treatment with biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients: A retrospective cohort study,2022,https://doi.org/10.1093/mr/roac093,35962564,False
1205,Can Patients With Controlled Rheumatoid Arthritis Taper Methotrexate From Targeted Therapy and Sustain Remission? A Systematic Review and Metaanalysis,2022,https://doi.org/10.3899/jrheum.220152,35970524,False
1206,Safety and efficacy in the nursing care of people with rheumatic diseases on janus kinase inhibitor therapy,2022,https://doi.org/10.1007/s00296-022-05185-2,35982184,False
1207,Development and validation of equations for conversion from DAS28ESR and DAS28CRP to the SDAI in patients with rheumatoid arthritis,2022,https://doi.org/10.1007/s10067-022-06259-z,35945466,False
1208,Validation of the Korean Leeds satisfaction questionnaire in rheumatoid arthritis with Rasch models,2022,https://doi.org/10.1111/1756-185x.14419,35945672,False
1209,The effective threshold dose of etanercept biosimilars in patients with methotrexate- resistant rheumatoid arthritis,2022,https://doi.org/10.21203/rs.3.rs-1933280/v1,,False
1210,The Assessment of the Quality of Life in Patients with Rheumatoid Foot,2023,https://doi.org/10.2174/1573397118666220819154605,35986529,False
1211,Clinical course in patients with chronic undifferentiated arthritis of the elbow after arthroscopic synovectomy,2022,https://doi.org/10.1016/j.jse.2022.07.011,36007866,False
1212,Adherence to methotrexate and associated factors considering social desirability in patients with rheumatoid arthritis: a multicenter cross-sectional study,2022,https://doi.org/10.1101/2022.08.24.22279163,,False
1213,Comment combler l’écart entre les essais cliniques et la pratique médicale courante dans les rhumatismes inflammatoires chroniques?,2022,https://doi.org/10.1016/j.rhum.2022.03.004,,False
1214,The Safety and Effectiveness of Infliximab Biosimilar in Managing Rheumatoid Arthritis: A Real-Life Experience from Jordan,2022,https://doi.org/10.1155/2022/3406783,36101813,False
1215,"Long‐term retention of golimumab treatment in clinical practice in a large cohort of patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis",2022,https://doi.org/10.1002/msc.1684,35996810,False
1216,The potential role of community pharmacy staff in reducing patient delay in consulting with symptoms of rheumatoid arthritis: a qualitative study,2022,https://doi.org/10.1186/s41927-022-00280-0,35999571,False
1217,Assessment of the effect of DMARD use on the mortality of patients with rheumatoid arthritis,2022,https://doi.org/10.4274/raed.galenos.2022.54264,,False
1218,"National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs)",2022,https://doi.org/10.1007/s00508-022-02062-7,36036323,False
1219,Association between locomotive syndrome and methotrexate discontinuation due to adverse events in rheumatoid arthritis patients: A retrospective observational study,2022,https://doi.org/10.1111/ggi.14475,36039830,False
1220,Treatment Sequence After Initiating Biologic Therapy for Patients With Rheumatoid Arthritis in Korea: A Nationwide Retrospective Cohort Study,2022,https://doi.org/10.4078/jrd.22.0024,,False
1221,Relationship between the prevalence of subclinical tenosynovitis and treatment in patients with RA in clinical remission: STARTER study,2022,https://doi.org/10.1093/rheumatology/keac518,36066434,False
1222,Is histopathological synovitis score a predictor of postoperative requirement for additional or alternative drug treatment in the patients with rheumatoid arthritis?,2022,https://doi.org/10.1093/mr/roac108,36069644,False
1223,Low Serum BAFF Concentration Is Associated with Response to TNF Inhibitors in Seropositive Patients with Rheumatoid Arthritis,2022,https://doi.org/10.3390/jcm11175207,36079136,False
1224,"Prevalence, mortality, and treatment of patients with rheumatoid arthritis: A cohort study of the French National Health Data System, 2010–2019",2023,https://doi.org/10.1016/j.jbspin.2022.105460,36113771,False
1225,Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database,2022,https://doi.org/10.1093/rheumatology/keac533,36099040,False
1226,Defining the relationship between pain intensity and disease activity in patients with rheumatoid arthritis: a secondary analysis of six studies,2022,https://doi.org/10.1186/s13075-022-02903-w,36088424,False
1227,EULAR 75-year anniversary: commentaries on<i>ARD</i>papers from 25 years ago,2022,https://doi.org/10.1136/ard-2022-222585,36104150,False
1228,Difficult-to-Treat Rheumatoid Arthritis in Older Adults: Implications of Ageing for Managing Patients,2022,https://doi.org/10.1007/s40266-022-00976-5,36104655,False
1229,"COVID-19 Pandemisi Sırasında Anti Romatizmal İlaçlara Halkın İlgisi: Türkiye’deki Google Trends Analizi, Kesitsel Çalışma",2022,https://doi.org/10.31832/smj.1035088,,False
1230,The role of monitoring the level of matrix metalloproteinase 3 in patients with rheumatoid arthritis on anti-B-cell therapy,2022,https://doi.org/10.47360/1995-4484-2022-473-480,,False
1231,lncRNA-mediated synovitis in rheumatoid arthritis: A perspective for biomarker development,2022,https://doi.org/10.1016/j.pbiomolbio.2022.09.007,36126801,False
1232,Withdrawal of MTX in rheumatoid arthritis patients on bDMARD/tsDMARD plus methotrexate at target: a systematic review and meta-analysis,2022,https://doi.org/10.1093/rheumatology/keac515,36125185,False
1233,New insights into the pathogenesis and management of rheumatoid arthritis,2022,https://doi.org/10.1002/cdt3.43,36420174,False
1234,Ultrasound response to tofacitinib in patients with rheumatoid arthritis: Data from a multicenter 24 weeks prospective study,2022,https://doi.org/10.3389/fmed.2022.990317,36226143,False
1235,Development of prediction models to select older RA patients with comorbidities for treatment with chronic low-dose glucocorticoids,2022,https://doi.org/10.1093/rheumatology/keac547,36165675,True
1236,Treat to Target (Drug-Free) Inactive Disease in JIA: To What Extent Is This Possible?,2022,https://doi.org/10.3390/jcm11195674,36233546,False
1237,Tapering belimumab in patients with systemic lupus erythematosus: a single-centre experience,2022,https://doi.org/10.1093/rheumatology/keac456,35946521,False
1238,Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Rheumatoid Arthritis Treated with Long-Term Upadacitinib Therapy in Five Randomized Controlled Trials,2022,https://doi.org/10.1007/s40744-022-00483-4,36125701,False
1239,Comparative efficacy and safety of JAK inhibitors as monotherapy and in combination with methotrexate in patients with active rheumatoid arthritis: A systematic review and meta-analysis,2022,https://doi.org/10.3389/fimmu.2022.977265,36248913,False
1240,Overtreatment in rheumatoid arthritis: are there reasons for concern?,2022,https://doi.org/10.1136/rmdopen-2022-002212,36180100,False
1241,Comparative effectiveness of biologics in patients with rheumatoid arthritis stratified by body mass index and sex: a cohort study in SCQM,2022,https://doi.org/10.1101/2022.09.30.22280396,,False
1242,Action of Tofacitinib in a Rat Model of Synovitis,2022,https://doi.org/10.1166/jbt.2022.3130,,False
1243,Latest models for the discovery and development of rheumatoid arthritis drugs,2022,https://doi.org/10.1080/17460441.2022.2131765,36184990,False
1244,Serum level of IFNβ distinguishes early from late relapses after biologics withdrawal in rheumatoid arthritis,2022,https://doi.org/10.1038/s41598-022-21160-0,36192530,False
1245,The effect of long non-coding RNAs in joint destruction of rheumatoid arthritis,2022,https://doi.org/10.3389/fcell.2022.1011371,36263019,False
1246,Estado actual y retos futuros en el tratamiento de las enfermedades reumáticas,2022,https://doi.org/10.51987/revhospitalbaires.v42i3.206,,False
1247,Differential retention of adalimumab and etanercept biosimilars compared to originator treatments: Results of a retrospective French multicenter study,2022,https://doi.org/10.3389/fmed.2022.989514,36275803,False
1248,Favourable effect of a ‘second hit’ after 13 weeks in early RA non-responders: the Amsterdam COBRA treat-to-target randomized trial,2022,https://doi.org/10.1093/rheumatology/keac582,36205538,True
1249,Similar effect of co-administration of methotrexate and folic acid for the treatment of arthritis compared to separate administration,2022,https://doi.org/10.1093/rheumatology/keac579,36205597,False
1250,Quelle place pour les inhibiteurs de JAK en 2022 ?,2022,https://doi.org/10.1016/j.rhum.2022.10.003,,False
1251,High Throughput Genetic Characterisation of Caucasian Patients Affected by Multi-Drug Resistant Rheumatoid or Psoriatic Arthritis,2022,https://doi.org/10.3390/jpm12101618,36294757,False
1252,Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study,2022,https://doi.org/10.1007/s40744-022-00498-x,36209441,False
1253,Assessment of mesenchymal stem/stromal cell-based therapy in K/BxN serum transfer-induced arthritis,2022,https://doi.org/10.3389/fimmu.2022.943293,36300108,False
1254,Effect of Er Miao San on rheumatoid arthritis via the NF-κB signaling pathway: Based on network pharmacology and experimental validation,2022,https://doi.org/10.21203/rs.3.rs-2076805/v1,,False
1255,Predictive model to identify multiple failure to biological therapy in patients with rheumatoid arthritis,2022,https://doi.org/10.1177/1759720x221124028,36226311,False
1256,Attitudes and practices in the laboratory monitoring of conventional synthetic disease modifying anti-rheumatic drugs by rheumatologists and rheumatology trainees,2022,https://doi.org/10.1186/s41927-022-00290-y,36244979,False
1257,Impact de la multimorbidité sur la réponse thérapeutique aux traitements de fond antirhumatismaux dans la polyarthrite rhumatoïde récente : données de la cohorte Espoir,2022,https://doi.org/10.1016/j.rhum.2022.10.006,,False
1258,Comparison of the inhibitory effect of tocilizumab and etanercept on the progression of joint erosion in rheumatoid arthritis treatment,2022,https://doi.org/10.1038/s41598-022-22152-w,36266430,False
1259,"Necesidades, impacto y perspectiva actual de los pacientes con espondiloartritis incluyendo la artritis psoriásica",2023,https://doi.org/10.1016/j.reuma.2022.08.005,,False
1260,Optimizing Medication Use in Older Adults With Rheumatic Musculoskeletal Diseases: Deprescribing as an Approach When Less May Be More,2022,https://doi.org/10.1002/acr2.11503,36278868,False
1261,The bone-protective mechanisms of active components from TCM drugs in rheumatoid arthritis treatment,2022,https://doi.org/10.3389/fphar.2022.1000865,36386147,False
1262,"Efficacy and safety of selective JAK 1 inhibitor Filgotinib in active rheumatoid arthritis patients with inadequate response to methotrexate: Comparative study with Filgotinib and Tocilizumab examined by clinical index as well as musculoskeletal ultrasound assessment (TRANSFORM study): Study protocol for a randomized, open-label, parallel-group, multicenter, and non-inferiority clinical trial",2022,https://doi.org/10.21203/rs.3.rs-1994034/v1,,False
1263,Associations Between microRNA-related Genetic Polymorphisms and Clinical Response to Methotrexate in Chinese Rheumatoid Arthritis Patients,2022,https://doi.org/10.2174/1381612829666221025154714,36284378,False
1264,Respiratory tract infections and risk factors for infection in a cohort of 330 patients with axial spondyloarthritis or psoriatic arthritis,2022,https://doi.org/10.3389/fimmu.2022.1040725,36389682,False
1265,Consistency of recommendations for pharmacotherapy of rheumatoid arthritis,2022,https://doi.org/10.3389/fphar.2022.967787,36386133,False
1266,Validating MRI and ultrasound findings to predict bone destruction in rheumatoid arthritis,2022,https://doi.org/10.1093/mr/roac129,36300951,False
1267,Patient outcomes improve when a molecular signature test guides treatment decision-making in rheumatoid arthritis,2022,https://doi.org/10.1080/14737159.2022.2140586,36305319,False
1268,Galectin-1: A Potential Biomarker Differentiating between Early Rheumatoid Arthritis and Spondyloarthritis,2022,https://doi.org/10.3390/jcm11216313,36362537,False
1269,Real-world Effectiveness and Safety of JAK Inhibitors in Rheumatoid Arthritis: A Single-centre Study,2022,https://doi.org/10.1016/j.reumae.2021.08.004,36309409,False
1270,Digitally-supported patient-centered asynchronous outpatient follow-up in rheumatoid arthritis - an explorative qualitative study,2022,https://doi.org/10.1186/s12913-022-08619-6,36307779,True
1271,"Benefit of Filgotinib, a JAK1 Preferential Inhibitor, in Rheumatoid Arthritis Patients with Previous Rapid Radiographic Progression: Post Hoc Analysis of Two Trials",2022,https://doi.org/10.1007/s40744-022-00503-3,36327094,False
1272,Patient knowledge about biosimilars and satisfaction with the education provided by rheumatologists or nurse specialists in a biosimilar multiswitch scenario – The perception study,2022,https://doi.org/10.1016/j.semarthrit.2022.152119,36341778,True
1273,Persistence and Safety of Golimumab in Elderly Patients with Rheumatoid Arthritis and Renal Dysfunction in a Real-World Setting,2022,https://doi.org/10.1007/s40801-022-00338-y,36334249,False
1274,"Consensus Statement der Österreichischen Gesellschaften für Rheumatologie und Rehabilitation, Pneumologie, Infektiologie, Dermatologie und Gastroenterologie zum Umgang mit latenter Tuberkulose bei Therapien mit biologischen oder „targeted synthetic“ DMARDs („disease modifying antirheumatic drugs“)",2022,https://doi.org/10.1007/s00393-022-01274-6,36342525,False
1275,"“Without Them, I Would Never Have Been Able to Carry on” Levers for the Sustained Employment of Patients with Chronic Inflammatory Arthritis: A French Qualitative Study",2022,https://doi.org/10.3390/ijerph192114616,36361496,False
1276,Incidence and factors related to SARS-CoV-2 infection in a cohort of patients with rheumatoid arthritis from a health service provider in Colombia during the COVID-19 pandemic,2022,https://doi.org/10.1177/20499361221135155,36349342,False
1277,Which should be first: biologic DMARDs or Janus kinase inhibitors?,2022,https://doi.org/10.1093/rheumatology/keac629,36355459,False
1278,"Associations between clinical metrics of joint deformity, disease duration, disease activity, functional capacity, quality of life, pain, and fatigue in patients with rheumatoid arthritis",2022,https://doi.org/10.1007/s10067-022-06432-4,36371481,False
1279,Filgotinib in rheumatoid arthritis,2022,https://doi.org/10.1080/1744666x.2023.2149495,36396615,False
1280,Epimedii Herba: An ancient Chinese herbal medicine in the prevention and treatment of rheumatoid arthritis,2022,https://doi.org/10.3389/fchem.2022.1023779,36465876,False
1281,Safety and effectiveness of tofacitinib in Korean adult patients with rheumatoid arthritis: A post-marketing surveillance study,2022,https://doi.org/10.1093/mr/roac136,36401881,False
1282,EC-18 prevents autoimmune arthritis by suppressing inflammatory cytokines and osteoclastogenesis,2022,https://doi.org/10.1186/s13075-022-02941-4,36397156,False
1283,Glucocorticoids in rheumatoid arthritis: Balancing benefits and harm by leveraging the therapeutic window of opportunity,2023,https://doi.org/10.1016/j.jbspin.2022.105491,36410680,False
1284,Evidence for Biologic Drug Modifying Anti-Rheumatoid Drugs and Association with Cardiovascular Disease Risk Mitigation in Inflammatory Arthritis,2023,https://doi.org/10.1016/j.rdc.2022.08.005,36424023,False
1285,Recommendations for the treatment of rheumatoid arthritis in Saudi Arabia: adolopment of the 2021 American College of Rheumatology guidelines,2022,https://doi.org/10.1186/s41927-022-00301-y,36414983,False
1286,Gaming for Adherence to Medication using Ehealth in Rheumatoid arthritis (GAMER) study: a randomised controlled trial,2022,https://doi.org/10.1136/rmdopen-2022-002616,36410776,True
1287,A Thermographic Disease Activity Index for remote assessment of rheumatoid arthritis,2022,https://doi.org/10.1136/rmdopen-2022-002615,36410775,False
1288,Efficacy and safety of tofacitinib in the treatment of rheumatoid arthritis: results of 10 years of use,2022,https://doi.org/10.21518/2079-701x-2022-16-21-139-145,,False
1289,"Nationwide, large-scale implementation of an online system for remote entry of patient-reported outcomes in rheumatology: characteristics of users and non-users and time to first entry",2022,https://doi.org/10.1136/rmdopen-2022-002549,36418086,False
1290,Clinical Advantage of Attaining Index-Based Remission Prior to Composite Remission in Treating Rheumatoid Arthritis,2022,https://doi.org/10.1016/j.reumae.2021.09.009,36435555,False
1291,High Serum Level of TNF-α in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis,2022,https://doi.org/10.3889/oamjms.2022.10337,,False
1292,Therapeutic consequences in patients with both inflammatory rheumatic diseases and multiple sclerosis,2022,https://doi.org/10.1093/rheumatology/keac665,36440887,False
1293,Novel Gut microbiota as new biomarkers to evaluate the therapeutic effect of different DMARDs in Rheumatoid Arthritis,2022,https://doi.org/10.21203/rs.3.rs-2318291/v1,,False
1294,Discontinuation of biologic DMARDs in non-systemic JIA patients: a scoping review of relapse rates and associated factors,2022,https://doi.org/10.1186/s12969-022-00769-5,36471348,False
1295,Prediction of response to anti-TNF treatment using laboratory biomarkers in patients with rheumatoid arthritis: a systematic review,2022,https://doi.org/10.1136/rmdopen-2022-002570,36597975,False
1296,Illustrations of rheumatoid arthritis symptoms to promote communication between patients and physicians,2022,https://doi.org/10.1093/mr/roac152,36484526,False
1297,Clinical and immunological effects of hydroxychloroquine in patients with active rheumatoid arthritis despite antirheumatic treatment,2022,https://doi.org/10.1093/mr/roac153,36484525,False
1298,Reumatoïde artritis,2022,https://doi.org/10.1007/978-90-368-2888-8_5,,False
1299,"Reasons for discontinuation of methotrexate in the treatment of rheumatoid arthritis and challenges of methotrexate resumption: a single-center, retrospective study",2022,https://doi.org/10.1186/s43166-022-00162-w,,False
1300,"A systematic comparison of different composite measures (DAS 28, CDAI, SDAI, and Boolean approach) for determining treatment effects on low disease activity and remission in rheumatoid arthritis",2022,https://doi.org/10.1186/s41927-022-00314-7,36482451,False
1301,Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance,2022,https://doi.org/10.1136/rmdopen-2022-002593,36598004,False
1302,"Persistence, Clinical and Economic Impact of Infliximab CT-P13 in Rheumatoid Arthritis, Psoriatic Arthropathy and Ankylosing Spondylitis Naïve and Switched Patients: After 5 Years of Follow-Up",2022,https://doi.org/10.29169/1927-5951.2022.12.06,,False
1303,Inducibility or predestination? Queries and concepts around drug-free remission in rheumatoid arthritis,2022,https://doi.org/10.1080/1744666x.2023.2157814,36511619,False
1304,"Antirheumatic treatment, disease activity and risk of<i>Staphylococcus aureus</i>bacteraemia in rheumatoid arthritis: a nationwide nested case–control study",2022,https://doi.org/10.1136/rmdopen-2022-002636,36517186,False
1305,"Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis (RA): A Retrospective Study From Two Centers in Jeddah, Saudi Arabia",2022,https://doi.org/10.7759/cureus.32240,36620821,False
1306,Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care,2022,https://doi.org/10.21203/rs.3.rs-2378275/v1,,False
1307,Key Conditions and Principles of Orthopaedic Management,2022,https://doi.org/10.1002/9781119833413.ch13,,False
1308,Subcutaneous injection of methotrexate: Advantages in the treatment of rheumatoid arthritis,2022,https://doi.org/10.1093/mr/roac156,36525530,False
1309,Analysis of Disease Activity Metrics in a Methotrexate Withdrawal Study among Patients with Rheumatoid Arthritis Treated with Tofacitinib plus Methotrexate,2022,https://doi.org/10.1007/s40744-022-00511-3,36534208,False
1310,Real-world patient characteristics and use of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a cross-national study,2022,https://doi.org/10.1007/s10067-022-06478-4,36534353,False
1311,Impact clinique de l’arrêt de la corticothérapie chez des patients atteints de polyarthrite rhumatoïde traités par upadacitinib ou adalimumab,2022,https://doi.org/10.1016/j.rhum.2022.10.252,,False
1312,Comorbidities and treatment patterns in early rheumatoid arthritis: a nationwide Swedish study,2022,https://doi.org/10.1136/rmdopen-2022-002700,36564100,False
1313,Impact of the COVID-19 pandemic on prescription refills for immune-mediated inflammatory disorders: a time series analysis (January 2019 to January 2021) using the English Prescribing Dataset,2022,https://doi.org/10.1136/bmjopen-2021-051936,36564115,False
1314,"Efficacy, safety, and cost-effectiveness of triple therapy in preventing relapse in rheumatoid arthritis: A randomized controlled trial (ESCoRT study)",2022,https://doi.org/10.1097/cm9.0000000000002336,36525606,True
1315,Receiver operating characteristic analysis using a novel combined thermal and ultrasound imaging for assessment of disease activity in rheumatoid arthritis,2022,https://doi.org/10.1038/s41598-022-26728-4,36543868,False
1316,Flare during tapering of biological DMARDs in patients with rheumatoid arthritis in routine care: characteristics and predictors,2022,https://doi.org/10.1136/rmdopen-2022-002796,36549857,False
1317,"Treat-to-target in rheumatoid arthritis: a real-world study of the application and impact of treat-to-target within the wider context of patient management, patient centricity and advanced therapy use in Europe",2022,https://doi.org/10.1136/rmdopen-2022-002658,36549856,False
1318,Comparison of Efficacy and Safety of Original and Biosimilar Adalimumab in Active Rheumatoid Arthritis in a Real-World National Cohort,2022,https://doi.org/10.3390/medicina58121851,36557052,False
1319,Association between disease-modifying antirheumatic drugs and bone turnover biomarkers.,2023,https://doi.org/10.1111/1756-185x.14550,36573666,False
1320,Precautions before starting tofacitinib in persons with rheumatoid arthritis,2022,https://doi.org/10.12998/wjcc.v10.i36.13467,36683637,False
1321,Multibiomarker disease activity score: an objective tool for monitoring rheumatoid arthritis? A systematic review and meta-analysis,2022,https://doi.org/10.1093/rheumatology/keac715,36575983,False
1322,"Investigation of the Effect of Selected Piperazine-2,5-Diones on Cartilage-Related Cells",2021,https://doi.org/10.3390/ecsoc-25-11650,,False
1323,Commentary: Janus kinase inhibitors and juvenile idiopathic arthritis associated uveitis,2022,https://doi.org/10.4103/ijo.ijo_1776_22,,False
1324,Profile of Patients with Rheumatoid Arthritis: a Descriptive Analysis,2022,https://doi.org/10.1590/1678-4324-2022220151,,False
1325,Prescription analysis of rheumatology and endocrinology departments of a teaching hospital in Western India,2022,https://doi.org/10.4103/jcrsm.jcrsm_26_22,,False
1326,Arthritiden – Begutachtung,2022,https://doi.org/10.1007/978-3-662-61937-7_73-1,,False
1327,Semi-automated socio-anthropologic analysis of the medical discourse on rheumatoid arthritis: Potential impact on public health,2022,https://doi.org/10.1371/journal.pone.0279632,36580470,False
1328,Evaluating the benefits of TNF-alfa inhibitor biosimilar competition on off-patent and on-patent drug markets: A Southern European analysis,2022,https://doi.org/10.3389/fphar.2022.1031910,36588696,False
1329,Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy,2022,https://doi.org/10.4081/reumatismo.2022.1511,36580064,False
1330,Acute Ischemic Stroke in the Patients with Inflammatory Arthritis: An Analysis of Data from National Health Insurance Service,2022,https://doi.org/10.15656/kjcg.2022.23.2.96,,False
1331,"Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis",2022,https://doi.org/10.1136/rmdopen-2022-002683,36585217,True
1332,"Interleukin 6 receptor inhibitors in the treatment of rheumatoid arthritis during the COVID-19 pandemic, Moscow experience",2022,https://doi.org/10.14412/1996-7012-2022-6-73-79,,False
1333,Clinical Value of IL6R Gene Variants as Predictive Biomarkers for Toxicity to Tocilizumab in Patients with Rheumatoid Arthritis,2022,https://doi.org/10.3390/jpm13010061,36675722,False
1334,The Yin-Yang Pharmacomicrobiomics on Treatment Response in Inflammatory Arthritides: A Narrative Review,2022,https://doi.org/10.3390/genes14010089,36672830,False
1335,Characteristics of Patients Treated with JAK Inhibitors in Rheumatoid Arthritis before versus after VTE Risk Warnings,2022,https://doi.org/10.3390/jcm12010207,36615007,False
1336,An AI-Powered Clinical Decision Support System to Predict Flares in Rheumatoid Arthritis: A Pilot Study,2023,https://doi.org/10.3390/diagnostics13010148,36611439,False
1337,Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs),2023,https://doi.org/10.1136/rmdopen-2022-002792,36599630,False
1338,Continuity of Care Within a Single Patient Support Program for Patients with Rheumatoid Arthritis Prescribed Second or Later Line Advanced Therapy,2023,https://doi.org/10.1007/s12325-022-02413-w,36604404,False
1339,Healthcare resource utilization and costs in stable patients with rheumatoid arthritis: Comparing nurse-led and rheumatologist-led models of care delivery,2023,https://doi.org/10.1016/j.semarthrit.2022.152160,36603500,False
1340,Dynamic Characteristics and Predictive Profile of Glucocorticoids Withdrawal in Rheumatoid Arthritis Patients Commencing Glucocorticoids with csDMARD: A Real-World Experience,2023,https://doi.org/10.1007/s40744-022-00527-9,36609980,False
1341,Cost Effectiveness of Rituximab Therapy for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Cost-Utility Studies,2023,https://doi.org/10.1007/s40261-022-01238-3,36624250,False
1342,Factors associated with selection of targeted therapy in patients with rheumatoid arthritis,2023,https://doi.org/10.1371/journal.pone.0280234,36626396,False
1343,Outcomes Following Adalimumab Bio-originator to Biosimilar Switch—A Comparison Using Real-world Patient- and Physician-Reported Data in European Countries,2023,https://doi.org/10.1007/s40744-022-00526-w,36631636,False
1344,Accelerated atherosclerosis in rheumatoid arthritis: a systematic review,2023,https://doi.org/10.12688/f1000research.112921.2,,False
1345,Serum Levels of IFABP2 and Differences in Lactobacillus and Porphyromonas gingivalis Abundance on Gut Microbiota Are Associated with Poor Therapeutic Response in Rheumatoid Arthritis: A Pilot Study,2023,https://doi.org/10.3390/ijms24031958,36768285,False
1346,Patient Disease Trajectories in Rheumatoid Arthritis Patients Treated with Baricitinib 4-mg in Four Phase 3 Clinical Studies,2023,https://doi.org/10.1007/s40744-022-00529-7,36662442,False
1347,Shared decision-making practices and patient values in pharmacist outpatient care for rheumatic disease: A multiple correspondence analysis,2023,https://doi.org/10.3389/jpps.2023.11135,36942300,False
1348,JAK Inhibition in Patients with Rheumatoid Arthritis: Haemodynamic Effects and Impact on Micro- and Macrovascular Function. Study Design and Rationale,2022,https://doi.org/10.31138/mjr.33.4.471,37034377,False
1349,"Efficacy and safety of biologic, biosimilars and targeted synthetic DMARDs in moderate-to-severe rheumatoid arthritis with inadequate response to methotrexate: a systematic review and network meta-analysis",2023,https://doi.org/10.1101/2023.01.20.23284852,,False
1350,"Correlation Between Total Bilirubin, Total Bilirubin/Albumin Ratio with Disease Activity in Patients with Rheumatoid Arthritis",2023,https://doi.org/10.2147/ijgm.s393273,36718146,False
1351,The effect of smoking on response to methotrexate in rheumatoid arthritis patients: A systematic review and meta-analysis,2023,https://doi.org/10.1093/mr/road013,36688574,False
1352,Anti-rheumatoid arthritis potential of Rhododendron molle G. Don leaf extract in adjuvant induced arthritis rats,2023,https://doi.org/10.1016/j.jep.2023.116175,36702447,False
1353,A rare case of scleritis and multiple rheumatoid pulmonary nodules associated with seronegative rheumatoid arthritis,2023,https://doi.org/10.1093/omcr/omac155,36694604,False
1354,"JAK inhibitors differentially modulate B cell activation, maturation and function: A comparative analysis of five JAK inhibitors in an in-vitro B cell differentiation model and in patients with rheumatoid arthritis",2023,https://doi.org/10.3389/fimmu.2023.1087986,36776828,False
1355,Barriers to the Diagnosis of Early Inflammatory Arthritis: A Literature Review,2023,https://doi.org/10.2147/oarrr.s282622,36733437,False
1356,Clinical Efficacy of Sarilumab Versus Upadacitinib Over 12 weeks: An Indirect Treatment Comparison,2023,https://doi.org/10.1007/s40744-022-00521-1,36725768,False
1357,Rééducation dans les formes axiales et périphériques de rhumatismes inflammatoires,2023,https://doi.org/10.1016/j.rhum.2022.12.016,,False
1358,Cardiovascular Manifestations in Rheumatoid Arthritis,2023,https://doi.org/10.1097/crd.0000000000000486,36729119,False
1359,Failure and multiple failure for disease modifying antirheumatic drugs in rheumatoid arthritis: Real-life evidence from a tertiary referral center in Italy.,2023,https://doi.org/10.1371/journal.pone.0281213,36730337,False
1360,Implementation of automated behavior metrics to evaluate voluntary wheel running effects on inflammatory-erosive arthritis and interstitial lung disease in TNF-Tg mice,2023,https://doi.org/10.1186/s13075-022-02985-6,36732826,False
1361,"Disease activity-guided tapering of biologics in patients with inflammatory arthritis: a pragmatic, randomized, open-label, equivalence trial",2023,https://doi.org/10.1080/03009742.2023.2164979,36745114,False
1362,Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP+,2023,https://doi.org/10.1007/s40744-022-00523-z,36749478,False
1363,Novel Gut microbiota as new biomarkers to evaluate the therapeutic effect of different DMARDs in Rheumatoid Arthritis,2023,https://doi.org/10.21203/rs.3.rs-2318291/v2,,False
1364,Intérêt du dosage des anticorps antimédicaments dans les rhumatismes inflammatoires,2022,https://doi.org/10.1016/b978-2-294-77859-9.00021-9,,False
1365,Microwave Radiometry for the Diagnosis and Monitoring of Inflammatory Arthritis,2023,https://doi.org/10.3390/diagnostics13040609,36832097,False
1366,Post Hoc Analysis of a Randomized Controlled Trial on Fasting and Plant-Based Diet in Rheumatoid Arthritis (NutriFast): Nutritional Supply and Impact on Dietary Behavior,2023,https://doi.org/10.3390/nu15040851,36839208,True
1367,HAS-Flow May Be an Adequate Method for Evaluating Human T-Cell Leukemia Virus Type 1 Infected Cells in Human T-Cell Leukemia Virus Type 1-Positive Rheumatoid Arthritis Patients Receiving Antirheumatic Therapies: A Retrospective Cross-Sectional Observation Study,2023,https://doi.org/10.3390/v15020468,36851682,False
1368,Real-world treatment persistence in patients with rheumatoid arthritis initiating DMARDs in Germany—a health insurance claims data analysis,2023,https://doi.org/10.1007/s00393-023-01323-8,36757417,False
1369,Influence of perception of glucocorticoids on compliance of treatment in patients with rheumatoid arthritis and systemic lupus erythematosus,2023,https://doi.org/10.1016/j.ejr.2023.01.002,,False
1370,Editorial: Disease-modifying antirheumatic drugs: Approaches and lessons learned from traditional medicine,2023,https://doi.org/10.3389/fphar.2023.1135803,36817142,False
1371,High-sensitivity cardiac troponin T is associated with disease activity in patients with inflammatory arthritis,2023,https://doi.org/10.1371/journal.pone.0281155,36763689,False
1372,Assessment of liver fibrosis in patients with rheumatoid arthritis treated with methotrexate: Utility of fibroscan and biochemical markers in routine clinical practice,2023,https://doi.org/10.1016/j.reuma.2022.12.003,,False
1373,Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active disease,2023,https://doi.org/10.1186/s12916-023-02746-5,36782189,False
1374,Computed tomography for malignancy screening in patients with rheumatoid arthritis before initiation of disease modifying antirheumatic drug,2023,https://doi.org/10.1093/rheumatology/kead075,36782362,False
1375,Appearance of Ankylosing Spondylitis in a Middle-Aged Female Patient With a Long History of Rheumatoid Arthritis,2023,https://doi.org/10.7759/cureus.34952,36938167,False
1376,"The efficacy and safety of olokizumab for rheumatoid arthritis: a systematic review, pairwise, and network meta-analysis",2023,https://doi.org/10.1007/s10067-023-06519-6,36792848,False
1377,Sex differences in adverse drug reactions from Adalimumab and etanercept in patients with inflammatory rheumatic diseases,2023,https://doi.org/10.1080/14740338.2023.2181340,36794307,False
1378,Recent insights into comorbidities in atopic dermatitis,2023,https://doi.org/10.1080/1744666x.2023.2181790,36796057,False
1379,Prevalence and predictors of long-term remission in rheumatoid arthritis in real-world practice: a longitudinal study,2023,https://doi.org/10.1007/s10067-023-06548-1,36800137,False
1380,Identification of anti-citrullinated osteopontin antibodies and increased inflammatory response by enhancement of osteopontin binding to fibroblast-like synoviocytes in rheumatoid arthritis,2023,https://doi.org/10.1186/s13075-023-03007-9,36804906,False
1381,Is there a reduction in hip destruction under a treat-to-target strategy in patients with rheumatoid arthritis?,2023,https://doi.org/10.1093/mr/road021,36806453,False
1382,Clinical Visit Frequencies in Rheumatology: A Systematic Literature Review,2023,https://doi.org/10.1002/acr.25106,36807719,False
1383,Targeting Tumor Necrosis Factor Receptor 1 with Selected Aptamers for Anti-Inflammatory Activity,2023,https://doi.org/10.1021/acsami.3c00131,36812453,False
1384,Patients’ perspectives towards biologic dose reduction in psoriasis: a qualitative study,2023,https://doi.org/10.1007/s00403-023-02566-w,36813868,False
1385,Glucocorticoid exposure and the risk of serious infections in rheumatoid arthritis: a marginal structural model application,2023,https://doi.org/10.1093/rheumatology/kead083,36821426,False
1386,"Circulating PCSK9 relates to aggravated disease activity, Th17/Treg imbalance, and predicts treatment outcome of conventional synthetic DMARDs in rheumatoid arthritis patients",2023,https://doi.org/10.1007/s11845-023-03323-8,36826711,False
1387,"Low rates of radiographic progression associated with clinical efficacy following up to 2 years of treatment with guselkumab: results from a phase 3, randomised, double-blind, placebo-controlled study of biologic-naïve patients with active psoriatic arthritis",2023,https://doi.org/10.1136/rmdopen-2022-002789,36828643,True
1388,Serum matrix metalloproteinase-3 levels monitor the therapeutic efficacy in Syrian patients with rheumatoid arthritis,2023,https://doi.org/10.1016/j.heliyon.2023.e14008,36895354,False
1389,Patterns in the sequential treatment of rheumatoid arthritis patients starting a b/tsDMARD: 10-year experience from a US-based registry,2023,https://doi.org/10.21203/rs.3.rs-2624931/v1,36909600,False
1390,"Continuation, reduction, or withdrawal of tofacitinib in patients with rheumatoid arthritis achieving sustained disease control: a multicenter, open-label, randomized controlled trial",2023,https://doi.org/10.1097/cm9.0000000000002561,36848153,True
1391,Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial Data,2023,https://doi.org/10.1007/s40744-023-00541-5,36848009,False
1392,"Guía de práctica clínica para la detección temprana, el diagnóstico, el tratamiento y el seguimiento de los pacientes con artritis reumatoide. Asociación Colombiana de Reumatología, 2022",2023,https://doi.org/10.1016/j.rcreu.2023.02.001,,False
1393,Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers,2023,https://doi.org/10.1136/rmdopen-2022-002924,36854568,False
1394,Open challenges in the management of autoimmune hepatitis,2023,https://doi.org/10.23736/s2724-5895.20.02805-6,33267568,False
1395,The link between rheumatic disorders and inborn errors of immunity,2023,https://doi.org/10.1016/j.ebiom.2023.104501,36870198,False
1396,Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study,2023,https://doi.org/10.1136/rmdopen-2022-002898,36863753,False
1397,Do Disease-Modifying Anti-rheumatic Drugs and Exercise Therapy Have a Combined Effect on Disease Activity in Patients with RA? A Scoping Review,2023,https://doi.org/10.1007/s11926-023-01098-6,36867308,False
1398,"Efficacy and safety of selective JAK 1 inhibitor filgotinib in active rheumatoid arthritis patients with inadequate response to methotrexate: comparative study with filgotinib and tocilizumab examined by clinical index as well as musculoskeletal ultrasound assessment (TRANSFORM study): study protocol for a randomized, open-label, parallel-group, multicenter, and non-inferiority clinical trial",2023,https://doi.org/10.1186/s13063-023-07176-5,36869356,False
1399,Advanced therapies in rheumatoid arthritis,2023,https://doi.org/10.1016/b978-0-323-85831-1.00010-3,,False
1400,"Effect of Saffron Extract, Astaxanthin, and Carnosic Acid on the Levels of Matrix Metalloproteinase-9 and on Body Weight Changes in Arthritis Experiments",2022,https://doi.org/10.2478/afpuc-2022-0016,,False
1401,The Proportion of Patients With Rheumatoid Arthritis Achieving ACR20/50/70; Consistent Patterns of a 60/40/20 as Demonstrated by a Systematic Review and Meta-analysis,2023,https://doi.org/10.1097/rhu.0000000000001945,36870081,False
1402,"Transcriptomic profile comparison of monocytes from rheumatoid arthritis patients in treatment with methotrexate, anti-TNFa, abatacept or tocilizumab",2023,https://doi.org/10.1371/journal.pone.0282564,36877690,False
1403,Geschlechtsspezifische Unterschiede in Diagnostik und Therapie entzündlich-rheumatischer Erkrankungen,2023,https://doi.org/10.1007/s00108-023-01484-3,36877237,False
1404,Changes in Bone Metabolism in Patients with Rheumatoid Arthritis during Tumor Necrosis Factor Inhibitor Therapy,2023,https://doi.org/10.3390/jcm12051901,36902687,False
1405,"Safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of WBP216, a novel IL-6 monoclonal antibody, in patients with rheumatoid arthritis: A phase Ia randomized placebo-controlled study",2023,https://doi.org/10.3389/fimmu.2022.1110992,36926529,True
1406,Frequency of Helicobacter pylori in Patients With Rheumatoid Arthritis Whose Methotrexate Was Stopped Due to Gastrointestinal Intolerance,2023,https://doi.org/10.1097/rhu.0000000000001952,36881834,False
1407,Difficult-to-treat rheumatoid arthritis (D2T RA): clinical issues at early stages of disease,2023,https://doi.org/10.1136/rmdopen-2022-002842,36889800,False
1408,Simultaneous quantitative analysis and in vitro anti-arthritic effects of five polyphenols from Terminalia chebula,2023,https://doi.org/10.3389/fphys.2023.1138947,36969583,False
1409,Sarcopenia and COVID-19 Outcomes,2023,https://doi.org/10.2147/cia.s398386,36923269,False
1410,Aetiologies of Acute Complications in Autoimmune Rheumatologic Diseases: A Hospital-Based Cross-Sectional Study,2023,https://doi.org/10.7759/cureus.35916,37050995,False
1411,A scoping review of shared care models for rheumatoid arthritis with patient-initiated follow-up,2023,https://doi.org/10.1016/j.semarthrit.2023.152190,36934470,False
1412,Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: A critical review,2023,https://doi.org/10.3389/fmed.2023.1129939,37007765,False
1413,Construct validity of the PROMIS PF-10 in patients with inflammatory rheumatic diseases and severe limitations in physical functioning,2023,https://doi.org/10.1080/03009742.2023.2182449,36939154,False
1414,"Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis",2023,https://doi.org/10.3390/ph16030465,36986565,False
1415,Efficacy and safety of levilimab in combination with methotrexate in patients with active rheumatoid arthritis: 56-week results of phase III randomized double-blind placebo-controlled trial SOLAR,2023,https://doi.org/10.47360/1995-4484-2023-87-99,,False
1416,Combining nanotechnology with monoclonal antibody drugs for rheumatoid arthritis treatments,2023,https://doi.org/10.1186/s12951-023-01857-8,36964609,False
1417,"Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study",2023,https://doi.org/10.1186/s41927-023-00329-8,36973741,False
1418,Digital Outcome Measurement to Improve Care for Patients With Immune-Mediated Inflammatory Diseases: Protocol for the IMID Registry,2023,https://doi.org/10.2196/43230,36995758,False
1419,An Evidence-Based Update on the Potential Association between Rheumatoid Arthritis and Lymphangioleiomyomatosis,2023,https://doi.org/10.3390/jpm13040607,37108993,False
1420,"Leishmania infantum infection after visiting southern Spain in patients on biological treatment; an observational, longitudinal, cohort study",2023,https://doi.org/10.1016/j.tmaid.2023.102570,37001789,False
1421,Vascular effects of biologic and targeted synthetic antirheumatic drugs approved for rheumatoid arthritis: a systematic review,2023,https://doi.org/10.1007/s10067-023-06587-8,36991244,False
1422,Feasibility of methotrexate discontinuation following tocilizumab and methotrexate combination therapy in patients with long-standing and advanced rheumatoid arthritis: a 3-year observational cohort study,2023,https://doi.org/10.5387/fms.2022-06,36990790,False
1423,Rheumatoid Arthritis,2023,https://doi.org/10.1007/978-3-031-23488-0_1,,False
1424,Meaningful Improvement and Worsening in Patients Who Do Not Achieve Low Disease Activity and Switch Therapy to a New Biologic or Targeted Disease-Modifying Antirheumatic Drug,2023,https://doi.org/10.1097/rhu.0000000000001956,37000177,False
1425,Tocilizumab experience in patients with rheumatoid arthritis: A retrospective study,2023,https://doi.org/10.4274/raed.galenos.2023.46036,,False
1426,Selective JAK1 inhibitors for the treatment of inflammatory bowel disease,2023,https://doi.org/10.1016/j.pharmthera.2023.108402,37004800,False
1427,Repurposing the antipsychotic drug amisulpride for targeting synovial fibroblast activation in arthritis,2023,https://doi.org/10.1172/jci.insight.165024,37014697,False
1428,"Naru-3 inhibits inflammation, synovial hyperplasia, and neovascularization in collagen-induced arthritis in rats",2023,https://doi.org/10.1016/j.jep.2023.116350,37019159,False
1429,Difficult-to-treat rheumatoid arthritis treated with Abatacept combined with Baricitinib: A case report,2023,https://doi.org/10.12998/wjcc.v11.i11.2474,37123310,False
1430,"Egyptian recommendations for the management of systemic lupus erythematosus: a consensus, evidence-based, clinical practice guidelines for treat-to-target management",2023,https://doi.org/10.1186/s43166-023-00187-9,,False
1431,Six-month follow-up of periodontal condition and oral mucosa lesions in arthritis patients undergoing anti-tumour necrosis factor-α therapy,2023,https://doi.org/10.21203/rs.3.rs-2728661/v1,,False
1432,Management of patients with inflammatory rheumatic diseases after treatment failure with a first tumour necrosis factor inhibitor: A narrative review,2023,https://doi.org/10.1093/mr/road033,37022142,False
1433,The Influence of Anti-Citrullinated Polypeptide Antibodies on Bone Mineral Density Decrease and Incident Major Osteoporotic Fractures in Patients with Rheumatoid Arthritis: A Retrospective Case-Control Study,2023,https://doi.org/10.3390/osteology3020006,,False
1434,A Charter to Fundamentally Change the Role of Oral Corticosteroids in the Management of Asthma,2023,https://doi.org/10.1007/s12325-023-02479-0,37027115,False
1435,Clinical characteristics of flares in patients with rheumatoid arthritis after total hip and total knee arthroplasty,2023,https://doi.org/10.1097/cm9.0000000000002564,37027290,False
1436,Comprehensive analysis of pain syndrome in patients with rheumatoid arthritis,2023,https://doi.org/10.26641/2307-0404.2023.1.276049,,False
1437,Rheumatoid Arthritis from Easy to Complex Disease: From the “2022 GISEA International Symposium”,2023,https://doi.org/10.3390/jcm12082781,37109118,False
1438,Single-cell RNA transcriptomic and plasma Lipidomic reveal the potential mechanisms of a Methotrexate-based therapy against Rheumatoid Arthritis,2023,https://doi.org/10.1016/j.phymed.2023.154816,37094424,True
1439,A Framework of Faster CRNN and VGG16-Enhanced Region Proposal Network for Detection and Grade Classification of Knee RA,2023,https://doi.org/10.3390/diagnostics13081385,37189485,False
1440,Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study,2023,https://doi.org/10.1007/s10654-023-01000-9,37052755,False
1441,Risk factors associated with relapse after methotrexate dose reduction in patients with rheumatoid arthritis receiving golimumab and methotrexate combination therapy,2023,https://doi.org/10.1111/1756-185x.14695,37058849,False
1442,Comparative effectiveness of TNF inhibitor vs IL-6 receptor inhibitor as monotherapy or combination therapy with methotrexate in biologic-experienced patients with rheumatoid arthritis: An analysis from the CorEvitas RA Registry,2023,https://doi.org/10.1007/s10067-023-06588-7,37060528,False
1443,Choice of and response to treatment in patients with early-diagnosed rheumatoid arthritis: Real-world data from an inception cohort in Japan (NICER-J),2023,https://doi.org/10.1016/j.jos.2023.03.020,37076376,False
1444,Administrative Databases and Diagnostic Therapeutic and Assistance Paths -PDTA- in the Monitoring Treatment of Rheumatoid Arthritis: The Experience of ATS Pavia,2023,https://doi.org/10.2147/por.s399221,37155480,False
1445,The Effectiveness of Telemedicine in Patients with Rheumatoid Arthritis: An Overview of Systematic Reviews and Meta-Analysis,2023,https://doi.org/10.1089/tmj.2023.0074,37074335,False
1446,The effect of JuanBiQiangGu granules in combination with methotrexate on joint inflammation in rheumatoid arthritis: a randomized controlled trial,2023,https://doi.org/10.3389/fphar.2023.1132602,37180723,False
1447,"Patients with spondyloarthritis including psoriatic arthritis: Current needs, impact, and perspective",2023,https://doi.org/10.1016/j.reumae.2022.08.006,37087379,False
1448,"The trajectory of clinical responses in patients with early rheumatoid arthritis who achieve sustained remission in response to abatacept: subanalysis of AVERT-2, a randomized phase IIIb study",2023,https://doi.org/10.1186/s13075-023-03038-2,37087459,True
1449,"Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor inhibitor therapy: efficacy and safety results of a randomised controlled phase III study",2023,https://doi.org/10.14412/1996-7012-2023-2-23-36,,False
1450,Molecular Basic of Pharmacotherapy of Cytokine Imbalance as a Component of Intervertebral Disc Degeneration Treatment,2023,https://doi.org/10.3390/ijms24097692,37175399,False
1451,Do it fast! Early access to specialized care improved long-term outcomes in rheumatoid arthritis: data from the REAL multicenter observational study,2023,https://doi.org/10.1186/s42358-023-00301-7,37095556,False
1452,Dipeptidyl peptidase 4 as a potential serum biomarker for disease activity and treatment response in rheumatoid arthritis,2023,https://doi.org/10.1016/j.intimp.2023.110203,37094543,False
1453,Sustained remission following the discontinuation of tofacitinib in patients with rheumatoid arthritis (XANADU study): an open-label randomised study,2023,https://doi.org/10.1136/rmdopen-2023-003029,37185309,True
1454,A review on pharmacokinetics of sinomenine and its anti-inflammatory and immunomodulatory effects,2023,https://doi.org/10.1016/j.intimp.2023.110227,37119677,False
1455,What is the best target in a treat-to-target strategy in rheumatoid arthritis? Results from a systematic review and meta-regression analysis,2023,https://doi.org/10.1136/rmdopen-2023-003196,37116986,False
1456,Efficacy and safety of tofacitinib combined with methotrexate in the treatment of rheumatoid arthritis: A systematic review and meta-analysis,2023,https://doi.org/10.1016/j.heliyon.2023.e15839,37215854,False
1457,A Bibliometric and Documentary Analysis of the Concept of Strategic Management: Perspective at Health Administration,2023,https://doi.org/10.54707/meric.1254567,,False
1458,The Barriers and Enablers to the Use of Parenteral Methotrexate in Rheumatoid Arthritis Patients: A Scoping Review,2023,https://doi.org/10.1002/acr.25141,37128818,False
1459,Safety of the JAK and TNF inhibitors in rheumatoid arthritis: real world data from the Hong Kong Biologics Registry,2023,https://doi.org/10.1093/rheumatology/kead198,37129549,False
1460,Rheuma und Geriatrie,2023,https://doi.org/10.1007/s12688-023-00615-w,,False
1461,"Effect of body mass index on treatment response of biologic−/targeted synthetic-DMARDs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis. A systematic review",2023,https://doi.org/10.1016/j.autrev.2023.103357,37150489,False
1462,FLARE-RA in patients with rheumatoid arthritis: translation and cross-cultural adaptation into Turkish,2023,https://doi.org/10.1080/09593985.2023.2209891,37158675,False
1463,Effect of a 12-week high-intensity exercise intervention: a comparison of cardiac exercise adaptations during biological disease-modifying antirheumatic drug treatment (TNF inhibitors vs IL-6 signalling inhibitors) in patients with rheumatoid arthritis – study protocol for a randomised controlled trial,2023,https://doi.org/10.1136/bmjopen-2022-068600,37169504,False
1464,Should We Use bDMARDs as an Induction Therapy in Early and Severe Rheumatoid Arthritis? Results at 5 years from the ERA UCLouvain Brussels Cohort,2023,https://doi.org/10.1007/s40744-023-00551-3,37183237,False
1465,Fallvorstellung: Geschwollene Hände,2023,https://doi.org/10.1007/978-3-662-63844-6_5,,False
1466,Prevalence and Predictors of Remission and Sustained Remission in Patients with Rheumatoid Arthritis from the United Arab Emirates: A Two-Year Prospective Study,2023,https://doi.org/10.2147/oarrr.s408894,37192954,False
1467,From misconceptions to reasonable osteoarthritis patients therapy,2023,https://doi.org/10.17749/2070-4909/farmakoekonomika.2023.183,,False
1468,Concomitant prednisone may alleviate methotrexate side-effects in rheumatoid arthritis patients,2023,https://doi.org/10.1186/s41927-023-00331-0,37198659,False
1469,Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study,2023,https://doi.org/10.1007/s40744-023-00557-x,37199884,False
1470,Patient–Physician Communication and Perception of Treatment Goals in Rheumatoid Arthritis: An Online Survey of Patients and Physicians,2023,https://doi.org/10.1007/s40744-023-00560-2,37208506,False
1471,New pro-inflammatory cytokine IL-40 is produced by activated neutrophils and plays a role in the early stages of seropositive rheumatoid arthritis,2023,https://doi.org/10.1136/rmdopen-2022-002894,37208028,False
1472,Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trial,2023,https://doi.org/10.1007/s10067-023-06623-7,37209188,False
1473,"TAp63, a methotrexate target in CD4+ T cells, suppresses Foxp3 expression and exacerbates autoimmune arthritis",2023,https://doi.org/10.1172/jci.insight.164778,37212280,False
1474,Relationship between frailty and methotrexate discontinuation due to adverse events in rheumatoid arthritis patients,2023,https://doi.org/10.1007/s10067-023-06639-z,37211570,False
1475,Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry,2023,https://doi.org/10.1186/s13075-023-03045-3,37217997,False
1476,Changes in knee joint destruction patterns among patients with rheumatoid arthritis undergoing total knee arthroplasty in recent decades,2023,https://doi.org/10.1007/s10067-023-06620-w,37222908,False
1477,"Using Twitter Data Analysis to Understand the Perceptions, Beliefs, and Attitudes about Pharmacotherapy Used in Rheumatology: An Observational Study",2023,https://doi.org/10.3390/healthcare11111526,37297665,False
1478,Shared inflammatory pathways of rheumatoid arthritis and atherosclerotic cardiovascular disease,2023,https://doi.org/10.1038/s41584-023-00969-7,37231248,False
1479,The Methotrexate Story: How did a Cancer Chemotherapeutic Agent Become a Disease-modifying Antirheumatic Drug,2023,https://doi.org/10.4103/injr.injr_13_23,,False
1480,"Associations of disease duration and anti-citrullinated peptide antibody status with the effectiveness of abatacept in biologic-naïve patients with rheumatoid arthritis: <i>Post-hoc</i> analysis of a multicentre, real-world observational study in Japan (ORIGAMI)",2023,https://doi.org/10.1093/mr/road045,37233722,False
1481,Exclusion of older adults from randomized controlled trials in rheumatoid arthritis,2023,https://doi.org/10.1093/rheumatology/kead257,37243691,False
1482,Rheumatology specialist care delivered at the Southern <scp>QLD</scp> Centre of Excellence in Aboriginal and Torres Strait Islander Primary Health Care,2023,https://doi.org/10.1111/imj.16144,37255053,False
1483,Patient groups in Rheumatoid arthritis identified by deep learning respond differently to biologic or targeted synthetic DMARDs,2023,https://doi.org/10.1371/journal.pcbi.1011073,37267387,False
1484,Intensive treatment for the progression of joint damage in rheumatoid arthritis patients with low disease activity or remission,2023,https://doi.org/10.1093/mr/road041,37267207,False
1485,Hypoxia with or without Treadmill Exercises Affects Slow-Twitch Muscle Atrophy and Joint Destruction in a Rat Model of Rheumatoid Arthritis,2023,https://doi.org/10.3390/ijms24119761,37298711,False
1486,Cardiovascular risk in rheumatoid arthritis patients treated with targeted synthetic and biological disease‐modifying antirheumatic drugs: A multi‐centre cohort study,2023,https://doi.org/10.1111/joim.13681,37282790,False
1487,Risk of venous thromboembolism with janus kinase inhibitors in inflammatory immune diseases: a systematic review and meta-analysis,2023,https://doi.org/10.3389/fphar.2023.1189389,37351513,False
1488,Four-years retention rate of golimumab administered after discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases,2023,https://doi.org/10.1186/s42358-023-00296-1,37287051,False
1489,The association between CYB5A gene rs1790834 polymorphism and clinical improvement after 6 months of leflunomide treatment in women with rheumatoid arthritis,2023,https://doi.org/10.1007/s10067-023-06653-1,37289314,False
1490,What are the core recommendations for rheumatoid arthritis care? Systematic review of clinical practice guidelines,2023,https://doi.org/10.1007/s10067-023-06654-0,37291382,False
1491,EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis,2023,https://doi.org/10.1136/ard-2023-224148,37295926,False
1492,Prevention and treatment of inflammatory arthritis with traditional Chinese medicine: Underlying mechanisms based on cell and molecular targets,2023,https://doi.org/10.1016/j.arr.2023.101981,37302756,False
1493,Tailored therapeutic decision of rheumatoid arthritis using proteomic strategies: how to start and when to stop?,2023,https://doi.org/10.1186/s12014-023-09411-2,37301840,False
1494,Biologics Initiation in Rheumatoid Arthritis by Race and Ethnicity: Results From a Randomized Survey Study,2023,https://doi.org/10.1002/acr2.11573,37312437,False
1495,"Subcutaneous abatacept for the treatment of rheumatoid arthritis in routine clinical practice in Germany, Austria, and Switzerland: 2-year retention and efficacy by treatment line and serostatus",2023,https://doi.org/10.1007/s10067-023-06649-x,37314665,False
1496,Influence of chronic pain in osteoarthritis on the risk of cardiovascular diseases and modern methods of drug prevention,2023,https://doi.org/10.17116/jnevro202312305120,37315238,False
1497,Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response,2023,https://doi.org/10.1186/s12916-023-02868-w,37316832,False
1498,"Connecting the use of innovative treatments and glucocorticoids with the multidisciplinary evaluation through rule-based natural-language processing: a real-world study on patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis",2023,https://doi.org/10.3389/fmed.2023.1179240,37387783,False
1499,Fibromyalgia and mental health in rheumatoid arthritis: a cross-sectional prevalence study from the COVID-19 pandemic,2023,https://doi.org/10.1136/bmjopen-2022-069014,37321814,False
1500,YouTube® as a source of information for Spanish-speaking patients with rheumatoid arthritis,2023,https://doi.org/10.1016/j.reuma.2023.05.002,,False
1501,Factors influencing prescribing the first add-on disease-modifying antirheumatic drugs in patients initiating methotrexate for rheumatoid arthritis,2023,https://doi.org/10.1016/j.rcsop.2023.100296,,False
1502,Risk of all-cause and cause-specific mortality associated with immune-mediated inflammatory diseases in Korea,2023,https://doi.org/10.3389/fmed.2023.1185300,,False
1503,Clinical scenarios-based guide for tofacitinib in rheumatoid arthritis,2023,https://doi.org/10.1177/20406223231178273,37360417,False
1504,What is new in the treatment of interstitial lung diseases,2023,https://doi.org/10.18332/pne/161867,,False
1505,The Emerging Safety Profile of JAK Inhibitors in Rheumatic Diseases,2023,https://doi.org/10.1007/s40259-023-00612-7,37351790,False
1506,"The Mediterranean diet, and not dietary inflammatory index, is associated with rheumatoid arthritis disease activity, the impact of disease and functional disability",2023,https://doi.org/10.1007/s00394-023-03196-8,37355497,False
1507,Comparative Effectiveness of Adalimumab vs Tofacitinib in Patients With Rheumatoid Arthritis in Australia,2023,https://doi.org/10.1001/jamanetworkopen.2023.20851,37382956,True
1508,"Serum <scp>CDC42</scp> is increased during tumor necrosis factor inhibitor treatment, and its elevation correlates with satisfactory treatment response in rheumatoid arthritis patients",2023,https://doi.org/10.1111/1756-185x.14778,37382403,False
1509,Management of patients with rheumatoid arthritis in real clinical practice: Switching from interleukin 6 receptor inhibitors to interleukin 6 inhibitor (olokizumab),2023,https://doi.org/10.47360/1995-4484-2023-307-319,,False
1510,Estimating Patient-Specific Relative Benefit of Adding Biologics to Conventional Rheumatoid Arthritis Treatment,2023,https://doi.org/10.1001/jamanetworkopen.2023.21398,37389866,False
1511,"Rhodiola rosea L. Extract, a Known Adaptogen, Evaluated in Experimental Arthritis",2023,https://doi.org/10.3390/molecules28135053,,False
1512,Pharmatherapeutic Treatment of Osteoarthrosis—Does the Pill against Already Exist? A Narrative Review,2023,https://doi.org/10.3390/jpm13071087,,False
1513,Physical function and severe side effects matter most to patients with RA (&lt; 5 years): a discrete choice experiment assessing preferences for personalized RA treatment,2023,https://doi.org/10.1186/s41927-023-00341-y,,False
